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3In the course of this study, our views on Möbius syndrome have changed 
considerably. In this introduction we will try to justify the evolvement of ideas 
and concepts.  As the various chapters have been written at different moments 
in time, we will comment with our present hindsight in the last chapter and 
summary. 
We embarked on this study of Möbius syndrome assuming that the autosomal 
dominant families with facial palsy would reﬂect the mild (dominantly inherited) 
end of the spectrum, and that in its severe form, this disorder would manifest 
itself in sporadic events.  A few individuals of two Dutch families with dominant 
inheritance were known to us. Our assumption implied that we had to ﬁnd the 
locus and subsequently the gene for the disorder in these two families (whom we 
initially thought were part of one large pedigree) and test this gene in sporadic 
Möbius patients. The identiﬁcation of the gene as well as subsequent functional 
studies would hopefully contribute to our understanding of the signaling cascade 
required for normal facial lower motoneuron unit development. The resulting 
gained insight into the unique developmental and physiological features of other 
cranial nuclei might help us to understand their selective involvement in various 
neurological disorders. However, the autosomal dominant families, who had what 
we now call hereditary congenital facial palsy, turned out not to be genealogically 
linked. In the end, the genetic loci in these families were different (Chapter 3) 
and the identiﬁcation of the genes not so simple. Clinical examination of entire 
families revealed subtle differences in the phenotypes.  A transition to the clinical 
picture of the sporadic cases with a more extended phenotype was, however, 
never found, leading to the suggestion that hereditary congenital facial palsy 
and Möbius syndrome are two different entities.  Also, homozygosity mapping 
in the sporadic cases excluded the loci for hereditary congenital facial palsy in 
these patients; therefore, it seemed unlikely that these loci are a major cause 
in Möbius syndrome. Detailed clinical examination characterized the sporadic 
syndrome as congenital facial weakness with impairment of ocular abduction 
and possible involvement of other cranial nerves, craniofacial dysmorphisms, 
limb malformations and long tract involvement. It is deﬁned as a developmental 
disorder of the entire lower brainstem (rhombencephalon) for which we reserve 
the name Möbius syndrome (Chapter 4). Neuro-imaging, neuropathology and 
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neurophysiological studies (Chapters 6, 7, 8 and 9) supported this view, and so 
hereditary congenital facial palsy can be seen as a different entity from the 
brainstem developmental disorder called Möbius syndrome. 
These evolving insights into congenital lower brainstem syndromes paralleled 
those on the upper brainstem syndromes, and led to a conference to discuss 
the commonalities and distinctions between these disorders. Despite the lack 
of substantial numbers of neuropathological studies and detailed biological 
parameters, it was felt there was sufﬁcient basis to group the various syndromes 
under the heading “congenital cranial dysinnervation disorders” (CCDDs). The 
CCDDs are characterized by abnormal motility of the eyes, eyelids and/or facial 
muscles and currently include congenital ﬁbrosis of the extra-ocular muscles, 
Duane retraction syndrome, horizontal gaze palsy with or without progressive 
scoliosis, congenital ptosis, congenital facial palsy and Möbius syndrome.  At 
present, however, Möbius syndrome should not be categorized within the 
actual deﬁnition of the CCDDs since it became apparent during this study that 
Möbius syndrome is a developmental disorder of the entire rhombencephalon, 
which is more extensive than a cranial nuclear developmental disorder. It 
should be noted that the CCDDs reﬂect genetic entities in many instances. In 
general, these are rare disorders and the frequent occurrence of sporadic cases 
(phenocopies) implies that somatic mutations, low penetrance, or other as yet 
ill-deﬁned genetic mechanisms are at work. The observation of considerable 
overlap in clinical manifestations is suggested to be compatible with the known 
redundancy and overlap in the biology of axon guidance, cell migration and 
brainstem segmentation. There is, in fact, ample room for alternative explanations, 
such as environmental factors and toxins interfering with neuronal or vascular 
developmental pathways, proposed on more than one occasion. The variability of 
the genetic background in individual cases determines whether such factors lead 
to a recognizable and reproducible phenotype. 
The above summarizes our present point of view and with this vision in 
mind we will try to recapitulate the historical meandering of ideas about Möbius 
syndrome in the following paragraphs.
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Review
Clinical features
At the start of this study, the state of affairs regarding the knowledge on Möbius 
syndrome was best summarized in the paper by Kumar.1 It stated that Möbius 
syndrome could be characterized as a congenital disorder involving complete or 
partial facial nerve palsy, either unilaterally or bilaterally, with or without paralysis 
of other cranial nerves. Particularly, the abducens nerve is regularly affected and 
often also the hypoglossal nerve. Malformations of the limbs occur often and facial 
dysmorphisms are frequently found. Furthermore, structural abnormalities of the 
ear, defective branchial musculature and mental retardation might accompany the 
cranial nerve palsies.1 
This clinical deﬁnition was based on the following historical descriptions: 
Congenital bilateral facial and abducens palsy was originally described in one 
patient by von Graefe in 1880.2 This was soon followed by two other case 
reports, each on one patient with congenital nonprogressive complete paralysis of 
the sixth and seventh nerves.3-6 
In 1888, Paul Julius Möbius (Figure 1) reviewed a group of three patients with 
congenital nonprogressive bilateral facial and abducens palsy, of which one was 
portrayed by himself (Figure 2).7 Ever since, the eponym Möbius syndrome has 
been used for this clinical condition. 
In 1939, Henderson reviewed the literature at that time and summarized some 
sixty reported cases of congenital facial diplegia. He suggested that the diagnosis 
Möbius syndrome could be made on the basis of presence of facial diplegia, usually 
accompanied by palsies of other cranial nerves, particular the abducens nerve, and 
also malformations of the limbs.8  
Richards reviewed the published papers up to 1953 and, more restrictively, 
described the essential features of the Möbius syndrome as complete or partial 
facial weakness, unilateral or bilateral loss of abduction of the eye and primary or 
secondary congenital malformations of the extremities, possibly with additional 
involvement of branchial musculature, such as absence of pectoral muscles and 
bulbar involvement.9 
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Van der Wiel studied a six generation pedigree with, in most cases, bilateral 
congenital facial palsy and no other neurological symptoms, and used the name 
monosymptomatic Möbius syndrome synonymously with facial diplegia.10 
Van Allen and Blodi retained only the ﬁrst two of Richards’ criteria as 
the essential features of the syndrome, though they mentioned that primary 
deformities of extremities are common.11
Thus, over a period of time, several authors disagreed on the nosological 
delineation of the syndrome and applied a variety of criteria when diagnosing 
Figure 1. Paul Julius Möbius (1853-1907), Leip-
zig neurologist, well known for an ocular sign in 
hyperthyroidism and description of ophthalmo-
plegic migraine (Möbius disease; 1884) and con-
genital facial paralysis (Möbius syndrome; 1888). 
He is less remembered for his monographs on 
physiologic weak-mindedness of women (1900) 
and pathology of men of genius (1880-1904).
Figure 2. The ﬁrst patient with bilateral facial 
and abducens palsy described by Paul Julius 
Möbius in 1888.
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Möbius syndrome, making the group of cases with this diagnosis highly 
heterogeneous. Both isolated congenital facial palsy and the extended phenotype 
of congenital facial palsy with abducens palsy, with or without craniofacial 
dysmorphisms and congenital abnormalities of the extremities, were criteria for 
the diagnosis of Möbius syndrome. 
Recently, we redeﬁned congenital facial palsy with impairment of ocular 
abduction as the primary criterion of Möbius syndrome (Figure 3).12 Whereas 
dysfunction of other cranial nerves, orofacial malformations, limb malformations 
and musculoskeletal system defects are commonly associated features, we 
considered them unnecessary for the diagnosis. By restricting the deﬁnition, we 
excluded congenital facial palsy and ascertained on clinical grounds that congenital 
facial palsy is a separate entity (Chapter 4).
Until now, there is ambiguity about the incidence of mental retardation. Most 
studies on Möbius syndrome provide only estimates of occurrence of mental 
Figure 3. Picture-gallery of Möbius patients. The primary criterion is facial weakness with impair-
ment of ocular abduction. (A, F) closing eyes, (B, G) showing teeth, (C, E) relaxing at young ages, 
(D) looking to the left, (H) raising eyebrows.
A B C D
E F G H
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retardation varying from 10 to 50%.8,13-16 Since intellectual performance was not
assessed formally in all reported cases, the question arose: did the clinical picture 
of the syndrome, i.e. the characteristic mask-like face with strabismus, drooling 
and speech difﬁculties, contribute to the assumption that the prevalence of 
mental retardation in patients with Möbius syndrome is high.1,8 There are three 
studies explicitly dealing with mental deﬁcits in relation to Möbius syndrome.17-19 
According to these studies, the incidence of mental retardation varies from 33 to 
75%. However, the selection of patients and the methods of measurement shed 
some doubt on the validity of the ﬁndings reported.  
In a previous clinical study, we were not able to conﬁrm the impression of a 
high rate of mental retardation.12 We, therefore, established the actual incidence of 
mental retardation in a group of Möbius patients using a number of standardized 
neuropsychological tests (Chapter 5).    
Critical review of the literature reveals that attention was mainly paid to the facial 
characteristics in the sporadic Möbius patient.  As a consequence, all associated 
morphological abnormalities and their possible explanation were neglected. 
It is, therefore, not clear how often there is overlap with other brainstem 
maldevelopemental syndromes. Defects in the embryonal development of the 
rhombencephalon can lead to a wide variety of clinical phenotypes which can 
be summarized as a group of neuromuscular diseases resulting from congenital, 
nonprogressive, sporadic or familial abnormalities of cranial musculature. These 
are caused by developmental abnormalities of, or the complete absence of, one 
or more cranial nerves which lead to primary or secondary dysinnervation of 
the ocular and facial motor muscles.20 In primary dysinnervation, normal muscle 
innervation is absent because alpha motoneurons of the appropriate cranial 
nerves either do not develop or are misguided during development. Secondary 
dysinnervation may occur when a muscle lacking normal innervation becomes 
aberrantly innervated during development by branches of other nerves. Recently, 
these disorders have been classiﬁed as CCDDs.20 A subclassiﬁcation within 
the CCDDs can be made based on the probable underlying defects (Table 1). 
Disorders involving predominantly vertical ocular motility defects are most 
likely to result from abnormalities in development of oculomotor and trochlear 
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nerves and/or nuclei (congenital ﬁbrosis of the extraocular muscles variants and 
congenital ptosis). Disorders involving predominantly horizontal ocular motility 
defects are probably due to maldevelopment of the abducens nerve and/or 
nucleus (Duane retraction syndrome and horizontal gaze palsy with or without 
progressive scoliosis). Disorders predominantly involving facial weakness are likely 
to result from abnormal development of facial nerve and/or nucleus, sometimes 
with associated ocular motor abnormalities (congenital facial weakness and 
Möbius syndrome). Thus far, ﬁfteen CCDD genetic loci and ﬁve CCDD disease 
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genes have been identiﬁed (Table 1). The latest attempt to structure the nosology 
of these congenital cranial nerve syndromes starts from a genetic point of view, 
which allows phenocopies to be explained on a genetic basis (i.e. new mutations), 
as environmental hazards (i.e. toxins interacting with molecular cascades or 
networks of developmental pathways), or a combination of the two, all causing 
large variations in outcome due to biological overlap and redundancy of systems.
Aetiology, pathogenesis and pathology
The aetiology and pathogenesis of Möbius syndrome have been debated since its 
original description in 1888 and are as yet unresolved. Further neuropathological 
and genetic studies are required. Obviously, Möbius syndrome is unlikely to 
be a single entity; based on clinical, neuropathological and genetic studies 
rather different aetiological factors have been suggested to cause a phenotype 
recognizable as Möbius syndrome.  
When our study started in 1997, two pathogenetic explanations were 
recommended for Möbius syndrome: a developmental rhombomeric defect 
including the facial cranial nerve nuclei resulting in developmental errors in 
innervation of the facial muscles due to a genetic cause,21,22 and an interruption 
in the vascular supply of the brainstem resulting in ischaemia in the region of the 
facial cranial nerve nuclei due to an environmental, mechanical or genetic cause.23-
25  Teratogenicity has been suggested to be an important environmental, possibly 
secondary factor in both explanations.26,27 
These postulated pathogenetic mechanisms in Möbius syndrome were based 
on limited pathological observations. The four different classes of pathology 
observed at autopsy in patients, in which congenital facial weakness is the prime 
feature, have been categorized most clearly in the paper of Towﬁghi (Table 2).28 
Group I is characterized by hypoplasia of cranial nerve nuclei and resembles the 
autosomal dominant families with hereditary congenital facial palsy; Group II 
demonstrates neuronal loss and evidence of active neuronal degeneration and can 
be seen in cases with a primary physical defect of the periphery of the facial nerve 
due to, for example, obstetric forceps extraction; Group III includes cases with 
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a decrease in the number of neurons and additional degeneration, focal necrosis 
with gliosis and calciﬁcations in the region of the tegmentum of the lower pons 
and medulla, conﬁned to the paramedian region where brainstem nuclei are 
located in the same way as can be seen in sporadic Möbius patients; and Group 
IV consists of cases with primary myopathic changes without lesions in the cranial 
nerve nuclei or cranial nerves, probably best encompassing facioscapulohumeral 
dystrophy or congenital myopathy.
These pathological observations are based on the following historical reports: 
Möbius regarded congenital cranial nerve palsies and those acquired in infancy 
and early childhood as being fundamentally the same. He thought that sixth and 
seventh cranial nerve palsies probably could not occur independently on account 
of the close relationship between their nuclei. In his original description of the 
condition in 1888, Möbius postulated that, in the absence of pathological evidence, 
the anomaly resulted from degeneration of the nuclei of the sixth and seventh 
cranial nerves.7,29 Probably, cases with birth trauma were included in Möbius’ 
group; moreover genetic concepts in medicine were absent at that time. The 
views of Möbius were generally accepted, although several authors were nearer 
the mark than he. 
In 1882, Chisholm thought the lesion was a local aplasia of the grey matter in 
the medulla.4 Kunn’s admirable review of the subject of congenital ocular palsy, in 
which he differentiated between congenital and acquired types and considered 
the former to be due to an aplasia of the corresponding nuclear cells, led to a 
change of opinion in favour of the aplastic concept.30 
This aplastic hypothesis appeared to be conﬁrmed by the pathological 
evidence of Heubner’s typical case consisting of congenital facial diplegia, bilateral 
abducens palsy and left lingual hemiparesis in 1900.31 He observed a diminished 
number of ganglion cells in the 3rd, 6th, 7th, 11th and 12th cranial nerve nuclei with 
corresponding small nerves and, additionally, hypoplastic medial longitudinal 
bundles, reticular formation, olives and pyramidal bundles. Heubner suggested 
cranial nuclear aplasia to be the chief underlying cause of Möbius syndrome, a 
view which is supported by others.32 
The case presented by Rainy and Fowler (1903) with almost complete facial 
diplegia confused the issue.33 In this case, a large number of cells in the nuclei 
15
Introduction
of the seventh pair had disappeared, whilst those which remained presented 
a distinctly atrophied aspect. Both facial nerves showed marked degeneration 
and there was gross atrophy of the facial muscles. Rainy and Fowler felt that the 
presence of nerve trunks in their case, even though degenerated, was positive 
proof of earlier existence of nuclei from which they arose, and, therefore, 
aplasia of nerves and cells could forceps trauma of both facial nerves,8,34 and 
we tend to agree because of absence of involvement of other cranial nerves or 
malformations. 
A similar mechanism was probably also the issue in the report by Neurath 
(1907) of an autopsy on a child who showed seventh nerve involvement.35 The 
nucleus of the seventh nerve was normal, as were the facial nerves. The congenital 
unilateral facial palsy in this case was probably due to intra-uterine pressure on 
the developing facial nerve.
Lennon (1910) interjected an entirely new pathological concept.36  While 
Möbius and Heubner considered the lesion to be a defect in the formation of the 
ectoderm resulting in failure of nuclear and later nerve tissue formation, Lennon 
suggested that the pathology might consist primarily of a defect in the mesoderm, 
with a failure of development of the muscles, and secondary underdevelopment of 
the nerves and nerve nuclei. The frequent association of musculo-skeletal defects, 
such as absent muscles, club feet, syndactyly and other presumably mesodermal 
abnormalities, is the mainstay of Lennon’s argument.37 
The aplastic, genetic theory continued to prevail despite further evidence. It 
was not until the report of Spatz and Ullrich’s sporadic case (1931) with complete 
facial diplegia, ophthalmoplegia externa and syndactyly that confirmation of 
Heubner’s findings was realized.38 Absence of neurons or reduction in the number 
of neurons in the 3rd, 4th, 6th and 7th cranial nerve nuclei, together with dysplasia 
of the intraparenchymal portions of the associated nerves and hypoplasia of the 
pons and medulla oblongata were observed. The similarity of the pathology in the 
cases of Heubner and Spatz and Ullrich strongly supports the view that aplasia 
or hypoplasia of the relevant nuclei and the nerves accounts for the cranial nerve 
palsies in all typical cases of the syndrome. 
Pitner et al. (1965) were the ﬁrst to describe a case in which the brain, facial 
nerves and all other cranial muscles involved had been examined.39 The presence 
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of morphologically normal facial nerves and the almost total absence of facial 
muscles suggests that a primary failure of formation of the facial musculature 
produces the Möbius syndrome. The changes in the brainstem, mainly consisting of 
hypoplasia, are believed to be secondary to the hemihypoplasia of the cerebellum 
and unrelated to the muscular defect. Finally, there was suggestive evidence of the 
formation of muscle fascicles, which would imply that innervation was present, 
as ﬁnal differentiation of muscle is not believed to occur in its absence.  Although 
Pitner et al. believed that the Möbius syndrome in their case is probably due to 
a primary dysplasia of the facial muscles, they thought it was more likely that in 
other instances it is due to a primary neuronal dysplasia.39 
Hannissian et al. (1970) reported clinical and pathological ﬁndings of Möbius 
syndrome in identical twins.40 The pons and medulla were hypoplastic and the 
cranial nerves were hypoplastic or absent with normal anatomy of the cranial 
nerve nuclei in both cases. The pectoral, the sternocleidomastoid, the tongue and 
facial muscles displayed dysplastic changes similar to those described by Pitner. 
This is the ﬁrst report suggesting a genetic cause for the disorder.
Thakkar et al. (1977) described two cases of clinically recognized Möbius 
syndrome with associated facial and skeletal malformations.41 These two are 
the ﬁrst cases in which old tegmental foci of necrosis and mineral deposits in 
multiple cranial nerve nuclei were reported, resembling the later classiﬁed Group 
III of Towﬁghi. They suggested that intrauterine injury with brainstem tegmental 
necrotic lesions represents the pathological basis for some cases of Möbius 
syndrome.  
Towfighi et al. (1979) presented neuropathological findings in the brain, 
spinal cord and eyes with extra ocular muscles attached to it, of an infant with 
congenital right facial and bilateral lateral rectus palsy.28 All extra ocular muscles 
were present and appear to be normal. Neither the seventh cranial nerve root 
nor either the sixth cranial nerve root could be identified. Multiple microscopic 
foci of necrosis were found in the lower pontine tegmentum, involving the region 
of the intramedullary course of the sixth and seventh cranial nerves. Towfighi et 
al. discussed four classes of pathology found at autopsy in patients classified in the 
literature as having Möbius syndrome on the basis of clinical findings; Towfighi’s 
patient falls into Group III (Table 2).
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Bavinck et al. (1986) proposed necrosis of cranial nuclei six and seven 
secondary to ischaemia as the pathogenetic basis of the Möbius complex.23 
The ischaemia would in turn be the result of an insufficient blood supply in the 
pontine branches during embryogenesis. One of the mechanisms leading to an 
insufficient blood supply in this region might be premature regression of the 
primitive trigeminal arteries and/or delayed formation of, or obstruction of, the 
basilar and/or vertebral arteries. In subclavian artery disruption, a postulated 
cause for Möbius syndrome, vascular compromise at specific locations around the 
sixth week of embryological development could result in predictable patterns of 
upper limb abnormalities involving hypoplasia of distal limb structures with more 
or less normal proximal structures, i.e. terminal transverse limb defects.23
Marques-Dias (2003) sustained this vascular hypothesis based upon three 
patients with Möbius syndrome related to misoprostol. These cases showed old 
ischaemic-anoxic foci with gliosis, necrosis and calciﬁcations from the rostral 
mesencephalon to the caudal aspect of the medulla involving certain cranial 
nerve nuclei (especially the IVth , VIIst and XIIth) that were partially or completely 
depopulated of neural cells.42 
On the basis of neuropathological ﬁndings in two patients with the Möbius 
sequence and Pierre-Robin complex, Verloes et al. (2004) concluded that in this 
clinical variant of Möbius syndrome, there was extensive brain stem involvement.43
Throughout the literature on Möbius syndrome, in which congenital facial 
weakness is the prime feature, there has been considerable speculation and 
controversy about whether the disorder is primarily degenerative or dysplastic, 
and whether the location of the primary lesion is the nucleus, the nerve or the 
muscle. Möbius suggested, in the absence of pathological evidence, a degenerative 
explanation toxic cause;7,29 however, most reports in literature favour the 
dysplastic theory.31 The static clinical course of the disorder is in itself indirect 
evidence against a degenerative process, as degeneration would be expected to 
continue into postnatal life.
Critical review of the literature reveals that most probably there was more 
awareness of the facial nucleus and nerve, and for this reason, less attention was 
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paid to the brainstem and other cerebral structures. Based upon the extent 
of structures involved, for example the cranial nerve nuclei, the entire lower 
brainstem, or the cerebellum, we provided neuropathological evidence that 
hereditary congenital facial palsy and Möbius syndrome are two different entities 
with a different pathogenesis (Chapter 6).
 
Genetics
Disorders with facial motility disturbances include disorders with congenital 
nontraumatic facial weakness in isolation or in association with ocular motility 
defects i.e., Möbius syndrome.
Isolated congenital facial weakness is usually reported as an autosomal 
dominant disorder that we refer to as ‘facial palsy’ or FNP; less frequently an 
autosomal recessive trait is reported (Table 3). Congenital facial weakness is 
suggested to result from maldevelopment of the facial nucleus and/or nerve. 
In the past we suggested congenital facial palsy to be a phenotypical subclass 
of Möbius syndrome,44,45 but recently we showed, on the basis of clinical and 
pathological differences, that these syndromes should be seen as two separate 
entities. In the course of the genetic studies in our department, we located two 
distinct loci for autosomal dominant inherited congenital facial palsy in two large 
Dutch families, thus showing genetic heterogeneity for this disorder (Table 1); the 
two FNP loci seem unlikely to be major causative factors in Möbius syndrome.
Patients from the ﬁrst pedigree showed a mostly bilateral, often asymmetric, 
nonprogressive congenital facial nerve palsy. Musculoskeletal abnormalities were 
absent.  A locus for FNP in this pedigree, with a penetrance of 95%, was initially 
deﬁned at chromosome 3q21-q25, spanning about 10 cM (FNP1; retired MBS2, 
MIM601471).44 Linkage analysis in additional family members reduced the critical 
interval to 3q21-q22, a region of 4.9 cM between the markers D3S1589 and ACPP.46 
A second FNP pedigree, is characterized by uni- or bilateral, often asymmetric, 
nonprogressive facial weakness, with variation in weakness of muscles of the three 
branches of the facial nerve (Figure 4). In some patients, additional hearing loss 
and rarely congenital deafness was present, without musculoskeletal abnormalities. 
19
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In this family, we localized a second locus for FNP on chromosome 10q21.3-22.1 
(FNP2; retired MBS3, MIM 604185) (Chapter 3).45 The critical region spans 3.7 cM 
between the markers D10S581 and D10S502. In this pedigree the penetrance was 
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signiﬁcantly lower than for FNP1, at only 60%. 
Besides these two pedigrees, OMIM lists several other familial cases of 
hereditary congenital facial palsy (MIM134100, 134200), but linkage analysis has 
not been performed or reported in these families.47-52  To expand the knowledge 
on the genetic defects involved in congenital facial palsy, it would be very helpful 
to analyse these and additional families to reﬁne existing loci, or identify new 
ones.
Recently, the involvement of chromosome 22q11 in congenital facial nerve 
palsy has been suggested.53 Deletions of this chromosome band were identiﬁed 
in three unrelated patients with unilateral facial palsy described as part of a wider 
syndrome, including congenital heart defects in all three cases and malformations 
of the cerebrum and cerebellum and involvement of other cranial nerves in 
separate instances.  At least one of these cases would probably better ﬁt the 
diagnosis Möbius syndrome, since involvement of eye abduction was also present.
In facial palsy, only facial motor neurons are involved, suggesting a primary 
disorder of the fourth rhombomere since facial motoneurons arise in this 
rhombomere.54 Each rhombomere is characterized by a unique combination of 
Hox genes.55-57 The Hoxb1 gene is expressed only in the fourth rhombomere. 
Mice with targeted disruption of Hoxb1 fail to form the facial motor nuclei, 
the abducens nuclei are formed normally.58 In other mouse models, such as the 
Kreisler mouse59 and Krox20-/- mice60, rhombomeres 5 and 6 and rhombomeres 
3 and 5 and their derivatives are absent, respectively, resulting in more extensive 
Figure 4. Affected members of the FNP2 family.  The facial palsy is uni- or bileteral and the weak-
ness of the muscles of the three branches of the facial nerve varies among the individuals.
A B C D
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patterns of absence of brainstem motor neurons. In Kreisler, the abducens nucleus 
and visceromotor, parasympathetic motor neurons of the facial nerve, both 
formed in the ﬁfth rhombomere, are absent but facial motor neurons are present. 
In Krox20-/- mutants, the abducens nucleus and the facial visceromotor neurons 
are absent, whereas the branchiomotor facial nucleus is hypoplastic. In the 
linkage intervals for FNP on chromosome 3 (MIM601471) and 10 (MIM604185), 
we investigated two human orthologs of genes that show involvement in Hox 
signalling; GATA2 at chromosome 3q21 and EGR2 at chromosome 10q21.3. 
GATA2 expression is restricted to rhombomere four during murine embryology 
and its expression is directly regulated by Hoxb1.61 Failure to express GATA2 
during murine development abolishes the downstream expression of GATA3 
and results in a phenotype similar to the Hoxb1 knock-out mouse.58 EGR2 is 
the human ortholog for murine Krox20, a gene regulating the expression of 
several Hox genes involved in hindbrain development, including Hoxa2, Hoxb2 
and Hoxb3.62-64 EGR2 was, therefore, considered to be an excellent candidate 
gene for FNP, even though it was positioned just outside the linkage interval. 
However, sequence analysis of the GATA2 and EGR2 genes in members from the 
corresponding families did not yield causative mutations,46 and  so these genes are 
not causally involved in facial palsy.
Möbius syndrome, i.e. congenital facial weakness plus abducens weakness 
or the extended phenotype with additional dysfunction of other cranial nerves, 
limb malformations, orofacial malformations and musculoskeletal defects such 
as Poland syndrome,65 which consists of unilateral absence or hypoplasia of 
the pectoralis muscle, most frequently involving the sternocostal portion of 
the pectoralis major muscle and a variable degree of ipsilateral hand and digit 
anomalies (MIM173800, MIM173750),12 is almost always described as a sporadic 
condition indicating a very low recurrence risk for siblings. In rare instances, 
however, autosomal dominant, autosomal recessive and even X-linked recessive 
modes of inheritance have been reported (Table 3), suggesting a genetic cause 
for Möbius syndrome. Several cytogenetic abnormalities have been reported 
in association with Möbius syndrome indicating genetic heterogeneity for this 
disorder (Table 1). No causative gene was identified in any locus, so far. 
One locus for Möbius syndrome was deﬁned cytogenetically at 13q12.2-13 
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(MBS1, MIM157900), by a three generation pedigree with seven affected members, 
who were phenotypically characterized by congenital facial palsy, mild ptosis, 
normal eye movements, congenital hearing loss and extremity malformations, and 
were carrying an apparently balanced translocation between chromosomes 1 and 
13 t(1;13)(p34;q13)66 and a report of an isolated Möbius patient with unilateral 
facial weakness, bilateral abduction weakness, tongue hypoplasia and micrognathia 
with a deletion of chromosome 13q12.2.67 
At chromosome 1p22 a locus for Möbius syndrome was deﬁned 
cytogenetically (MBS4, included in MIM157900) based on de novo translocations 
t(1;11)(p22;p13) in an isolated Möbius patient with Poland syndrome, cleft palate, 
dextrocardia, mandibular hypoplasia and hand deformities,68 and t(1;2)(p22;q21.1) 
in a sporadic patient with facial diplegia, ptosis, upward gaze palsy and normal 
horizontal eye movements, malformed ears and developmental delay.69  
In human embryos, facial and abducens motor neurons arise in the fourth 
rhombomere at about four weeks of development.54 The facial motor neurons 
migrate caudally for quite some time in the foetal period, passing the abducens 
nucleus. This caudal migration of the facial motor neurons may explain the 
combination of facial and abducens motor neuron loss seen in cases of the 
Möbius syndrome and related disorders.  Any focal destructive brainstem lesion, 
hypoxic-ischaemic, hemorrhagic, or due to a developmental defect in the ﬁfth 
week of development until well into the foetal period may result in such a 
combination. The extent of these putative destructive lesions may explain the 
involvement of other brainstem motor nuclei and passing long ﬁbre systems such 
as the pyramidal tract.
Recently, the RIG1/ROBO3 gene, which encodes an axon guidance protein 
that is required for midline crossing of neurons in the hindbrain, has been 
identiﬁed in patients with horizontal gaze palsy and progressive scoliosis with 
hindbrain dysplasia and hypoplastic pontine nuclei in whom ascending sensory 
and descending motor pathways failed to cross the midline (HGPPS).70,71 This 
gene may play a role in Möbius syndrome since in one of our Möbius patients 
the corticospinal tracts failed to decussate, the inferior olives were located too 
centrally and the brainstem was hypoplastic (Chapter 5).
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Since in the CCDD group, currently including congenital fibrosis of the extra-
ocular muscles (CFEOM), Duane retraction syndrome (DRS), horizontal 
gaze palsy with or without progressive scoliosis (HGPPS), congenital ptosis 
(CP), congenital facial palsy (FNP) and Möbius syndrome (MBS), considerable 
overlap in clinical manifestations is observed, the phenotypical characteristics, 
the neuropathological findings, if present, and genetics of all subclasses will be 
discussed briefly.
The first subclass of the CCDDs contains the CFEOM variants and congenital 
ptosis. CFEOM has three phenotypical variants, and to date four loci have 
been described (Table 1).  A primary dysinnervation of the oculomotor and/or 
trochlear innervated extraocular muscles is believed to be the cause of CFEOM. 
The genetic loci for the CFEOM phenotypes are referred to as FEOM. Currently, 
three CFEOM phenotypes and four FEOM loci have been defined. 
The most common CFEOM variant, ‘classic’ CFEOM1, characterized by 
autosomal dominantly inherited congenital bilateral restrictive ophthalmoplegia 
and ptosis with full penetrance, was mapped at chromosome 12p11.2-q12 
(FEOM1, MIM135700).72,73 The primary position of the eyes is infraducted with 
bilateral restriction of upgaze and variably restricted horizontal gaze. These 
patients commonly have positive forced ductions and misdirected eye movements 
such as synergistic convergence on attempted upgaze. They are rarely noted to 
have retraction of the globe. Occasionally mild facial weakness is present.  Autopsy 
study of one affected member of a large CFEOM1 pedigree revealed the absence 
of the superior division of both oculomotor nerves and the corresponding alpha 
motoneuron subnuclei in the midbrain, which innervate the levator palpebrae 
superioris and superior rectus muscles.74 These results also compliment studies of 
Duane syndrome, in which absence of the abducens nerve and its corresponding 
alpha motoneurons in the pons was noted.75,76 Mutations in the kinesin motor 
protein gene KIF21A were shown to cause CFEOM1.77 The KIF21A protein is 
known to homodimerize, and the majority of the mutations identiﬁed appear 
to interfere with this dimerization. In rare cases, CFEOM3 families map to the 
locus for FEOM1.78 For the congenital ﬁbrosis syndromes, including Duane 
syndrome and CFEOM, although historically believed to result from primary 
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extraocular muscle ﬁbrosis, both neuropathological and genetic studies suggest 
that at least a subset of these disorders results from distinct, but analogous, 
primary developmental defects of the motor nuclei in the brainstem, supporting a 
neurogenic hypothesis.
CFEOM type 2, which was described as a rare autosomal recessive form 
of CFEOM characterized by bilateral ptosis, ﬁxed exotropia and severely 
limited horizontal and vertical eye movements, was mapped at chromosome 
11q13.2 (FEOM2, MIM602078).79 Neuropathological examination of genetically 
manipulated mice with absence of the PHOX2A gene suggests that the human 
phenotype results from a primary developmental defect of both the oculomotor 
and trochlear nuclei.80 
CFEOM3 with a third locus at chromosome 16q24.4-q24.3 (FEOM3, 
MIM600638) is an autosomal dominantly inherited disorder with incomplete 
penetrance. Patients present a variable phenotype within one pedigree, with at 
least one member not meeting the criteria for CFEOM1.81,82 Examples would 
include unilateral disease, absent or unilateral ptosis, ortho- or hypertropia in 
primary gaze and/or close to normal elevation of the globe.  Affected individuals 
commonly have positive forced ductions but rarely show misdirected eye 
movements or retraction. In rare cases the CFEOM1 families map to the FEOM3 
locus.83  It is suggested that CFEOM3 results from a variable defect in the 
development of the oculomotor nucleus. It has been shown that mutations in the 
KIF21A gene can be causal in CFEOM3, though with reduced penetrance.84
Additionally, one CFEOM3 family has been reported with a chromosomal 
translocation co-inherited in an autosomal dominant pattern. This locus has been 
designated FEOM4, but no chromosomal position has yet been reported.20
Two loci for congenital ptosis have been reported, and it has been proposed 
that at least some forms of congenital ptosis may result from aberrant 
development of the unpaired caudal central oculomotor subnucleus.
Congenital ptosis with a locus at chromosome 1p32-p34.1 (PTOS1, 
MIM178300) is an autosomal dominantly inherited disorder with a penetrance of 
approximately 90%, consisting of unilateral or bilateral ptosis with varying degrees 
of severity.85
PTOS2 (MIM300245) at chromosome Xp24-27.1 is the locus for a disease 
25
Introduction
which is inherited in a X-linked pattern and characterized by congenital bilateral 
symmetrical and severe ptosis with characteristic chin-up head posture and 
pronounced overactivity of the frontal muscles.86
The second subclass in the CCDD family consists of disorders with primary 
dysinnervation of the abducens innervated lateral rectus muscle including Duane 
retraction syndrome (DURS) and horizontal gaze palsy (HGP) (Table 1). 
It is suggested that DURS results from aberrant innervation by the 
oculomotor nerve of the lateral rectus, the common clinical feature being co-
contraction of the lateral rectus and medial rectus on attempted adduction 
leading to retraction of the globe and narrowing of the palpebral ﬁssure. 
Congenital limitation of horizontal globe movement and some globe retraction on 
attempted adduction must be present to make the diagnosis. Ptosis is uncommon. 
Abducens motor neurons are most likely reduced in number or absent and 
function to a highly variable degree.87 The abducens interneurons, whose axons 
ascend in the contralateral medial longitudinal fasciculus and terminate on the 
medial rectus oculomotor subnucleus neurons, are most probably spared. The 
phenotype will vary due to the combination of innervational and mechanical 
abnormalities. Likewise, the phenotype may change through life due to ongoing 
mechanical changes. As at least three loci have been identiﬁed, Duane syndrome is 
genetically heterogeneous. 
The ﬁrst locus of Duane retraction syndrome (DURS1, MIM126800) is based 
upon a deletion at chromosome 8q13. Usually, DURS is bilateral and, depending 
on the size of the deletion, may be found in association with other features 
including mental retardation, branchio-oto-renal syndrome, genital tract anomalies 
and other somatic mutations.88-90 The gene disrupted by a balanced translocation 
in the DURS1 locus is CPAH , a carboxypeptidase gene, the most prominent 
candidate gene for involvement in DURS1.91
A second locus for DURS at chromosome 2q13 (DURS2, MIM604356) is 
inherited in an autosomal dominant pattern.92,93 DURS2 may be unilateral or 
bilateral, and additional features include a variety of vertical deviations such as 
apparent underaction of the superior oblique and dissociated vertical deviation, 
and often amblyopia.92,94 Patients have been noted to have decreased abduction 
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with or without decreased adduction. No associated somatic abnormalities have 
been found. 
Duane radial ray syndrome or Okihiro syndrome maps at chromosome 20q13 
(DRRS, MIM607323), and is an autosomal dominantly inherited disorder consisting 
of unilateral or bilateral Duane syndrome, including decreased or absence 
abduction with or without decreased adduction and radial dysplasia which can 
be unilateral or bilateral.95,96 The radial defect can range from thumb hypoplasia, 
hypoplasia of the thenar eminence to phocomelic limbs. Deafness and somatic 
malformations are often present. Truncating mutations have been identiﬁed in a 
gene encoding a putative zinc ﬁnger transcription SAll4.97-99 SALL4 is a member of 
the spalt-like family of proteins showing homology to the D. Melanogaster spalt 
(sal) an important developmental regulator.
A locus at chromosome 22pter-q11.2 has been inferred on the basis of 
three reports in isolated Duane patients showing association with the region or 
chromosomal aberrations.100-102 
A ﬁfth locus is inferred at chromosome 4q27-q13 based on a deletion in an 
isolated Duane patient,103 and Duane’s retraction syndrome in conjunction with 
Rieger syndrome.104  
It has been proposed that horizontal gaze palsy results from agenesis of the 
abducens nuclei including both alpha motoneurons and interneurons. One locus 
has been identiﬁed. Horizontal gaze palsy and progressive scoliosis, an autosomal 
recessive disorder characterized by congenital complete absence of conjugate 
horizontal gaze and childhood onset progressive scoliosis with motor pathways 
that failed to cross the midline, localizes at chromosome 11q23-q25 (HGPPS, 
MIM607313).105 Occasionally, nystagmus, esotropia and/or retraction of the globe 
on adduction are present.  Affected individuals have no associated ptosis or 
somatic abnormalities.  At least in some patients brainstem hypoplasia is present 
on magnetic resonance imaging.106 The gene ROBO3 has recently been cloned and 
is responsible for an axon guidance receptor molecule.70,107
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Ischaemic theory
The vascular hypothesis is still being adhered to but in its present form cannot 
explain all associated defects.
Bavinck et al. suggested a vascular hypothesis to explain the development 
of the syndrome.23 They hypothesized that an ischaemic process, resulting 
from an interruption in the vascular supply of the brainstem during early foetal 
development, probably around the fourth to sixth week of gestation, results in 
the facial and limb anomalies of the Möbius syndrome. They suggested that the 
development of the subclavian artery and its tributaries, including the basilar 
and/or vertebral arteries, is interrupted at or around the 6th intrauterine week 
compromising the vertebrobasilar ﬂow to the brain, neck, pectoral muscles and 
upper limb. They theorized that in Möbius syndrome the primitive trigeminal 
artery supplying the hindbrain during foetal life regresses or is obstructed before 
the establishment of an adequate perfusion from the vertebral arteries, and that 
another mechanism might be obstruction or delayed formation of the basilar and/
or vertebral arteries, thus impairing cranial nerve nuclear development. Possible 
causes for interruption or reduction of blood ﬂow include mechanical factors 
such as blood vessel oedema, thrombi, emboli, haemorrhage, early intrauterine 
compression, delayed or abnormal formation of blood vessels, disruption of 
newly formed vessels, or premature disappearance of transient vessels.11 Certain 
normal conﬁgurations of the embryological blood vessels at certain times during 
morphogenesis might, for instance, predispose the embryo to the development 
of vascular obstructions and the subclavian artery supply disruption sequence 
(SASD). The cause of these vascular interruptions may be environmental, 
mechanical or genetic but the ﬁnal result is ischaemia, oedema and hypoxia to the 
embryonic tissues or cranial nerve nuclei supplied by that vessel.23,108 
SASD is also presented as a hypothesis to explain the pathogenesis of the 
Poland anomaly.23,109 St. Charles et al.24 present a case with Möbius syndrome, 
Poland anomaly, terminal transverse limb defects and absence of the right 
diaphragm with discrete foci of brainstem calciﬁcations in the region of the dorsal 
respiratory group on both CT-scan and histological sections, with microscopic 
evidence of diffuse brainstem injury. 
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Although the subclavian artery supplies a fair part of the rostral embryo, 
it is doubtful that ischaemia of part of its supply-zones leads to speciﬁc and 
recognizable syndromes with involvement of a limited number of structures, 
tissues and germ layers such as in Poland or Klippel-Feil syndrome. Furthermore, 
this vascular hypothesis does not explain the frequent occurrence of lower 
extremity involvement or congenital abnormalities outside the subclavian arterial 
bed.
Sarnat argued that most cases with Möbius syndrome probably represent 
bilateral watershed infarcts in the foetal and neonatal brainstem tegmentum.110 
The most frequent condition that results in such anatomically restricted infarcts 
is systemic hypotension, but other conditions of reduced basilar perfusion may 
also be the cause. He suggested that the tegmental watershed infarcts occur at 
any time in the late first, second or third trimester, since foetuses are vulnerable 
to ischaemia in all trimesters. He further suggested that the extent and nature 
of the associated defects are variable and depend on the specific location of the 
vascular insufficiency and on the timing of the infarction. We interjected, however, 
that this vascular hypothesis, does not explain the frequent occurrence of limb 
malformations (86% in our series).  
Uterine contractions, induced by abortifacient drugs such as ergotamine and 
misoprostol in the ﬁrst trimester of gestation resulting in placental ischaemia 
due to vasoconstriction, may account for some cases of Möbius syndrome.111,112 
In Möbius patients, neuropathological ﬁndings related to misoprostol include 
old ischaemic-anoxic foci with gliosis, necrosis and calciﬁcations in the pons, 
suggesting a circulatory mechanism.42 These cases obviously do not prove the 
teratogenecity of drugs but provide additional evidence of its potential hazard 
to the foetes and suggest that the Möbius sequence may represent an ischaemic 
defect.
Environmental factors and teratogens
The cranial nuclei which are affected in Möbius syndrome undergo their most 
rapid period of development at about the fourth and ﬁfth week of intra-uterine 
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life, i.e. at the 10 mm stage. It seems likely, therefore, that Möbius syndrome may 
be caused by the action of a noxious agent at this period when the mother is 
barely aware that she is pregnant. Hence, any event that interferes with foetal 
circulation, whether pharmacological effects of drugs26,27,42,111-121 or alcohol,26 
hyperthermia,26,122,123 generalized hypoxia,124 trauma,118,125,126 rupture of placenta 
membranes releasing the vasoconstrictor angiotension II into the foetal or 
maternal circulation,26 or other as yet undeﬁned events, has been reported as a 
possible aetiological factor in Möbius syndrome. The reports do not, however, 
explain the probably frequent instances when Möbius syndrome does not develop. 
In our study, we could not substantiate the claims that teratogens are a possible 
cause of the syndrome; there were no common obstetric events compatible 
with a causative mechanism (Chapter 4).12 Needless to say, a good history of all 
possibly relevant events in pregnancy is important.
Further investigations
Möbius syndrome is a diagnosis which depends largely upon clinical neurological 
examination. Diagnosis is usually reached in the ﬁrst weeks or months of life. 
Diagnostic evaluation, i.e. radiological and electrophysiological studies, brings no 
diagnosis; in some cases, however, it might support the diagnosis. Imaging studies 
are not diagnostic since most of the neuroanatomical structures involved are 
beneath the resolution of present image techniques. However, imaging is useful for 
excluding other congenital malformations and neoplasms of the fossa posterior. 
Electrophysiological studies may, at times, provide support for tegmental lesions. 
Evoked potentials are most useful, because the pathways ascend through the 
tegmentum and may be affected. Finally, post-mortem examination conﬁrms the 
diagnosis.
Radiology
To date, most studies on radiological ﬁndings in Möbius syndrome are case 
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reports in which compu-tomography (CT) or magnetic resonance imaging (MRI) 
studies of the brain were reported as part of routine diagnostic work-up. 
In approximately 63 cases with Möbius syndrome, 53 CT and 36 MR scans, 
aimed at identifying structural abnormalities of the brain have been reported in 
the literature. Imaging of the cranial nerves in Möbius syndrome has not been 
reported.
Twenty-eight CT 117,127-145 and 15 MRI131-134,138,140,141,143,144,146-148 studies 
were reported to be unremarkable. Hypoplasia of the brainstem has been 
demonstrated in ﬁve CT117,129,149-151 and in 13 MRI135,141,143,149,150,152-156 studies, in 
which no quantitative measurements of the brainstem were presented. Sixteen 
CT studies24,130,135,143,145,147,149-151,157 and one MRI study149 demonstrated calciﬁcations 
in the brainstem tegmentum adjacent to the ﬂoor of the fourth ventricle, with 
undeﬁned clinical consequences in all of them.  A hypoplastic cerebellum was seen 
in four CT129,149,152,158 and seven MRI148,149,152,153,155,157,159 studies, out of which two 
cases demonstrated hypoplasia of the vermis158,159 and one case demonstrated 
poorly deﬁned vermian ﬁssures.153 In 12 of 57 cases, other brain malformations 
such as bilateral ventricle enlargement in seven cases, unilateral ventricle 
enlargement in two cases, hypoplasia of the corpus callosum in six cases, Dandy-
Walker variant in ﬁve cases and hydrocephalus with aqueductal stenosis and a 
posterior fossal cyste in one case have been described. 
 Review of this literature was the incentive for our radiological study  
(Chapter 7).
Electrophysiology
The literature contains only one electrophysiological study on the facial 
muscles and nerves in a series of seven Möbius patients.143 Jaradeh suggested a 
brainstem process predominantly affecting the facial nuclei and their internuclear 
connections.143 Other studies on electrophysiological ﬁndings in Möbius syndrome 
mainly deal with case reports without discussing the signiﬁcance of these ﬁndings. 
In the literature, blink reﬂex studies have been carried out in 12 patients with 
Möbius syndrome. Blink reﬂexes were absent in ﬁve cases130,140,143,144,160 and 
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long latencies were found in seven.138,143 Nerve conduction studies have been 
performed in 22 cases, 11 of whom revealed no response 9,11,15,130,143,161-164 while 
seven did show a response to the orbicularis oris muscle.9,15,161-164 The latency to 
the orbicularis oculi muscles was prolonged143,165-167 and normal138,143,166 in six cases 
despite facial palsy, and a reduced amplitude of the fCMAP was demonstrated in 
nine cases.138,143,166 Needle electromyography (EMG) studies of the facial muscles 
have been performed in some 19 cases revealing absent action potentials during 
planned activity in 10 cases.116,117,130,140,143,156,167-169 Impaired recruitment was seen in 
four cases11,140,166,170 and a single motor unit pattern in one.165 Though not always 
mentioned, MUAPs were found to be normal in three cases,143 high voltaged 
in one case,165 and polyphasic, low voltaged and disperse in four cases.143 EMG 
revealed spontaneous activity in the form of ﬁbrillations in ﬁve cases.11,15,143 From 
all these reports one can draw the overall conclusion that the electrophysiological 
study performed in the individual patient is too incomplete for any deductions to 
be made about the site of the primary lesion.  After reviewing the literature, we 
conducted a neuroelectrophysiological study of the facial muscles and nerves in 
Möbius syndrome (Chapter 8).
Several case reports on auditory brainstem evoked potentials (BAEPs) have 
been published, leading to the same conclusion22,111,117,130,132-136,138,140,143,144,148,150,1
52,154,160,171,172: a pontine anomaly at a supranuclear site is part of the syndrome. 
At that time, these findings reflected a different view on the pathophysiology of 
Möbius syndrome, which has not received adequate attention in the literature. It 
is amazing that, based on these studies, the conclusion was not reached earlier 
that Möbius syndrome is more than a cranial nerve nuclear developmental 
disorder and should be viewed as a more regional developmental disorder of the 
brainstem. Just three cases demonstrated normal BAEP studies.111,132,134
Until now, only a few electrophysiological reports studying the long motor and 
sensory tracts in Möbius syndrome have been published which provide support 
for widespread involvement of the brainstem. One motor evoked potential 
(MEP) study has been performed which showed an increased central conduction 
time, suggesting a pontine lesion.144 Of seven somatosensory evoked potential 
(SSEP) studies, five showed abnormalities at brainstem level suggesting pontine 
pathology117,133,144 and two were normal.130,138 We performed evoked potentials 
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in our Möbius patients to provide further evidence for our concept that the 
Möbius syndrome is a complex regional developmental disorder of the brainstem, 
including the long tracts (Chapter 9).
Twenty-three EMG studies on extremities of patients with Möbius syndrome 
have been reported. In 17, there was no evidence of peripheral neuropathy or  
myopathy;117,130,138,138,140,143,150,157,164,173,173 the EMG findings were indicative of 
peripheral neuropathy in five cases, with a hypogonadotrophic hypogonadism 
in four of them,132,142,169 and Kallman syndrome in one;162 in one case, 
facioscapulohumeral dystrophy appeared to be present rather than Möbius 
syndrome.161 We interpret this rather wide range of observations as reflecting, at 
a neurophysiological level, the spectrum of clinical features in addition to the core 
definition of facial muscle and ocular abduction weakness.
Hidden in all these reports and not properly summarized, lies the conclusion 
that Möbius syndrome is more than a cranial nerve nuclear developmental 
disorder and  should be regarded as a more regional maldevelopment of the 
brainstem.
Epidemiology
Möbius syndrome is a rare disorder for which there are no prevalence ﬁgures and 
for which the exact population incidence has not be determined. In the literature, 
males and females are equally affected. Based on our clinical study, we estimated a 
prevalence of 0.002% of births (four per 189,000 newborn) and found no regional 
clustering of Möbius cases in The Netherlands.
Therapy
The life prognosis of a Möbius patient is the same as that of a healthy person, 
unless a severe primary respiratory dysfunction that results in lack of respiratory 
drive, is part of the syndrome and present at birth, and unless severe swallowing 
problems are present.
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There is no treatment for patients with Möbius syndrome other than 
symptomatic therapy; no curative therapy exists. Many therapeutic measures 
need to be considered in patients with Möbius syndrome. Respiratory support 
is required in case of respiratory dysfunction. Poor sucking and swallowing can 
be aided by using a suitable comforter and by the development of compensation 
mechanisms. Delay in language and speech development and poor articulation 
requires early logopedic attention. Hypotonia, delay in motor development, lack 
of fine motor skills and poor coordination and balance performance require 
physiotherapy. Eye surgery should be considered in cases with abnormal eye 
position. Orthopaedic measures might be needed in case of clubfoot or other 
leg abnormalities, and plastic surgery in case of hand and facial deformities.  And, 
genetic counselling should be offered. 
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This thesis addresses various aspects of Möbius syndrome. Our ideas 
about Möbius syndrome have evolved over time, a process reﬂected in this 
thesis which consists of a series of papers published over the period of 
the study. This chapter has been written with the insight and hindsight of 
the present day. I shall, therefore, try to reconstruct how we looked at the 
questions dealt with in each chapter at the time we studied that speciﬁc 
aspect of Möbius syndrome and shall summarize what our current view is 
on the subject.
Our present opinion is that the term Möbius syndrome has been used 
ambiguously in the past. It encompasses two conditions: ﬁrstly an autosomal 
condition which can best be described as congenital facial palsy, and another 
condition that occurs mainly in a sporadic way, for which we reserve the name 
Möbius syndrome, and which we view as a maldevelopment of the lower 
brainstem.
This study was initiated with the aim to deﬁne Möbius syndrome 
accurately and in greater detail in order to delineate reproducible 
phenotypes that allow proper pathophysiological studies and to reveal the 
genetic and possibly the molecular conditions of Möbius syndrome. The 
starting point was the fact that autosomal dominant, autosomal recessive 
and sporadic types of the syndrome existed.  All of these forms are quite 
rare.  As one might expect, autosomal dominant forms are relatively mild, 
and autosomal recessive forms relatively more severe. Sporadic forms are 
supposed to be the result of new mutations and clinically so severe that 
they generate no offspring.
When we started this study in 1997, we knew of two large families with 
autosomal dominant Möbius syndrome consisting primarily of congenital 
facial palsy. The expectation was that in these families the gene for Möbius 
syndrome could be detected, and that subsequently one could test for this 
gene in sporadic cases of Möbius syndrome.
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• First we performed linkage analysis in the second large Dutch family 
with autosomal dominant congenital facial palsy (Chapter 3). Clinical 
examination of the two families indicated that congenital facial palsy is 
a more appropriate name for these conditions and that this disorder is 
considerably different from Möbius syndrome.
In the meantime, we have studied 37 sporadic cases of Möbius syndrome. 
In this gradually expanding patient group the clinical aspects of Möbius 
syndrome have been investigated. In reality, the clinical facts of Möbius 
syndrome appeared to be far more complex than suggested in the 
literature until that time. The overall conclusion was that the name 
Möbius syndrome covered variable phenotypes showing overlap in clinical 
characteristics. Combined clinical, genetic, radiological, pathological 
and electrophysiological studies might help to delineate the different 
phenotypes within the Möbius anomaly and provide greater insight into the 
pathogenesis of the syndrome. This study has focused on elucidating the 
syndrome on all these levels.
• In order to throw more light on the variability of the Möbius condition, 
the clinical features of our patient group were studied and compared 
to those of the Möbius patients described in the literature. Clinical 
similarities and differences were established suggesting a homogeneous 
disorder, diffuse in extension of brainstem involvement and therefore 
variable in severity (Chapter 4): 
a. In the majority of Möbius patients, we observed a homogeneous 
clinical picture characterized by facial diplegia of the upper and lower 
facial muscles, bilateral abduction impairment, hypoglossia, craniofacial 
and limb malformations and mild symptoms of the long tracts.
b. The distribution of the facial palsy in the Möbius syndrome cases, 
with more severe involvement of the upper facial muscles and a 
relative sparing of the lower facial muscles, contrasts considerably 
with that found in the common supranuclear and infranuclear types 
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of facial palsy, and appears to be characteristic of Möbius syndrome.
c. In contrast to previously reported series, in a minority of Möbius 
cases abduction impairment is simply caused by an isolated abducens 
nerve palsy. In all other cases we demonstrated horizontal gaze 
palsy, suggesting that it is not only the 6th cranial nerve nucleus 
that is involved, Duane retraction syndrome which must have been 
overlooked quite often in the literature, and congenital ﬁbrosis of the 
extra-ocular muscles which suggests that overlap with mesencephalic 
developmental syndromes occurs more frequently than previously 
thought.
d. In a minority of Möbius cases we encountered primary respiratory 
dysfunction. 
e. We were not able to conﬁrm the impression of a high occurrence of 
mental retardation as suggested in the literature (10 to 75%).
Based on these clinical characteristics, we concluded that Möbius 
syndrome is more than a cranial nerve or nuclear developmental disorder, 
and that it is a syndrome of a complex regional developmental disorder of 
the rhombencephalon involving predominantly motor nuclei and axons, as 
well as traversing long tracts in which, in extreme cases, the caudal part of 
the brainstem is so poorly developed that central respiratory dysfunction 
occurs.
• To establish the occurrence of mental retardation in Möbius patients we 
assessed intellectual performance, memory functioning and attention in 
12 Dutch patients, using a number of standardized neuropsychological 
tests (Chapter 5).
As a result of several descriptions of the syndrome in the past, the group 
of cases with the diagnosis Möbius syndrome is highly heterogeneous. In 
the literature, both isolated congenital facial palsy with and without ocular 
muscle weakness are criteria for the diagnosis of Möbius syndrome. In 
the clinical and genetic literature, there is a longstanding discussion about 
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whether both congenital facial palsy and Möbius syndrome are the same 
entity. Based on the results of our clinical study, we redeﬁned the primary 
criterion of Möbius syndrome. By restricting the deﬁnition, we excluded 
congenital facial palsy, and as such we ascertained on clinical grounds that 
congenital facial palsy is a separate entity.
• In order to support the hypothesis that hereditary congenital facial palsy 
and Möbius syndrome are two different entities, we wanted to obtain 
greater insight into the pathology of the two disorders. Therefore, we 
studied the brainstem of three members of one family with autosomal 
dominant congenital facial palsy and compared these ﬁndings with 
neuropathological observations in patients with Möbius syndrome 
(Chapter 6).
After analysing the clinical variability of Möbius syndrome, we suggested 
that the syndrome could be viewed as a rhombencephalic developmental 
disorder of variable severity, involving motor nuclei and axons, as well as 
traversing long tracts.
• In order to support this new concept and to gain insight into the 
pathogenetic mechanism of the syndrome, we performed standardized 
MRI studies of the brain in six patients with Möbius syndrome to clarify 
the rhombencephalic structures involved, the severity of involvement and 
the type of damage as marker for either a genetic or ischaemic cause 
(Chapter 7).
 
In our radiological study, we demonstrated absence of the facial nerve in 
all six examined patients with Möbius syndrome. This ﬁnding is remarkable 
because we observed residual function in some lower facial muscles which is 
the characteristic pattern of facial weakness in Möbius patients. Hence, our 
radiological ﬁndings suggest that other cranial nerves aberrantly innervate 
some facial muscles, especially in the lower part of the face, probably due to 
a mechanism of reinnervation similar to that in Duane retraction syndrome.
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• To study the nature and extent of facial muscle innervation in Möbius 
syndrome and to clarify the pathophysiological mechanism of the 
syndrome, we conducted standardized blink reﬂexes, direct responses 
of facial nerves and performed electromyography of facial muscles in 
eleven patients with Möbius syndrome (Chapter 8).
In our clinical study, we observed, in over 80% of patients with Möbius 
syndrome, clumsiness, i.e. lack of ﬁne motor skills and poor coordination 
and balance performance. We suggested that this is the functional result 
of hypoplasticity of the long tracts, i.e. maldevelopment of either the 
corticospinal or cortico-pontocerebellar tracts. In this sense, we suggested 
that Möbius syndrome is more than a cranial nuclear developmental 
disorder and that it could be viewed as a syndrome of rhombencephalic 
maldevelopment involving both motor nuclei and axons as well as the long 
tracts.
• To study the nature of clumsiness in Möbius syndrome and to clarify 
the pathophysiological mechanism of the syndrome, standardized 
electrophysiological studies were conducted, with special emphasis on the 
long motor and sensory tracts and peripheral nerves, in seven patients 
with Möbius syndrome who demonstrated clumsiness (Chapter 9).
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Abstract
Möbius syndrome (MIM 157900) consists of a congenital paresis or paralysis 
of the VIIth (facial) cranial nerve, frequently accompanied by dysfunction of 
other cranial nerves. The abducens nerve is regularly affected and often, also, 
the hypoglossal nerve. In addition, orofacial and limb malformations, defects of 
the musculoskeletal system and mental retardation are seen in patients with 
Möbius syndrome. Most cases are sporadic, but familial recurrence can occur. 
Different modes of inheritance are suggested by different pedigrees. Genetic 
heterogeneity of Möbius syndrome has been suggested by cytogenetic studies 
and linkage analysis. Previously, we identified a locus on chromosome 3q21-22, in 
a large Dutch family with Möbius syndrome consisting essentially of autosomal 
dominant asymmetric bilateral facial paresis. Here we report linkage analysis in a 
second large Dutch family with autosomal dominant inherited facial paresis.  After 
exclusion of more than 90% of the genome, we identified the locus on the long 
arm of chromosome 10 in this family, demonstrating genetic heterogeneity of this 
condition. The reduced penetrance suggests that at least some of the sporadic 
cases might be familial.
A second gene for autosomal dominant
Mobiüs syndrome is localized to 
chromosome 10q, in a Dutch family
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Introduction
Möbius syndrome (MBS; MIM 157900) is a rare congenital disorder involving 
complete or partial facial nerve palsy, either unilateral or bilateral, with or 
without paralysis of other cranial nerves. In particular, the abducens nerve is 
typically affected and often, also, the hypoglossal nerve. Malformations of the limbs 
occur frequently and include syndactyly, ectrodactyly, brachydactyly and talipes 
equinovarus. Facial dysmorphisms, such as micrognathia, prominent epicanthic 
folds and a broad ﬂat nose, may also occur. Furthermore, structural abnormalities 
of the ear, defective branchial musculature (especially absence of the pectoral 
muscle) and mild mental retardation can accompany the cranial nerve palsy.1,2 
Only a minority of cases of congenital facial paralysis are uncomplicated by other 
cranial nerve palsies; in this group, deformities of the limbs are rare.3 
The aetiology and the pathogenesis of the syndrome are uncertain. It is 
probable that the site, nature and extent of the lesion are somewhat different 
in various cases.4,5 The two major explanations suggested for this type of cranial 
nerve dysfunction are (1) a primary metameric defect in the brainstem nuclei 
in the region of the tegmentum and (2) an ischaemic process resulting from 
an interruption of the vascular supply of the brainstem during early foetal 
development. These rather divergent proposed mechanisms are based on limited 
pathological observations in patients with MBS.  Agenesis or hypoplasia of the 
central brainstem nuclei and brainstem atrophy as a cause of peripheral nerve 
involvement or myopathy are observed. Hypoplasia of cranial nerve nuclei with 
active neuronal degeneration or with focal necrosis, gliosis and calciﬁcation has 
been described as well.2  
The majority of the published reports on MBS refer to sporadic cases without 
any evidence of a known environmental causative factor, but familial occurrence 
has been described as well. The patterns of inheritance in families with the 
syndrome suggest different modes of inheritance: autosomal dominant, autosomal 
recessive and X-linked recessive inheritance. Variable expression and decreased 
penetrance could explain the lack of clear Mendelian inheritance patterns in 
individuals of these families.6,7 Several genetic loci have been implicated in MBS. 
On the basis of the 46,XX,del(13)(q12.2) karyotype in a sporadic patient8 and of 
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the cosegregation of the translocation t(1;13)(p34;q13) with the syndrome in a 
three-generation family,9 13q12.2-q13 is thought to harbour a locus for MBS. In 
two sporadic patients, the karyotypes 46,XY,t(1;11)(p22;p13)10 and  
46,XY,t(1;2)(p22;q21.1)11 raise the possibility that another gene for MBS is located 
in or near band p22 on chromosome 1.  Previously, we localized a gene for 
autosomal dominant congenital facial paralysis in a Dutch family to chromosome 
3q21-22.12
In the present study, we performed linkage analysis in a second Dutch family 
partly described elsewhere.13,14 The phenotype in this family is characterized 
by unilateral or asymmetric bilateral congenital facial paralysis; in some cases 
deafness occurs.  After exclusion of more than 90% of the genome, including the 
candidate regions, we localized the gene involved in MBS in this family to the long 
arm of chromosome 10. 
Materials and methods
Patients 
We examined MBS patients in the family, one branch of which was described by 
Fortanier and Speyer13 and two members of which were described by Nicolai.14 
Affected members of this family have unilateral or bilateral facial weakness. 
Weakness of the muscles of the three branches of the facial nerve varies among 
individuals. Besides facial weakness, hearing loss is present in a number of patients, 
ranging from congenital deafness to progressive hearing loss with age. In one 
patient with hearing loss, there is a deformity of the os petrosum. 
Unaffected members of this family lack congenital hearing loss as well as facial 
paralysis, examined with speciﬁc functional facial testes on neurological examination.
 
Typing of DNA markers
Genomic DNA used for the typing of the DNA polymorphisms was isolated as 
described by Miller et al. (1988).15 Ampliﬁcation of the polymorphic regions and 
analysis of the ampliﬁed fragments was performed according to Kremer et al. 
(1994).12
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Statistical evaluation
We calculated two-point LOD scores, using the subroutine MLINK of the 
LINKAGE program (version 5.1).16-18 Multipoint analysis was performed by 
means of ﬁve-point linkage analysis (FASTLINK version 2.30)19,20 combined 
with the sliding window technique.  A mutated MBS allele frequency of 0.00001 
and a penetrance of 80% were assumed. The penetrance was deduced from 
the number of clinically affected persons (21) and the number of obligate gene 
carriers (6). The order of the markers is according to the Généthon map and the 
chromosome 10 contig by Genome Therapeutics Corporation.
Results
Linkage to chromosome 10q21.3-22.1
We performed linkage analysis in this second Dutch family with autosomal 
dominant MBS.13,14 Fifty-six persons were included in the DNA analysis, 19 of 
whom were affected and 5 of whom were obligate carriers.
We excluded the MBS locus on 3q and the regions involved in chromosomal 
abnormalities of MBS patients on chromosome 1, 2, 11 and 13. Subsequently, a 
random genome scan was initiated with polymorphic markers spaced 10-15 cM 
apart.  After exclusion of more than 90% of the genome, an indication for linkage 
was obtained with marker D10S606 on the long arm of chromosome 10. The 
maximum LOD score was 2.02 at recombination fraction (θ ) 0.06. Exclusion of 
the region distal to D10S606 pointed to a more proximal location of the disease 
gene.
Fine mapping
For ﬁne mapping of the gene, 15 polymorphic markers derived from the region 
proximal to D10S606 were tested (Genome Database, Généthon, Genome 
Therapeutics Corporation, GeneMap ’99). Two-point LOD scores between the 
relevant markers and the disease locus are given in Table 1.  A maximum LOD 
score of 4.47 at θ = 0.05 was obtained with the marker D10S581. 
Haplotypes were constructed to deﬁne the borders of the cosegregating 
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region (Figure 1). The proximal border of the critical region is determined by a 
recombination, present in individuals V:13 and V:20, between the markers D10S581 
and D10S557. The distal border of the region is determined by a recombination, 
present in individual V:7, between the markers D10S599 and D10S502. Besides 
the ﬁve obligate carriers, nine clinically unaffected individuals (IV:15, V:8, V:11, V:15, 
V:16, V:21, V:24, VI:13 and VI:17) underline the incomplete penetrance in this family 
because, for the relevant interval, they carry the chromosomal fragment that 
cosegregates with the syndrome. Therefore, after linkage has been established in 
this family, the penetrance was recalculated, leading to a value of 60%.
Five-point linkage analysis was performed to determine the location of the 
gene involved with the highest likelihood (Figure 2). The analysis resulted in the 
maximum LOD score of 6.2 in the interval flanked by the markers D10S581 and 
D10S557. 
θ
θ
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Discussion
In the present study, linkage analysis enabled us to localize a gene responsible for 
autosomal dominant inherited MBS to the long arm of chromosome 10. Herewith, 
we have demonstrated genetic heterogeneity for autosomal dominant MBS, since 
we previously described a locus for MBS on chromosome 3q21-22.12 The critical 
region that is delimited by the markers D10S581 and D10S502 spans ~3.7 cM at 
10q21.3-22.1 (Généthon). The early growth response 2 gene (EGR2) maps to this 
interval (GeneMap ’99) and is an interesting candidate gene, since disruption of the 
mouse ortholog, also known as Krox-20, results in elimination of rhombomeres 3 
and 5 and thus affects the motor nuclei of cranial nerves V, VI, VII and IX.21 
The penetrance in the present family is 60%, given the ﬁve obligate carriers and 
nine clinically unaffected individuals in which haplotypes of the critical region show 
the  “affected” genotype. In contrast, the penetrance in the ﬁrst Dutch family with 
autosomal dominant segregating MBS is 95%.12 The reduced penetrance seen in 
the present family suggest that at least some of the seemingly sporadic cases might 
be members of a (small) family with a low penetrance of MBS. Furthermore, the 
reduced penetrance for MBS indicates that other factors, genetic or nongenetic, 
inﬂuence the development of the condition.
Pathogenetically, we assume that there are at least two different groups of 
patients with MBS. One group consists of patients with autosomal dominant 
congenital facial palsy, in which agenesis or hypoplasia of the cranial nerve nuclei is 
pathologically present. The palsy in this group is caused by genetic factors, and any 
occurring nonpenetrance might be explained by genetic as well as by nongenetic 
factors.  A second group of patients with congenital facial palsy is characterized by 
hypoplasia of cranial nerve nuclei, accompanied by necrosis, gliosis and 
calciﬁcations secondary to ischaemia. The postulated ischaemia of the brainstem 
in these cases might be explained as a primary (genetic) or a secondary 
(environmental) mechanism.22 At present, it is unclear which part of MBS is caused 
by genetic and which part by nongenetic factors. Identiﬁcation of the gene involved 
in the present family and subsequent mutation analysis in sporadic patients 
might shed some light on this question and also on cranial nerve and brainstem 
development.
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Figure 2. Five-point linkage analysis combined with the sliding window technique, resulting in a 
maximum LOD score of 6.2 in the interval between D10S581 and D10S557.
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Abstract 
Objective
To investigate the variable clinical picture of Möbius syndrome (MIM no. 157900) 
and to further understand the pathogenesis of the disorder. 
Methods
A standardized questionnaire was submitted to 37 Dutch patients with Möbius 
syndrome.  All underwent standardized neurological examination with special 
attention to cranial nerve functions, motor skills and facial and limb anomalies. 
Results
Of 37 patients with facial paresis, 97% had bilateral and 3% had unilateral ocular 
abduction weakness. Further analysis showed isolated abducens nerve palsy in 
9%, a conjugated horizontal gaze paresis in 48%, features of Duane retraction 
syndrome in 34% and congenital ﬁbrosis of the extraocular muscles in 9%. Other 
signs included lingual involvement (77%), dysfunction of palate and pharynx 
(56%), general motor disability (88%), poor coordination (83%) and respiratory 
abnormalities (19%). 
Conclusion
Möbius syndrome is more than a cranial nerve or nuclear developmental disorder. 
It is a syndrome of rhombencephalic maldevelopment involving predominantly 
motor nuclei and axons, as well as traversing long tracts. The authors also noted 
gaze palsies, Duane retraction syndrome, feeding and respiratory problems and 
poor motor development, suggesting a regional developmental disorder. 
Möbius syndrome redefined:
a syndrome of rhombencephalic 
maldevelopment
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Introduction
Congenital facial and abducens palsy was originally described by Von Graefe in 
1880,1 followed by other reports.2 In 1888, Möbius drew attention to patients 
with congenital nonprogressive bilateral facial and abducens palsy. The eponym 
Möbius syndrome has since been used for this condition.3 A variety of criteria 
have been applied when diagnosing the syndrome, varying from congenital facial 
palsy without abducens palsy to congenital facial palsy with abducens palsy and 
with or without craniofacial dysmorphisms and congenital abnormalities of the 
extremities.4 
Aetiology and pathogenesis of the syndrome are unclear,4 but two 
explanations have been proposed: a primary genetic5,6 and a primary ischaemic 
cause.7-9 Teratogenicity is suggested as an important aetiolical factor in both.10 
The postulated aetiological mechanisms are based on limited pathological 
observations, which include agenesis or hypoplasia of cranial nerve nuclei, atrophy 
of cranial nerve nuclei secondary to peripheral nerve involvement and primary 
muscle involvement without abnormalities in the brainstem or cranial nerves.11 
Nontraumatic congenital facial weakness without ocular muscle weakness 
has been reported frequently as an autosomal dominant trait (Table 1), for which 
two loci have been deﬁned.12,13 Facial weakness plus abducens weakness or 
the extended phenotype is most frequently described as a sporadic condition. 
However, rare instances of autosomal dominant, autosomal recessive and even 
X-linked recessive inheritance have been described (Table 1). Cytogenetic studies 
have suggested two loci: 1p2214,15 and 13q12.2-13.16,17 
The delineation of the syndrome has been hampered by a large number of 
reports on a relatively small number of patients mostly examined at a young age. 
To determine the variability of the Möbius condition, we studied a number of 
cases of various age and obtained a homogeneous clinical picture, diverse both 
in extent of structures involved and in severity of involvement. This suggested 
a developmental disorder of the entire lower brainstem with variable severity 
rather than absence of cranial nerve nuclei. For the current study, we have defined 
the Möbius syndrome as a congenital facial weakness with impairment of ocular 
abduction.
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Subjects and methods
Subjects 
Thirty-seven Dutch patients with Möbius syndrome were included in a 
nationwide survey. Ten of them were obtained through a request for participation 
by the Dutch Möbius association and 14 on referral by neurologists, paediatricians, 
ophthalmologists, genetic counsellors, ears-nose-throat specialists, or plastic 
surgeons.  An additional 13 patients were referred by both the Möbius association 
and medical specialists. We defined Möbius syndrome as a congenital facial 
weakness with impairment of ocular abduction.  All patients who satisfied both 
criteria were included. Dysfunction of other cranial nerves, orofacial and limb 
malformations, musculoskeletal defects and mental retardation commonly occur 
as associated features. 
Questionnaire 
A questionnaire on pregnancy, delivery, post-partum vital functions, clinical 
symptoms, psychomotor development and family history was given to the 
patients. 
Physical examination
A standardized neurological examination, using a speciﬁc checklist paying 
special attention to cranial nerve functions, motor skills and facial and limb 
dysmorphisms, was performed by the same clinician (H.T.F.M.V.). The medical 
records of all patients were reanalyzed once consent had been obtained. 
Results
The study resulted in a well-deﬁned clinical picture. Tables 2 through 5 contain a 
summary of the clinical ﬁndings in 17 female and 20 male with Möbius syndrome, 
ages ranging from 6 months to 53 years. 
Pregnancy and delivery 
Twenty-five of 35 patients (71%) were delivered after an uncomplicated pregnancy. 
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Pregnancy information was not available for two patients. Of the remaining 8 
cases, one mother (case 14) had diabetes, one mother (case 3) used Trinordiol and 
alcohol, three mothers (cases 12, 19 and 20) had influenza early in pregnancy, one 
mother (case 4) had sinusitis and one mother (case 33) had gastro-enteritis. Two 
mothers (cases 12 and 26) had vaginal blood loss in pregnancy. 
     Nine children (cases 2, 5, 6, 18, 20, 23, 26, 27 and 33) were hypotonic at birth: 
one child (case 3) was hypertonic.
Post-partum vital functions  
Seven patients (19%) exhibited respiratory difficulties. In two patients (cases 29 and 
33), a severe primary respiratory dysfunction was present at birth. These patients 
died soon after deferring artificial ventilation, as a result of the conclusion that 
the lack of respiratory drive was part of the syndrome. In five patients, problems 
included breath-holding spells up to the age of 1 year (cases 2 and 19), apnea and 
bradycardias up to the age of 12 weeks (cases 3 and 5) and acute respiratory arrests 
in case 5 at 1 year and in case 12 at 13 years of age.  All five patients survived.
Family history 
In one case, there was a family history of cranial nerve palsy. Both mother and son 
(cases 35 and 36) had a congenital bilateral facial palsy of mainly the upper face and 
bilateral ocular abduction paresis.
Facial paresis (Table 2)  
Thirty-four of the patients (92%) had bilateral and 3 (8%) had unilateral facial 
weakness. In the two subjects who died, the extent of bilateral facial weakness 
could not be accurately reconstructed. Facial diplegia was complete in 11 out of 
32 patients (34%); in 20 patients (62%) there was a palsy of the upper face with 
a relative sparing of the lower half of the face, including the perioral muscles and 
platysma (Figure 1). In one patient the upper and the lower face was paralyzed to 
the same extent (case 16). Three patients had unilateral weakness: one (case 6) 
complete and two (cases 19 and 37) partial. 
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Abnormal ocular motility (Table 2) 
Esotropia at birth was present bilaterally in 19 patients (54%) and unilaterally in 
four patients (11%; cases 13, 19, 21 and 37). Three patients (9%; cases 30, 35 and 
36) demonstrated exotropia of both eyes and two patients (6%; cases 1 and 7) 
of one eye. On convergence, the pupils constricted normally in all cases. Thirty-
three patients, excluding the four patients with exotropia, were unable to abduct 
the eyes beyond the midline, 32 patients (97%) bilaterally and 1 patient (case 37) 
Figure 1. Facial 
paresis. Incomplete (1) 
and complete (2) facial 
palsy. Raising eyebrows 
(A), smiling (B).
 1A  1B
 2A  2B
Chapter 4
74
Möbius syndrome, a syndrome of rhombencephalic maldevelopment
unilaterally. Information on eye movements was incomplete in the two deceased 
patients (cases 29 and 33).  Abducens nerve palsy was present in 3 of 35 patients 
(9%; cases 18, 31 and 37). Seventeen patients (48%) had conjugated horizontal 
gaze palsies (Figure 2). Twelve patients (34%) demonstrated features of Duane 
retraction syndrome, consisting of limitation of abduction as well as a variable 
degree of limited adduction and retraction of the eye on attempted adduction 
with narrowing of the palpebral ﬁssure, caused by an aberrant innervation of 
the lateral rectus muscle by ﬁbers of the oculomotor nerve (see Figure 2).18 In 
this study, ﬁve patients had type I Duane retraction syndrome characterized by 
marked limitation of abduction with minimally defective or normal adduction 
and retraction of the adducting eye, and seven patients had type III Duane 
retraction syndrome for which combined limitation or absence of both abduction 
and adduction are speciﬁc features next to retraction of the eye on attempted 
adduction. Three patients (9%; cases 1, 30 and 35) with prominent facial paresis 
showed features of congenital ﬁbrosis of the extraocular muscles, consisting of 
restrictive external ophthalmoplegia, ptosis and eyes ﬁxed in an abnormal position, 
resulting from a developmental anomaly of all or portions of the oculomotor 
or trochlear nuclei.19,20 In this study,  one patient had type I or classic congenital 
ﬁbrosis of the extraocular muscles (CFEOM) characterized by ptosis and a 
restrictive infraductive external ophthalmoplegia with on attempted abduction, 
elevation and depression retraction of the eyelid, and two patients had type II 
CFEOM with ptosis and a restrictive exotropic external ophthalmoplegia. Nine 
patients (cases 2, 5, 11, 23, 24, 26, 28, 34 and 36) had undergone strabismus surgery. 
Figure 2. Abnormal ocular motility. (1) Horizontal gaze palsy and (2) Duane retraction 
syndrome type I. (A) Looking to the right, (B) looking to the left.
 1A  1B
 2A  2B
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Lingual features (Table 2) 
There was insufficient information concerning the tongue in the two deceased 
patients. Twenty-seven patients (77%) had a hypoplastic tongue that could not 
be protruded beyond the lips (Figure 3). Thirteen patients (37%) showed an 
asymmetry in size of the tongue (see Figure 3). In 8 patients (23%; cases 2, 7, 9, 
10, 12, 15, 26 and 34) we observed a groove over the midline of the tongue with 
elevations on both sides (see Figure 3). In the majority of cases, function of the 
affected tongues was normal, but the range of motion was limited. Three patients 
(9%; cases 4, 8 and 23) demonstrated a unilateral paresis of the tongue (see Figure 
3). In 8 patients (23%) the tongue had a normal appearance and function.
Palate and pharynx (Tables 2 and 3) 
Feeding problems at birth due to insufﬁcient sucking, swallowing, palatal weakness, 
or regurgitation were present in 32 patients (86%). In 21 of these, tube feeding 
was necessary throughout the ﬁrst weeks and, in some cases, even during the 
ﬁrst months of life. Two patients (cases 5 and 18) underwent gastrostomy. Three 
patients (cases 5, 6 and 27) could not be assessed properly because of limited 
cooperation, and there was no information available on the two deceased patients 
(cases 29 and 33).
     Nasal dysarthria was evident in 22 of 29 speaking patients (76%).  A delay in 
language development occurred in 16 out of 29 patients (55%). Information is 
Figure 3. Lingual features. Hypoplastic and asymmetric, dysplastic tongue (1), hypoplastic and 
asymmetric, dysplastic tongue that could not be protruded beyond the lips and unilateral paresis 
of the tongue (2), hypoplastic tongue and a groove over the midline of the tongue with elevations 
on both sides (dysplasia) (3).
 1  2  3
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lacking in eight patients because of premature death (cases 29 and 33), young age 
(cases 3, 4, 6, 20 and 31) and foreign language problems (case 32).
Trigeminal paresis  
Six patients (16%) demonstrated masticatory difﬁculties due to a weak bite (cases 
10, 11, 16 and 25) and the absence of jaw rotation during chewing (Cases 17, 24 
and 25). Four patients (11%; cases 6, 12, 19 and 24) showed a loss of sensation of 
the lip, the cheek, the forehead and the cornea, suggesting a partial defect of the 
sensory root of the trigeminal nerve. 
Vision  
The frequencies of mild hypermetropia, myopia, astigmatism and amblyopia did 
not differ from the normal population. Severe visual disability occurred in one 
patient. Case 30 had bilateral optic nerve hypoplasia and retinal detachment. 
Hearing loss 
Of 35 patients, 10 (29%; cases 1, 6, 7, 9, 11, 14, 17, 20, 23 and 25) complained of 
some degree of hearing loss, but no examinations were performed to conﬁrm 
this. One of these patients (case 19) was congenitally deaf in both ears. 
 
Smell and taste  
Our assessment did not reveal indications of olfactory loss. There were no 
complaints about taste.  
Craniofacial malformations (Tables 2 and 4)  
Epicanthic folds (89%), flattened nasal bridge (81%), micrognathia (64%), high arch 
palate (61%), external ear defects (47%), teeth defects (33%) and hypertelorism 
(25%) were the most frequent features present in the group under study. Other 
malformations are listed in Table 4.
Mental deﬁciency 
Examination of mental status was not done, so there is no detailed information 
on IQ- levels.  All schoolgoing patients, with the exception of two autistic patients 
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(cases 5 and 11), had attended elementary school, with IQs of at least 80. Of 
these patients, 6 were attending elementary school, 11 had finished elementary 
school and one or more grades of high school, and 12 were attending special 
education for physically affected children. 
Extremity malformations (Tables 2 and 5)  
Thirty-one (86%) had malformed extremities with variable degrees of severity. 
Hand deformities were evident in 22 patients (61%), ranging from brachydactyly, 
clinodactyly, campylodactyly, syndactyly and ectrodactyly to low set thumbs, 
Figure 4. Extremity malformations. Hypoplasia of the lower legs (1), brachydactyly, syndactyly, 
ectrodactyly and campylodactyly (2), arthrogryposis multiplex (3).
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hypoplasia of the phalanxes, aplasia and hypoplasia of the metacarpals, nail 
deformities and clenched hands (Figure 4). Twenty-ﬁve patients (69%) showed 
deformities of the legs, varying from pes planus or valgus, femur and hip defects 
to hypoplasia of the lower legs (see Figure 4).  Anisomelia was observed in one 
patient. Two patients (6%) exhibited arthrogryposis multiplex, 16 (44%) had talipes 
equinovarus; in 11 of these cases both feet were affected. 
Other malformations (Tables 2 and 5)  
Poland syndrome, diagnosed by unilateral absence or hypoplasia of the pectoralis 
muscle, most frequently involving the sternocostal portion of the pectoralis major 
muscle, and a variable degree of ipsilateral hand and digit anomalies,21 was present 
in four patients (11%; cases 2, 19, 24 and 32). Cardiovascular malformations 
occurred in two patients (cases 2 and 14). Other malformations and their 
frequency of occurrence are listed in Table 5. 
Motor dysfunction (Table 2) 
Thirty of 34 patients (88%) demonstrated motor disabilities. There was a lack of 
information in three patients because of early death (cases 29 and 33) and young 
age (case 31). Only four patients (12%; cases 13, 35, 36 and 37) showed no motor 
problems. In 23 patients (68%), there was retardation in motor development; they 
took longer than average to master the milestones of major motor skills such as 
sitting, standing, walking and, even more clearly, of running, jumping and hopping; 
the presence of skeletal deformities appeared to have inﬂuenced these motor 
skills only to a small degree. When attempting to run, six patients (cases 9, 12, 18, 
19, 23 and 26) kicked their legs awkwardly to all sides, failing to reach any speed. 
In time, most of them developed relatively normal walking and running abilities. 
In 20 of the 23 patients, ﬁne motor skills were uniformly awkward; none could 
dance, do gymnastics, or play musical instruments. Eight of 11 patients (cases 1, 3, 
4, 8, 15, 20, 22 and 32) without a history of retarded motor development showed 
the same clumsiness. On examination, 28 of 34 patients (82%) showed clumsy 
movements, even when skeletal deformities were taken into account. Information 
on two patients is lacking because of young age. In 11 patients (31%) a remarkable 
hypotonia of neck, thorax and extremities occurred up to the age of 4 years.
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Coordination dysfunction (Table 2)  
Twenty-nine of 35 persons (83%) had poor coordination. Twenty of the 30 
patients (67%) who could walk, ﬁve (cases 3, 4, 6, 20 and 31) were too young, had 
a disturbed tandem gait. Seven patients lurched when riding a bike, and three of 
them (cases 23, 25 and 30) were committed to a tricycle because lurching was 
getting worse. Of 30 patients who could be instructed, ﬁve (cases 3, 4, 6, 20 and 
31) were too young, 19 (63%) demonstrated dysdiadochokinesis of the hands.  An 
axial imbalance was present in 12 patients (34%). In seven of them (cases 3, 4, 12, 
20, 23, 24 and 31), balance improved to normal within 6 months to 3 years after 
birth, and in ﬁve patients (cases 5, 6, 19, 25 and 30) imbalance was still present at 
2, 5, 9, 36 and 53 years of age. Six patients had no problems with coordination; 
two patients had died.
Sensory disturbances (Table 2)  
One patient (case 30) suffered from a progressive sensory polyneuropathy of 
unknown origin. In ﬁve patients (cases 15, 19, 26, 27 and 34) parents noticed a 
high tolerance to pain. In the other 32 cases there were no disturbances.
Tendon reﬂexes  
In general, tendon reﬂexes were normal. Reﬂexes were diminished only in the 
patient with neuropathy (case 30). Pathological reﬂexes were not observed.
 
Discussion
All previous reviews on Möbius syndrome are compilations of the literature and 
focus mainly on a particular aspect of the syndrome.2,22-37 To date, the largest 
number of Möbius syndrome patients studied by a single author is 27, and the 
pertinent report is restricted to a retrospective analysis with patients not re-
examined at later stages.35 In the current study, we analyzed the characteristics 
of the syndrome in 37 Dutch Möbius patients of different age groups, taking all 
clinical aspects into consideration. The same physician (H.T.F.M.V.) studied all 
patients.
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     The patients referred by medical specialists as compared to the number and 
type of cases obtained from the patients’ association suggests that we studied a 
true cross-section of the Dutch population. Because of the overlap of patients 
mentioned, especially of those in the ﬁrst decade, we are conﬁdent that we 
identiﬁed almost all of the Dutch patients with Möbius syndrome born in 1996. 
In this year, the prevalence of Möbius syndrome is at least 0.002% of births (4 
per 189,000 newborn).  A similar percentage was obtained in 1997 and 1998. 
The majority of our patients are in their ﬁrst or second decade of life, and in 
the subsequent decades the number of patients declines due to limited ﬁling by 
specialists and reduced interest of the patients (Table 2). There is no indication of 
early death.
The aim of the study was to gain more insight into the variability of anomalies 
associated with Möbius syndrome and thereby into the pathogenesis of the 
syndrome. For this study, we deﬁned the syndrome as a congenital facial palsy 
with impairment of ocular abduction. Whereas dysfunction of other cranial 
nerves, orofacial malformations, limb malformations, musculoskeletal system 
defects and mental retardation are commonly associated features, we considered 
them unnecessary for the diagnosis.
In the majority of patients, we observed a homogeneous clinical picture 
characterized by facial diplegia of the upper and lower facial muscles, bilateral 
abduction impairment, hypoglossia, craniofacial and limb malformations and 
symptoms of the long tracts. Two patients with unilateral facial palsy and bilateral 
abduction palsy also showed this well-deﬁned extensive clinical picture. Two 
patients, mother and son, with upper facial diplegia and bilateral abduction 
weakness and one patient with unilateral facial and abducens nerve palsy lacked 
craniofacial and limb malformations and symptoms of the long tracts, and could 
therefore be considered as a subset of the Möbius syndrome. Furthermore, 
we found no indication that a speciﬁc type of ocular ﬁnding, oral dysfunction, 
craniofacial and extremity involvement, or motor dysfunction is accompanied by 
speciﬁc associated ﬁndings.
The distribution of the facial palsy in the Möbius syndrome cases, with more 
severe involvement of the upper facial muscles and a relative sparing of the lower 
facial muscles, contrasts considerably with that found in the common supranuclear 
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and infranuclear types of facial palsy. This distribution appears to be characteristic 
for Möbius syndrome and, in the absence of the accompanying features, may be of 
diagnostic value.2,4,38
We observed that the inability to abduct the eye beyond the midline, usually 
bilateral and complete, constitutes, by deﬁnition, a highly characteristic feature 
of the syndrome. In contrast to previous series,2,28,34-37 we observed an isolated 
abducens nerve palsy in a minority of cases. In many cases we found horizontal 
gaze palsies, suggesting that more than the 6th cranial nerve nucleus is involved. 
Also, we found that Duane retraction syndrome was frequently present and can 
only conclude that it may have been overlooked previously.18,3218,32,36,37 The cases 
with oculomotor palsies, which we diagnosed as CFEOM, suggest that overlap 
with mesencephalic developmental syndromes occurs more frequently than 
previously thought.19,20 The recent identiﬁcation of a gene for this condition39,40 
might contribute to a better understanding of midbrain motor neuron 
development and give an insight into molecular pathways necessary for brainstem 
development involved in the pathogenesis of Möbius syndrome. 
We observed two types of tongue abnormalities: a global hypoplasia of the 
tongue and an appearance resembling a nonprogressive asymmetric lingual 
dysplasia. More autopsy studies of these phenomena are required.
Our ﬁndings indicate considerable dysfunction of palate and pharynx with 
remarkable clinical consequences, which has escaped full attention in the 
literature.2,30,34,37 In accordance with earlier reports,30,40 in a large number of 
cases (86%), we observed feeding problems in the earlier phases of life, probably 
because of combined facial, lingual and palatal abnormalities, making infants 
prone to recurrent aspiration and necessitating tube feeding. Most patients 
overcame these problems using a suitable comforter and by the development of 
compensatory mechanisms. Delay in language and speech development, observed 
frequently (55%) in our patients, requires early attention by a speech therapist. 
Difﬁculties with suckling and feeding should trigger treatment to develop normal 
prespeech activities and maximize the range of motion of the articulators to 
optimize the condition for speech later in life. 
The weak bite and absence of jaw rotation during chewing may be caused by 
trigeminal motor nerve involvement. However, we observed a striking sparing of 
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the masticatory muscles. Occlusion defects because of oromandibular hypoplasia 
played an important role in chewing difﬁculties. In a small number of cases we 
found trigeminal sensory nerve involvement.
Mental retardation has been reported in Möbius syndrome patients, occurring 
from 10 to 75% of cases.2,28,33,37,41-44 We did not observe a high occurrence of 
mental retardation, but prospective studies using standardized scales to evaluate 
mental capacities are needed.
We conﬁrmed that limb malformations, particular of the hands and feet, are 
abnormalities most commonly associated with Möbius syndrome.4 Whereas 
lower leg hypoplasia was frequently seen, a similar hypoplasia of the arms was not. 
Genes may be responsible for the phenotype of brainstem syndromes associated 
with limb malformations, such as recently demonstrated in Okihiro syndrome.45,46
     Summarizing the cases of congenital absence of muscles, we noted that the 
pectoralis muscles were most frequently absent, which could be classiﬁed as 
part of the Poland syndrome. In view of the high frequency of Poland-Möbius 
syndrome,47 it has been proposed as a formal genesis syndrome, i.e. it has a 
pathogenesis that is at least to some extent similar or related.33,48 These clinical 
overlap syndromes might represent variable expression of a single gene or might 
represent a contiguous gene syndrome. 
      Hypotonia at birth is often present and motor development and coordination 
do not reach normal levels at older ages, even when skeletal deformities are 
taken into account. The lack of ﬁne motor skills and the poor coordination and 
balance performance can be best summarized as clumsiness.49 The developmental 
nature of this condition probably preludes recognizable pyramidal or cerebellar 
signs as indicated by lesions occurring later. We suggest, and feel supported by 
radiological studies,49 that clumsiness is the functional result of hypoplasticity, 
i.e. maldevelopment of either the corticospinal or cortico-bulbocerebellar long 
tracts. In a minority of cases we saw primary respiratory dysfunction, supporting 
the concept that the caudal part of the brainstem is poorly developed. In this 
sense, Möbius syndrome could be viewed as a syndrome of rhombencephalic 
maldevelopment involving both nuclei and traversing long tracts. In extreme cases, 
the caudal part of the brainstem is so poorly developed that primary respiratory 
dysfunction occurs, which is incompatible with independent life. This observation 
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is consistent with reported MRI ﬁndings, demonstrating hypoplasia of the lower 
brainstem.50,51
In this survey,  examination of patients with Möbius syndrome showed 
evidence of possible pharmacological, hormonal, or toxic effects in only one or 
two instances. Therefore, we could not substantiate the claims that teratogens 
are a possible cause of the syndrome. There were no common obstetric events 
compatible with a causative mechanism. We did not observe geographic clustering 
of cases; patients were scattered all over The Netherlands.
The vascular hypothesis for Möbius syndrome supposes ischaemic events in 
the median avascular and paramedian watershed zones of the lower brainstem 
to be the result of hypoperfusion or occlusion of the developing primitive 
subclavian artery.7,9 Although this artery supplies a fair part of the rostral embryo, 
it is doubtful that ischaemia of part of its supply-zones leads to speciﬁc and 
recognizable syndromes with involvement of a limited number of structures, 
tissues and germ layers such as in Poland or Klippel-Feil syndrome. This vascular 
hypothesis does not explain the frequent occurrence of lower extremity 
involvement (86% in our series) or congenital abnormalities outside the subclavian 
arterial bed.
A wide spectrum of severity of Möbius syndrome, as seen in our study, is not 
incompatible with a genetic cause of this disorder. Two reports with abnormal 
karyotypes14,16 and one report of identical twins with Möbius syndrome52 have 
been documented, suggesting a genetic cause for the disorder. Six families with 
autosomal dominant, two with autosomal recessive and three families with X-
linked inherited Möbius syndrome have been reported (Table 1). In our study, we 
observed a mother and son with Möbius syndrome, suggesting that dominant 
inheritance is likely. We also observed one proband with three healthy children, 
which does not make autosomal dominant inheritance likely. The mother and son 
appeared less severely affected by upper facial diplegia and bilateral abduction 
weakness without craniofacial and limb malformations and symptoms of the long 
tracts, suggesting that they might suffer from a subset of the Möbius syndrome, 
possibly with a unique aetiology. One sporadic patient showed comparable 
although not the same features. i.e. unilateral facial palsy and a unilateral abducens 
nerve palsy without craniofacial and extremity malformations and without 
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symptoms of the long tracts. We found no secondary cases in the 54 sibs of 37 
probands, making autosomal recessive inheritance extremely unlikely. The lack of 
a clear hereditary pattern in the vast majority of cases does not rule out genetic 
causes. The observation that the questionnaire did not elicit any significant history 
of stillbirths or spontaneous abortions suggests that the genes involved are not 
lethal. The lack of affected siblings may be because the disorder is polygenetic, 
i.e. the phenotype only emerges if there are coexisting mutations in more than 
one developmental gene, which has been shown for the Bardet-Biedl syndrome.53 
Also, genes acting as modifiers may prevent or enhance the phenotype, as recently 
demonstrated in the tubby mice.54 The clinical heterogeneity of Möbius syndrome 
with congenital facial weakness accompanied by impairment of ocular abduction 
as the prime feature may be due to a combination of a number of loci involved 
and different types of mutation at each locus.  Also, just as folic acid in pregnancy 
lowers the risk of neural tube defects in humans and retinoic acid can rescue 
the inner-ear defects of Hoxa1 deficient mice,55 external factors influencing the 
intrauterine environment could play a modifying role in the manifestations of 
Möbius syndrome. Such explanations are in accordance with observations that 
cocaine and prostaglandin abuse is occasionally associated with the occurrence of 
Möbius syndrome.9,56,57  We hypothesize that the spectrum of Möbius syndrome 
is the sum of changes in a number of genes that are functional in the organization 
and development of the lower brainstem at a specific gestational age. In some 
cases, these changes may also interact with environmental factors in a specific 
time period in the development of the lower brainstem. 
Because Möbius syndrome is a complex developmental disorder of the lower 
brainstem, rather than a congenital absence of certain cranial nerves, it is clear 
that the associated deﬁciencies of the syndrome require a multidisciplinary 
approach by paediatricians, neurologists, ophthalmologists, genetic counselors, 
orthopedic, plastic and dental surgeons, audiologists, physical therapists and 
speech therapists.
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Abstract
Objective
To establish the occurrence of mental retardation in a group of patients with 
Möbius syndrome and subsequently, if mental retardation is absent, to screen 
major aspects of memory and attention, in order to assess possible pervasive 
dysfunction in these cognitive domains which might be responsible for the 
current view that mental retardation occurs frequently in Möbius syndrome.
Methods
In a group of 12 Dutch Möbius patients, intellectual performance, memory 
function and attention were assessed using a number of standardized 
neuropsychological tests. 
Results
The mean general intellectual performance did not differ signiﬁcantly from that 
of the Dutch population. Screening of selective attention and memory did not 
provide indications of pervasive dysfunctions in these domains. 
Conclusion
The rate of occurrence of mental retardation in our group of Möbius patients did 
not differ from that in the normal Dutch population. Furthermore, there was no 
evidence of attention and memory dysfunction in our group of Möbius patients.
Cognitive evaluation in adult patients 
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Introduction
Möbius syndrome is a rare congenital disorder characterized by congenital facial 
weakness with impairment of ocular abduction.1,2 While dysfunction of other 
cranial nerves, orofacial malformations, limb malformations, musculoskeletal system 
defects and mental retardation are commonly associated features, they are not 
essential to the diagnosis.2
Mental retardation in relation to Möbius syndrome has been reported. In a 
number of studies, estimates of occurrence vary from 10 to 50% of cases.3-6 7 As 
intellectual performance was not always assessed formally, the question arose: 
did the clinical picture of the syndrome, i.e. the characteristic mask-like face 
with strabismus, drooling and speech difﬁculties, contribute to the assumption 
that there is a high prevalence of mental retardation in patients with Möbius 
syndrome.6,8
Three studies which deal explicitly with mental deﬁcits in relation to Möbius 
syndrome report a rate of mental retardation varying from 33 to 75%.9-11
In a previous study, we analysed the clinical characteristics of the Möbius 
syndrome in a number of patients and were not able to conﬁrm the impression 
of a high rate of occurrence of mental retardation.2 In the present study, we 
established the actual rate of occurrence of mental retardation in a group of 
patients with Möbius syndrome and subsequently screened major aspects of 
memory and attention in order to assess possible pervasive dysfunction in these 
cognitive domains in Möbius patients who were not mentally retarded. 
Subjects and methods 
Subjects
In an initial study, we examined 37 Dutch patients with Möbius syndrome derived 
from a nationwide survey.2 Participants ranged in age from 6 months to 53 years 
at the time of the study. Ten were recruited following a request for participation 
by the Dutch Möbius Association and 14 through referral by physicians from all 
over the country, including neurologists, paediatricians, ophthalmologists, genetic 
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counsellors, ears-nose-throat specialists and plastic surgeons. An additional 13 patients 
were referred by both the Möbius Association and medical specialists. All patients met 
the inclusion criteria: nonprogressive congenital facial weakness and impairment of 
ocular abduction.  Among these 37 patients, 34 demonstrated a homogeneous clinical 
picture characterized by bilateral facial palsy of the upper and lower facial muscles, 
bilateral abduction impairment, hypoglossia, craniofacial and limb malformations 
and signs of clumsiness. Two patients, mother and son, with upper facial diplegia and 
bilateral abduction weakness and one patient with unilateral facial and abducens nerve 
palsy, lacked craniofacial and limb malformations and did not show signs of clumsiness, 
and could, therefore, be considered as a subset of the Möbius syndrome. Vision or 
hearing deﬁcits, that could affect the results of the tests, were not encountered. 
Previously reported studies assessed cognitive functioning using a variety of 
heterogeneous and non-equivalent tests, which might have affected the results.9-11 
For this reason, we decided to assess the cognitive performance of our patient group 
with an identical battery of standardized tests. The common age range of validation 
of the respective tests prescribed the age of patients to be included in this study. 
Thus, only patients aged 17 years or older could be included in this study; 23 patients 
were under 17. Of these 23 patients, one female lives in a habilitation unit because 
of autistic behaviour and mental retardation; none of the remaining 22 revealed any 
indication of mental retardation, as far as could be judged from school performances 
and daily functioning. Of the remaining 14 patients, two declined to participate: one is 
an independently functioning mother of three healthy children who was not available 
for testing and the other an autistic and severely mentally retarded female patient 
on whose behalf the institutional staff of the centre in which she was living refused 
consent. 
To summarize, our study focused on 12 cooperative subjects with Möbius 
syndrome, 7 males and 5 females. The youngest patient was 17 years of age, the oldest 
55.  The mean age of our subjects was 28.6 years with a standard deviation of 12.2. 
The neuropsychological assessment took about two hours and was performed at the 
patient’s home by the same neuropsychologist (NvE). The degree of impairment of 
cranial nerve and extremity functions for these subjects is shown in Table 1. Prior to 
their inclusion in the neuropsychological study, informed consent was obtained from 
patients and parents.
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Tests 
Intellectual performance                                                                            
To assess intellectual functioning we selected a wide range of subtests from 
the Groninger Intelligence Test (GIT),12 which was initially developed in The 
Netherlands based on the kit of selected tests described by French.13 The norms 
of the GIT are based on a representative sample of the Dutch population. We 
preferred administering the GIT rather than the WAIS- III,14 because the scores 
of the GIT-subtests are less dependent on time constraints and manual dexterity 
than those of the WAIS-III. They are, therefore, more appropriate for Möbius 
patients who often suffer from limb malformations. Moreover, the recent Dutch 
adaptation of the WAIS-III has been criticized because of inadequate norm 
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groups. In a recent study, GIT scores turned out to be more in accordance with 
the level of education than the WAIS-III scores.15 The GIT measures a variety of 
verbal abilities. The subtest Vocabulary determines vocabulary level; the subject 
is required to identify correct synonyms of a series of words arranged in order 
of difﬁculty in a multiple-choice paradigm. Vocabulary level has proven to be an 
appropriate guide for establishing general mental ability.16 The subtest Word 
Matrices determines verbal reasoning; the subject is required to identify and 
to apply analogous semantic relations in word pairs. The subtest Verbal Fluency 
assesses word productivity; the subject is required to list as many animals 
and as many professions as possible within one minute. We also selected two 
subtests to evaluate non-verbal intelligence: a two-dimensional Visualization task 
assessing visuoperceptual functions. The subtest Form Board reﬂects visuospatial 
construction; the subject is required to indicate how two-dimensional geometric 
ﬁgures ﬁt into an outline. The subtest Figure Completion reﬂects speed of 
closure; the subject is required to unify apparently disparate perceptual ﬁgures 
into a single percept. Total IQ was based on these ﬁve subtests. 
Attention                    
The Stroop Color Word Test17 assesses the ability to pay attention selectively by 
warding off distracting stimuli. The test consists of Parts A, B and C. Part A reﬂects 
speed of word denomination and Part B speed of color bar denomination. Since 
the test consists of only four very simple and commonplace words, part A is a 
measure of speed of word production. The activity required in Part C is described 
as the selective processing of only one visual feature while continuously blocking 
out the processing of others. The color words are printed in incongruously 
colored ink and the color of the ink has to be named. The resulting delay due to 
the language interference is expressed as a proportion; the score is obtained by 
subtracting the average duration of Parts A and B from that of Part C, divided 
by the average of Part A and Part B. On the Stroop Color-Word Test, extra time 
needed to complete Part C is expressed by the formula [C - ½ (A + B)]/ ½ (A 
+ B),18 in which the performance of part C is corrected for differences in motor 
speed performance.
Chapter 5
106
Cognitive evaluation in patients with Möbius syndrome
Memory
The Dutch adaptation (VLGT)19 of the California Verbal Learning Test20 was 
administered to assess memory function. The test consists of ﬁve learning trials 
of a 16-word target-shopping list composed of four items, each derived from four 
different semantic categories (fruit, tools, spices and clothing). The sequence in 
which the words are read is ﬁxed; each subsequent word belongs to a different 
category from the category to which the preceding word belongs.  After each 
learning trial, free recall was measured; short-term recall is reﬂected in the total 
number of words recalled across the trials 1-5.  After learning a second shopping 
list (the interference trial), the subject is asked to recall as many items of the ﬁrst 
shopping list as possible; long-term recall is reﬂected in the difference between 
the total number of words recalled after the delay of the interference trial and 
the number of words recalled at the ﬁfth and last learning trial.19,21
Statistics
If necessary, the one-sample T-test was used to test the difference between the 
mean scores of our sample and normative means. Results with p-values less than 
0.05 (two-sided) were considered to be signiﬁcant.
Results
Intellectual performance                                                                                 
 The total IQ scores indicate a mean general IQ level within the normal range 
(Table 2). The IQ-equivalents on the 5 GIT subtests were successively:   Vocabulary 
= 112,  Word Matrices = 109, Verbal Fluency = 100, Form Board = 115 and Figure 
Completion = 90 (t = -1,86; p = 0,09).
Attention  
On the Stroop Color-Word Test, the mean reading times in Part A and Part B 
were 55.6 (SD = 22.9) and 71.0 (SD = 20.5) seconds, respectively. The normative 
means for Parts A and B are 40.1 (SD = 7.5) and 51.1 (SD = 9.9) seconds, 
respectively.18 The mean reading time in Part C was 104.7 (SD = 34.5) and after 
correction for the delay due to motor speed interference 67.8 (SD = 31.2). The 
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normative means for Part C before and after correction are 77.3 (SD = 11.4) and 
71.7 (SD = 14.4) seconds, respectively. The lower the corrected score, the better 
the performance.
Memory  
In our group of Möbius patients, the mean number of total words recalled 
immediately after ﬁve trials, which represents short-term memory, was 46.4, 
whereas the normative mean was 51.6  (t = -1.3; p = 0.2). The mean of the 
difference scores between the total number of words recalled after the delay 
of the interference trial and the number of words recalled at the ﬁfth and last 
learning trial, which represents long-term memory, was -0.83. The normative 
difference score was -0.89. (t = 0.12; p = 0.91).21       
 
Discussion
To date, most studies on Möbius syndrome report on physical ﬁndings of the 
syndrome and provide only estimates of occurrence of mental retardation, 
varying from 10 to 50%.3-6 7 In these reports, no reference is made to any method 
of neuropsychological evaluation.
To our knowledge, only three studies which focus on neuropsychological 
functions in relation to Möbius syndrome, have been described to date.9-11
These studies, though not population-based, confirmed the assumption of a high 
rate of occurrence of mental retardation. Gillberg and Steffenburg found an 
occurrence rate of mental retardation of 47% in a group of 17 patients, varying 
in age from 2 to 34, with 15 of them under 17 years.19 Because of this age range, 
the intellectual level of these patients was assessed using heterogeneous tests, 
some focusing on establishing intellectual level based on test performance, others 
focusing on assessing developmental level based on observation. Furthermore, 
the recruitment advertisement explicitly focused on a possible relation 
between Möbius syndrome and autism, which might have brought about an 
overrepresentation of patients with symptoms of both syndromes, thus biasing 
the selection of patients. Cronemberger et al. found a varying degree of mental 
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retardation in 75% of patients with Möbius syndrome.9 However, the institution in 
which this study was performed was a national referral centre for the treatment 
of patients with cerebral palsy, which most likely also represents a selection bias. 
Moreover, the age of more than two-thirds of the patients involved was less than 
43 months. Subsequently, mental retardation had to be established based on 
the overall level of development of the subjects rather than on their intellectual 
performance. The accuracy of this measure is debatable as we have demonstrated 
that motor development in Möbius syndrome is retarded due to lower brainstem 
involvement.2 Johansson et al. reported mental retardation to be present in 33% 
of the patients involved.11 Since many participants in this last study were referred 
from habilitation units with the prime goal of analysing the prevalence of autistic 
disorders in Möbius syndrome, patients with severe and multiple disorders might 
have been overrepresented. Besides, mental development was mainly assessed on 
the basis of clinical observation, information about the educational level, estimates 
of cognitive development and measures of social behaviour. Less than one-third of 
the participants was evaluated using standardized intelligence tests.
Summarizing the three studies mentioned above, it seems that the prevalence 
of mental retardation in patients with Möbius syndrome is high. The selection of 
patients and the methods of measurement do, however, shed some doubts on 
the validity of the ﬁndings reported. Consequently, the high prevalence ﬁgures 
of mental retardation in these studies have to be interpreted with caution and 
cannot be extrapolated to the entire Möbius population.
In our study, we initially included 37 patients with Möbius syndrome, all 
of whom met the inclusion criteria of the syndrome and were sent to us by 
the Dutch medical community and the Dutch Möbius association in 1996 and 
1997. The composition of our group of patients suggests that we studied a true 
cross-section of the Dutch population. Because of the overlap of patients, i.e. 
patients recruited by both the Dutch medical community and the Dutch patients’ 
organization, especially of those patients in the first decade, we are confident 
that we have identified all Dutch patients born with Möbius syndrome in these 
two years, and to the best of our knowledge, have identified all names of older 
patients with Möbius syndrome known at that time. Therefore, we are confident 
that our previous study can be considered to be population-based.2 From this 
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population-based sample, we selected patients and used only one exclusion 
criterion; the participants had to be 17 years of age or older in order to avoid 
the use of heterogeneous and non-equivalent tests to assess a single ability 
such as intelligence, attention and memory, as this in our opinion has biased 
former studies. Based on the above, we believe our patients to be a reliable 
representation of the entire Dutch Möbius population, despite the fact that the 
group of patients aged 17 years or older is smaller than expected considering the 
birth rate in younger age groups.2 This discrepancy might be explained by several 
factors: older individuals with Möbius syndrome were hesitant about registering 
for the Möbius Syndrome Association and old records were not available, 
had been lost or discarded, because most patients did not feel the need for a 
regular follow-up.  Also, some patients might not have been recognized as having 
Möbius syndrome as we found that media attention resulted in several patients 
recognizing their syndrome for the first time. On the other hand, the discrepancy 
cannot be explained by an excessive death rate, as there is no disorder, which is 
part of the Möbius syndrome or related to it that causes an early demise. With 
the exception of the one patient with autism, all school-age children below the 
age of 17 years, who were excluded from this study, attended normal elementary 
and secondary school, thus contradicting an increased rate of occurrence of 
mental retardation. Consequently, it is plausible that the test results in our group 
of 12 patients can be extrapolated to the entire Dutch Möbius population. 
In assessing intellectual performance, we found that the mean IQ-score of 
our patients did not differ from that of the Dutch population. Since we did not 
include a matched control group in our study, one might argue that our data 
reﬂect a bias resulting from the composition of our group not being matched to 
the Dutch norm group of the GIT. We have a fairly ﬁrm indication that this is not 
the case: not only the mean, but also the standard deviation of our intelligence 
scores (SD = 14.7) is almost identical to that of the Dutch norm group (SD = 
15.0). The discrepancy between previous studies and ours can best be explained 
by the care we took to minimize selection of patients and by the methods of 
measurement. Our sample is very small but is composed of all available patients in 
The Netherlands.
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Of the total group of 37 patients, two (5.4%) showed signs of mental 
retardation. Since, an IQ of 75 in a standard population equals the ﬁfth percentile 
(mental retardation is deﬁned as IQ ≤ 75), we demonstrated evidence that 
the occurrence of mental retardation in patients with Möbius syndrome is not 
signiﬁcantly different compared to the normal Dutch population. 
In the two mentally retarded patients, autism occurred. This is 5.4% of the 
total group, a ﬁnding which suggests an association between mental retardation 
and autism rather than between mental retardation and Möbius syndrome. In this 
sense, we were unable to support the notion of a strong association of Möbius 
syndrome and autism as has been suggested.10,11  
Furthermore, we screened major aspects of attention and memory in order 
to assess pervasive dysfunction in these cognitive domains in Möbius patients 
who were not mentally retarded. In evaluating attention with the Stroop task, the 
Möbius patients showed a slower performance according to the norms of the 
Dutch population in part A as well as in part B. However, their mean interference 
score that corrects for differences in speed of word production in part C, 
showed a normal performance. The discrepancy in performance on Stroop A 
and B can best be explained by problems such as dysarthria and eye movement 
disturbances causing slowness of talking and reading, and is not likely to indicate 
central nervous participation. 
In assessing memory function with the VLGT, the mean scores of the Möbius 
patients, reﬂecting short-term memory and long-term memory, did not deviate 
from the average performance in the normal population. We are aware that our 
study did not involve a comprehensive assessment of all aspects of information 
processing. In Möbius patients without autism and associated mental retardation, 
speciﬁc and subtle deﬁcits cannot be excluded on the basis of our results in a 
relatively young group of Möbius patients. However, the presence of ﬁrm deﬁcits 
in the domain of information processing is not plausible.    
From a neuropsychological point of view, Möbius patients are able to function 
in the same way as healthy subjects. This opinion is supported by the report of 
Meyerson who summarized that many adults with Möbius syndrome were or had 
been gainfully employed in a variety of professional and vocational positions.22 
In addition, on the ICF levels ‘activity limitation’ and ‘participation restriction’ 
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according to the World Health Organization, our Möbius patients had moderate 
difﬁculties with the performance and capacity of communication as far as speaking 
and producing non-verbal messages was concerned, and with interpersonal 
interactions and relationships. Most probably, because of lack of facial expression 
and good articulation, communication and interpersonal interactions are difﬁcult. 
Despite these problems, however, no difﬁculties were demonstrated with 
education, employment, economic independency, nor with areas of community, 
religious, recreational and political life or human rights. No performance problems 
were present in any other domains of these ICF levels, such as learning, mobility, 
general tasks, self-care and domestic life. The capability for eating, drinking and ﬁne 
hand movements and walking was mildly to moderately reduced in our Möbius 
patients, probably because of combined facial, lingual and palatal abnormalities and 
clumsiness, respectively.
In addressing the Möbius patient, health care professionals should be aware 
that their retarded appearance may cause certain limitations in social and 
interpersonal interaction, but should realize that these limitations in general do 
not reﬂect mental retardation or more speciﬁc cognitive dysfunction.  
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The neuropathology of 
Abstract
Objective
To characterize the neuropathology of hereditary congenital facial palsy. 
Methods
The authors compared brainstem pathology of three members of one family with 
autosomal dominant congenital facial palsy to that in three age-matched controls. 
The neuropathological ﬁndings of the familial patients were compared with those 
of patients with Möbius syndrome. 
Results
The authors observed a marked decrease in the number of neurons in the facial 
motor nucleus with corresponding small facial nerve remnants. In the patients 
with congenital facial palsy the number of facial motoneurons ranged between 
280 and 1,680 as compared to 5,030 and 8,700 for controls. No signs of neuronal 
degeneration or necrosis with neuronal loss, gliosis, or calciﬁcations were present. 
There were no other abnormalities of the rhombencephalon and its associated 
structures. The corticospinal tracts were fully developed. In contrast, Möbius 
syndrome is part of a more complex congenital anomaly of the posterior fossa 
with hypoplasia of the entire brainstem, including the traversing long tracts, with 
signs of neuronal degeneration and other congenital brain abnormalities. 
Conclusion
Neuropathological ﬁndings conﬁrm clinical observations that hereditary 
congenital facial palsy and Möbius syndrome are two different entities with a 
different pathogenesis.
vs Möbius syndrome
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Introduction
In 1888, Möbius reported patients with congenital nonprogressive bilateral facial 
and abducens nerve palsy.1 A clear delineation of the Möbius syndrome has been 
hampered by varying deﬁnitions. Isolated congenital facial palsy and the extended 
phenotype of congenital facial palsy with ocular muscle weakness, with or without 
craniofacial dysmorphisms and congenital abnormalities of the extremities were 
criteria for the diagnosis of Möbius syndrome.2 Recently, we suggested facial 
palsy with impairment of ocular abduction as the primary criterion for Möbius 
syndrome.3 While dysfunction of other cranial nerves, orofacial malformations, 
limb malformations, and musculoskeletal system defects are associated features, 
we did not consider them.3 By restricting the deﬁnition, we excluded congenital 
facial palsy, and ascertained on clinical grounds that congenital facial palsy is a 
separate entity.
While unilateral facial palsy might be caused by an obstetric trauma, facial 
palsy in the absence of trauma, either uni- or bilateral, appears to be a genetic 
condition for which we have found two separate loci on 3q4 and 10q.5 Moreover, 
in three unrelated patients congenital unilateral facial nerve palsy has been 
described as part of a wider syndrome on chromosome 22q11.6 The pathogenesis 
of Möbius syndrome is unclear as hereditary cases are rare and most cases 
are sporadic.3 Two explanations have been proposed: a primary genetic7,8 and a 
primary ischaemic cause.9-11 Teratogenicity has been suggested as an important 
environmental possibly secondary factor in both explanations.12 The postulated 
pathogenetic mechanisms in Möbius syndrome are based on limited pathological 
observations.13 Previously, we suggested, on clinical grounds, that Möbius 
syndrome is more than a cranial nerve or nuclear developmental disorder and 
that it could be viewed as a rhombencephalic developmental disorder with 
variable severity, involving motor nuclei and axons, as well as traversing long 
tracts.3 
To investigate the hypothesis that hereditary congenital facial palsy and Möbius 
syndrome are two different entities, we studied the brainstem of three members 
of one family with autosomal dominant congenital facial palsy, and compared these 
ﬁndings with those of patients with Möbius syndrome.
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Methods
In a family with autosomal dominant congenital, nonprogressive facial palsy, either 
uni- or bilateral,4 three affected female members died: two of them, sisters, at 
the ages of 88 (patient 1; II-44) and 86 years (patient 2; II-64), due to no speciﬁc 
cause. The third case, a grand-daughter of patient 2, died suddenly because of an 
undiagnosed acute bacterial meningitis, at the age of 41 years (patient 3; IV-64). 
Patients 1 and 2 demonstrated a bilateral congenital facial paresis; in patient 1 
the left side was more affected than the right side and in patient 2 the right side 
was more affected than the left side. Patient 3 showed a congenital right-sided 
facial palsy. From our neuropathological archive, we randomly selected three 
age-matched control subjects who died without clinical evidence of brainstem 
pathology.
Furthermore, a sporadic patient with Möbius syndrome, a girl born at 37 
weeks after an uneventful pregnancy, died at the age of 11 days due to severe 
primary respiratory dysfunction. This patient demonstrated facial diplegia, 
horizontal gaze palsy, oral dysfunction, craniofacial and extremity malformations 
and severe muscle hypotonia (case 333). 
The brains of all subjects were ﬁxed in 10% phosphate-buffered formalin for 
routine parafﬁn sectioning. In addition to routine sampling, the entire brainstem 
from the mesencephalon through the medulla oblongata was blocked into 5 
mm thick transverse slices for hematoxylin-eosin sectioning. The brainstem was 
serially cut into 8 µm thick sections that were stained with hematoxylin-eosin, 
Luxol fast blue-hematoxylin-eosin and cresyl violet.
The number of cells in each facial nucleus was estimated by counting the 
distinct nucleoli of facial motoneurons present in every tenth section and by 
multiplying the number obtained by 10.14  
Results
In all familial cases, neither cerebral nor cerebellar hemispheres showed obvious 
pathological changes, except for evidence of an acute bacterial meningitis in 
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patient 3. The brainstem was macroscopically normal and no hypoplasia or 
malformation of the rhombencephalon were observed. The corticospinal long 
tracts were fully developed. In the sporadic patient, the cerebral hemispheres 
and the cerebellum were normal. The brainstem (Figure 1) was asymmetric and 
hypoplastic with dysplastic, centrally situated inferior olivary nuclei and dysplastic 
pyramidal tracts which failed to decussate.15
In the familial cases, on sectioning the brainstem, all pairs of cranial nerves 
were identified and appeared, with the exception of the seventh, to be fully 
developed. Microscopic examination of the facial nuclei and nerves revealed the 
following changes. Patient 1 (Figure 2) showed bilaterally a decrease in number 
of neurons with preservation of a few normal neurons which lay scattered in 
the region of the seventh motor nucleus, the left side being more affected than 
the right side (Table 1: left 520 and right 950 motoneurons). Both facial nerves 
consisted of a few fine fibres only. Patient 2 (Figure 3) demonstrated a decreased 
number of facial neurons on both sides, the right side being more affected than 
the left side (see Table 1: left 960, right 600 motoneurons). The intramedullary 
Figure 1. Sporadic patiënt with Möbius syn-
drome. (A) At the level of the upper medulla 
oblongata malformations in the long tracts and 
in other nuclei than the facial nuclei are present 
(LFB-HE-stain). The inferior olives (IO) on both 
sides meet each other in the midline, above the 
dysplastic pyramids with on the left side one large 
pyramid and on the right side several bundles. 
Several areas of destruction of tegmental nuclei 
with calciﬁcations are present (arrows). (B) Detail 
in box with microcalciﬁcations, gliosis and en-
crusted neurons (arrows; hematoxylin-eosin stain).
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Figure 2. (A) Patient 1 with asymmetric, bilateral facial palsy (Luxol fast blue-hematoxylin-
eosin stain; LFB-HE). (B,C) Detail in boxes with a marked decrease in number of neurons 
bilaterally in motor facial nucleus, with a few normal neurons preserved, the left side (B) being 
more affected than the right side (cresyl violet stain).
Figure 3. (A) Patient 2 with asymmetric, bilateral facial palsy (LFB-HE). (B,C) Detail facial 
nucleus in boxes with a marked decrease in number of neurons in both facial motor nuclei,
the right side (C) being more affected than the left side (cresyl violet stain).
Figure 4. (A) Patient 3 with right-sided facial palsy (LFB-HE). (B,C) Detail in boxes: on the left 
side (B) normal facial neurons, on the right side (C) a decrease in number of neurons in the 
facial motor nucleus (cresyl violet stain).
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fibre tract of both facial nerves was also underdeveloped. In patient 3 (Figure 4), 
an evident decrease in the number of neurons in the right facial motor nucleus 
was present (see Table 1: 280 motoneurons). Corresponding to the decrease in 
the number of cells in the facial nuclei, the roots of the right facial nerve were 
only sparsely developed. The left seventh motor nucleus and nerve apparently 
looked normal, but the facial motor nucleus contained only 1,680 neurons 
whereas neuron counts in the three controls varied from 5,030 to 8,700 (see 
Table 1) within the range of 4,500 to 9,460 described before.14 In the sporadic 
case, we found neuronal loss, gliosis and microcalcifications in the paramedian 
tegmentum at the junction between the lower pons and the medulla oblongata 
but also more ventrally in the medulla oblongata, affecting the medial reticular 
nuclei, the VIth, VIIth and XIIth cranial nerve nuclei. Additionally, many other 
malformations were present in this Möbius patient (Table 2). 
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Discussion
To date, this is the ﬁrst neuropathological study of hereditary congenital facial 
palsy in several cases from one family; only ﬁve neuropathological studies on 
sporadic congenital facial palsy have been reported.16-20
In the clinical and genetic literature, a long-standing discussion exists about 
whether congenital facial palsy and Möbius syndrome are one and the same 
entity.21 Congenital facial palsy, both with and without ocular muscle weakness, 
appears in the literature as the criterion for the diagnosis of Möbius syndrome.2 
Recently, we suggested congenital facial palsy with impairment of ocular abduction 
as the primary criterion for Möbius syndrome.3 By restricting the deﬁnition, we 
excluded congenital facial palsy.
Obviously, Möbius syndrome is unlikely to be a single entity, as in the limited
pathological observations in patients classiﬁed as having Möbius syndrome 
rather different lesions have been described; four groups of pathology have been 
categorized (see Table 2).13 Group I is characterized by hypoplasia of cranial 
nerve nuclei and is probably a result of rhombomeric maldevelopment. Group II 
includes neuronal loss and evidence of neuronal degeneration possibly secondary 
to a primary physical defect in the peripheral part of the facial nerve. Group III 
demonstrates, in addition to a decreased number of neurons and degeneration, 
focal necrosis with gliosis and calciﬁcations in the region of the tegmentum of the 
lower pons and medulla where brainstem nuclei are located. These ﬁndings may 
be due to vascular insufﬁciency.9-11 However, calciﬁcations in cases with Möbius 
syndrome equally support the concept of a maldevelopmental pathogenesis, as 
occurs in other developmental disorders.22 No mention is made of descending 
tract degeneration in this group. Group IV consists of primary myopathic changes 
without lesions in the cranial nerve nuclei or nerves. 
The pathological findings in our patients with hereditary congenital facial 
palsy consist of hypoplasia of the facial motor nuclei and nerves. No brainstem 
hypoplasia or maldevelopment of the long tracts, such as the corticospinal tracts 
were observed, which is in line with the absence of clinical signs of involvement of 
these tracts. In contrast, all our cases with Möbius syndrome, forming a spectrum, 
ranging from the severest affected patients with tegmental calcifications whether 
or not associated with marked brainstem hypoplasia, patients with brainstem 
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hypoplasia to cases without brainstem hypoplasia, show clumsiness, i.e. lack of 
fine motor skills, poor coordination and poor balance performance. The degree 
of clumsiness is greater than could be explained by foot and hand deformities, 
and is probably the result of hypoplasia of of either the corticospinal or 
corticopontocerebellar tracts, or of hypoplasia of the cerebellum.3 Except for two 
reports of Möbius patients and progressive spastic paresis,23,24 no mention is made 
in the literature about involvement of the long tracts in Möbius syndrome. We 
found support for our long tract hypothesis in two cases with Möbius syndrome 
who have been described previously,25 and in the present sporadic case in whom 
the architecture of the entire brainstem, including part of the long tracts, was 
thoroughly affected by dysgenesis, degeneration and necrosis (see Figure 1). The 
corticospinal tracts were dysplastic and failed to decussate.15 Recently, in patients 
with horizontal gaze palsy with progressive scoliosis (HGPPS), the gene ROBO3, 
which encodes an axon-guidance protein that is required for hindbrain axon 
midline crossing, has been identified.26 
Our pathological findings showed conclusively that in hereditary congenital 
nonprogressive facial palsy a central defect is crucial, and that this defect is due 
to a developmental hypoplasia limited to the facial motor nuclei, rather than 
to a primary developmental disorder of the entire lower brainstem including 
traversing long tracts, or to acquired degeneration or atrophy of the cranial 
nuclei.  A primary ischaemic process in the brainstem, a primary developmental 
disorder of the facial muscle and a primary defect in the periphery of the 
facial nerve could be excluded as the primary mechanism of pathogenesis. This 
nuclear maldevelopment may also be the pathogenetic mechanism in sporadic 
patients with uni- or bilateral congenital facial palsy, as demonstrated in the 
case of Richter.19 The great majority of cases of congenital facial palsy, especially 
unilateral, are, however, the consequence of antepartum or intrapartum injury 
to the facial nerve or nucleus,27,28 and might be misnamed in some instances as 
having Möbius syndrome.16-18,20 The neuropathological observations in our familial 
cases could be compared with the pathological findings in cases of Group I.13 
Obviously, both the extent of structures involved and the severity of involvement, 
which is in accordance with the clinical heterogeneity, are far greater in cases 
with an extended phenotype of congenital facial palsy than in cases with isolated 
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congenital facial palsy (see Table 2). Much more striking is the difference between 
pathological findings in our familial cases compared to the findings in our present 
sporadic case with Möbius syndrome, which can be classified into Group III13 
and demonstrated contiguous destruction of the entire brainstem including the 
traversing long tracts.
In hereditary congenital facial palsy, a primary disorder of the fourth 
rhombomere has been suggested since facial motoneurons arise in this 
rhombomere.29 Each rhombomere is characterized by a unique combination of 
Hox genes.30-32 The Hoxb1 gene is expressed only in the fourth rhombomere. 
Mice with targeted disruption of Hoxb1 fail to form the facial motor nucleus.33 
In other mouse models, such as the Kreisler mouse34 and Krox20-/- mice,35 
rhombomeres 5 and 6 and 3 and 5 are absent, resulting in more extensive 
patterns of absence of brainstem motoneurons. In Kreisler, the abducens nucleus 
and visceromotor, parasympathic motoneurons of the facial nerve, both formed 
in the fifth rhombomere, are absent but facial motoneurons are present. In 
Krox20-/- mutants, the abducens nucleus and the facial visceromotoneurons are 
absent, whereas the branchiomotor facial nucleus is hypoplastic. In the linkage 
intervals for hereditary congenital facial palsy on chromosomes 34 and 105, 
we investigated two human orthologs of genes that show involvement in Hox 
signalling; GATA2 at chromosome 3q21 and EGR2 at chromosome 10q21.3. 
GATA2 expression is restricted to rhombomere 4 during murine embryology 
and its expression is directly regulated by Hoxb1.36 Failure to express GATA2 
during murine development abolishes the downstream expression of GATA3, and 
results in a phenotype similar to the Hoxb1 knockout mouse. EGR2 is the human 
ortholog for murine Krox20, a gene regulating the expression of several Hox 
genes involved in hindbrain development, including Hoxa2, Hoxb2 and Hoxb3.37-39 
EGR2 was, therefore, considered to be an excellent candidate gene for hereditary 
congenital facial palsy, even though it was positioned just outside the linkage 
interval. However, sequence analysis of the GATA2 and EGR2 genes in members 
from the corresponding families did not yield causative mutations,40 and so these 
genes are not causally involved in hereditary congenital facial palsy.
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This report strengthens the brainstem pathogenetic mechanism in 
congenital facial palsy, one of the disorders recently deﬁned as congenital cranial 
dysinnervation disorders (CCDD).41 The CCDDSs encompass congenital, 
nonprogressive, sporadic or familial abnormalities of cranial musculature that 
result from developmental abnormalities of, or the complete absence of, one 
or more cranial nerves with primary or secondary muscle dysinnervation. 
Probably the same developmental mechanism is involved in cases of Möbius 
syndrome; however, in Möbius syndrome a developmental defect of the entire 
lower brainstem is implied with possibly different mechanisms leading to a similar 
phenotype. 
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Abstract  
Objective
To detail the radiological ﬁndings in Möbius syndrome, in order to clarify its 
pathogenetic mechanisms. 
Methods
High resolution three-dimensional T1 (MP rage) and T2 (CISS) weighted MRI were 
used to study the cisternal and canalicular portion of the seventh cranial nerve 
in six Möbius patients.  Also, the anteroposterior dimension of the brainstem 
was measured at the level of the pons in the authors’ 6 patients and in 20 age-
matched healthy control subjects. Furthermore, the MRIs were evaluated for 
associated congenital brain anomalies. 
Results
The facial nerves were absent in all six patients despite residual function in some 
facial muscles. The authors conﬁrmed brainstem hypoplasia but did not ﬁnd 
tegmental calciﬁcations. The anteroposterior dimension of the brainstem ranged 
between 17 and 25 mm vs 20 to 27 mm for controls. In three patients there were 
congenital abnormalities in the posterior fossa. 
Conclusion
The absent facial nerves on MRI and the unusual distribution of the facial 
weakness, which is characteristic of Möbius syndrome, suggests that other cranial 
nerves, possibly the trigeminal, hypoglossal or glossopharyngeal nerve, aberrantly 
innervate some lower facial muscles. Radiological ﬁndings support the notion 
that Möbius syndrome is part of a more complex congenital anomaly of the fossa 
posterior. 
Radiological evidence for absence of 
the facial nerve in Möbius syndrome      
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Introduction
Möbius syndrome is a rare congenital disorder characterized by congenital 
facial weakness with impairment of ocular abduction.1 Dysfunction of other 
cranial nerves, orofacial malformations, limb malformations and musculoskeletal 
system defects are common associated features, but they are not obligatory 
for the diagnosis. The syndrome is, therefore, extremely variable in its clinical 
manifestations.1
Möbius syndrome is most frequently described as a sporadic condition. 
However, rare instances of autosomal dominant, autosomal recessive and X-linked 
recessive inheritance have been reported.1 Cytogenetic studies have suggested 
two loci for Möbius syndrome: 1p22 and 13q12.2-13.1
Neither aetiology nor pathogenesis of the syndrome have yet been elucidated 
and are likely to be diverse in nature.1 Two major pathogenetic explanations 
have been suggested: a primary genetic cause, implying a maldevelopment of 
the brainstem, and a primary ischaemic cause, possibly due to embryological 
or environmental toxic factors mediating an interruption in the blood supply 
of the brainstem during early embryological development.1 Teratogenicity has 
been suggested to be an important additional factor in both mechanisms.1 
The postulated pathogenetic mechanisms are based on a few postmortem 
observations, which include hypoplasia of cranial nerve nuclei with or without 
active neuronal degeneration and focal necrosis with neuronal loss, gliosis and 
calciﬁcations in the brainstem.1
Previous radiological studies in patients with Möbius syndrome have been 
aimed at identifying hypo- or dysplasia of the brainstem and at identifying markers 
of post-hypoxic ischaemic damage, such as calciﬁcations in the ﬂoor of the 4th 
ventricle or in the nuclei of cranial nerves; imaging of the cranial nerves in Möbius 
syndrome has not been reported before. 
In a previous study, we analysed the clinical variability of Möbius syndrome.1 
There, we argued that Möbius syndrome is more than a cranial nuclear 
developmental disorder and that it could be viewed as a rhombencephalic 
developmental disorder with variable severity, involving motor nuclei and axons, 
as well as traversing long tracts, in which in extreme cases the caudal part of the 
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brainstem is so poorly developed that central respiratory dysfunction occurs. 
In order to support this new concept and to gain insight into the pathogenetic 
mechanism of the syndrome, we performed MRI studies of the brain in patients 
with Möbius syndrome to identify the rhombencephalic structures involved, the 
severity of involvement and the type of damage as an indicator of either a genetic 
or an ischaemic cause.  
 
 
Subjects and methods 
 
Subjects
In a previous study, we examined 37 Dutch patients with Möbius syndrome 
in a nationwide survey.1 At the time of the study, the group of participants 
varied in age from 6 months to 53 years.  All patients met the inclusion criteria: 
nonprogressive congenital facial weakness and impairment of ocular abduction. 
For the present study, we randomly selected six cooperative patients (ﬁve male 
and one female), from this group of 37 patients. The youngest patient was 12 years 
of age; the oldest, 24. Consent for the MRI study was obtained from patients and 
parents. From our radiological archive we randomly selected 20 control subjects 
without clinical evidence of pathology of the posterior fossa or supratentorial 
lesions inﬂuencing the posterior fossa who had undergone brain MRI for other 
reasons. Ten controls were born between 1975 and 1985 and 10 between 1985 
and 1995.
 
MRI
In our patients we used a three-dimensional T1-weighted, gradient echo technique 
(MP rage), encompassing the whole head and allowing reconstruction of 1 mm 
thick slices in any desired plane, and a three-dimensional constructive interference 
in steady state (CISS) sequence, resulting in slightly T1-weighted, heavily T2-
weighted images, allowing identification of cranial nerves in their cisternal part. 
This latter technique allows reliable imaging of the cisternal part of the third, 
fifth, seventh and eighth cranial nerves. Flow artefacts are minimized by averaging 
two scans which are acquired with opposite-direction phase cycling of excitation 
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RF pulses. Parameters for these sequences were as follows: three dimensional 
gradient echo (MP rage)—repetition time (TR) 1,900 msec, echo time (TE) 3.93 
msec, flip angle (FA) 15 degrees, bandwidth 210 Hz, resolution 1 x 1 x 1 mm; and 
three-dimensional-CISS—TR 10.13 msec, TE 5.06, FA 70 degrees, bandwidth 130 
Hz, 32 partitions, resolution 0.6 x 0.5 x 1.0 mm.
Midsaggital anteroposterior diameter measurements of the pons, measured 
at its largest distance perpendicular to the ﬂoor of the fourth ventricle were 
reproduced ﬁve times in six patients and in 20 age-matched, healthy control 
subjects.2 The imaging studies were performed and reviewed by one of the 
authors, a qualiﬁed neuroradiologist (J.V.). 
Statistics
Midsaggital anteroposterior diameter measurements of the pons in Möbius 
patients were compared with the diameter measurements in healthy control 
subjects. The results were analysed using the Mann-Whitney U test. Results with p 
values less than 0.05 (two-sided) were considered to be signiﬁcant.
Results
Subjects           
The clinical features of six patients with Möbius syndrome are summarized 
in Table 1.  All patients, except Patient 5, were born at term following an 
uncomplicated pregnancy and delivery. Patient 5 was born prematurely at 36 
weeks by Cesarean section because of placenta praevia and prenatal asphyxia. 
In this patient the pregnancy was complicated by vaginal blood loss in the 28th 
week. In all patients, post-vital functions, including respiratory functions, were 
normal. None of the patient’ family history was remarkable.                 
     Neurological examination revealed a paralysis of the upper facial muscles 
and a paresis of the lower facial muscles including the perioral muscles and 
platysma in four patients, and a complete bilateral facial palsy in two patients. 
Duane syndrome type III, characterized by marked limitation of both abduction 
and adduction of the eyes and retraction of the eye on attempted adduction, was 
Radiological absence of the facial nerve in Mobiüs syndrome
141
present in four cases. One case demonstrated Duane syndrome type I, consisting 
of marked limitation of abduction with minimally defective or normal adduction 
and retraction of the adducting eye, and the sixth patient had a horizontal gaze 
palsy.  All patients showed hypoglossia: two had an asymmetric hypoplastic tongue 
and one a paretic tongue. Oral dysfunction was demonstrated by swallowing 
difﬁculties, palatal weakness, regurgitation, or dysarthria. Except for conductive 
hearing loss of 20 dB on both sides in case 2, there was no hearing impairment. 
All patients showed craniofacial malformations including epicanthic folds, a 
ﬂattened nasal bridge, hypertelorism, microphthalmia, micrognathia, high arched 
palate, dental defects, lacrimal duct defects and external ear defects. None of the 
cases was mentally retarded. Five cases showed hand malformations including 
metacarpal hypoplasia, brachydactyly, syndactyly, or camptodactyly. Four cases 
had talipes equinovarus with lower leg hypoplasia. Case 4 demonstrated scoliosis, 
kyphosis, lumbar vertebral defects and aplasia of abdominal muscles.  All patients 
had a delay in motor development; it took longer than average to master the 
major motor milestones. Clumsy motor performance and dysdiadochokinesis was 
present in all cases, and an abnormal tandem walk in ﬁve of them. Case 4 showed 
hypotonia until one year of age and an axial imbalance until three. 
MRI  
Figure 1 demonstrates how the three-dimensiomal CISS technique can assist in 
diagnosing eighth cranial nerve pathology. This figure shows, in a child analysed 
for possible cochlear implantation, absence of the cochlear nerve on the left side, 
which is a clear contraindication for the procedure.
We made use of this technique to analyse in particular the seventh cranial 
nerve in patients with Möbius syndrome, and compared the images obtained 
with normal findings. We used both images in the transverse plane to compare 
the right and left sides (Figure 2), and 1 mm thick reconstructions perpendicular 
to the internal auditory channel (Figure 3). In these latter images four dots can 
be identified, representing the facial nerve, the acoustic nerve, the superior 
vestibular nerve and the inferior vestibular nerve. 
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Table 2 lists the abnormalities of the seventh cranial nerves in all six patients, 
and in addition other abnormalities of the posterior fossa. From this table it 
is clear that in five of the six patients, the seventh cranial nerve could not be 
detected on both sides using the three-dimensional-CISS sequence. In case 4, the 
inner auditory cannal was narrow on one side and perpendicular reconstruction 
was inconclusive, suggesting absence of the seventh cranial nerve. In cases 2 and 
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Figure 1. Three-dimensional constructive interference in steady state (CISS) study in a patient consid-
ered for cochlear implant on the left side. The cochlear nerve on the left side is absent.
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5 no clear separation of structures in the internal acoustic meatus was possible, 
perhaps because of adhesions. The remaining structures in the internal acoustic 
meatus were clustered, and there was no structure recognizable on the locus of the 
facial nerve.
The mean anteroposterior diameter measurements of the pons in Möbius 
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Figure 2. Three-dimensional constructive interference in steady state (CISS) images of normal pon-
tocerebellar cisterns. The seventh and eight nerves are clearly demonstrated. Also the loop of the AICA 
is visualized. Three-dimensional CISS images of a patient with Möbius syndrome showed absence of 
the seventh cranial nerve on both sides.
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Figure 3. Three-dimensional constructive interference in steady state (CISS) sequences with reconstruc-
tions perpendicular to the internal meatus, showing four nerves within the internal meatus acousticus of 
a control subject, and three nerves, with absence of the facial nervex, in a patient with Möbius syndrome.
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patients (Figure 4) was 19.7 mm (SD = 2.9) whereas the normative mean was 
22.5 mm (SD = 1.47) (p = 0.018). No tegmental calcifications were present. 
In three patients there were congenital abnormalities of the fossa posterior: 
Arnold-Chiari malformation in patients 1 and 6, a pineal cyst in patient 1, a 
deformed pons due to the Chiari malformation in patient 6 (see Figure 4) and an 
enlarged mastoid cavity on the left side with a hypoplastic hemicerebellum and 
asymmetric lateral ventricles in patient 4. 
Discussion
To date, most studies on radiological findings in Möbius syndrome have been 
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case reports in which CT or MRI studies of the brain appeared as part of a 
routine diagnostic workup.  Apparently, these studies were carried out without 
the appropriate settings for detailed examination of the rhombencephalon. In 63 
cases with Möbius syndrome, 52 CT and 33 magnetic resonance (MR) scans have 
been performed. Table 3 summarizes these reports of imaging studies, and also 
the CT and MRI studies which were carried out as part of the routine diagnostic 
workup in 22 patients, i.e. approximately 50%, from our previous clinical study.1 
In the literature, 28 CT3-21 and 15 MRI8-11,15,17,18,20-24 studies were considered 
unremarkable. Hypoplasia of the brainstem has been demonstrated in five CT5,6,25-
27 and 13 MRI12,18,20,25,26,28-32 studies, in which no quantitative measurements of the 
brainstem were presented. Sixteen CT studies7,12,20,23,25-27,33,34 and one MRI study25 
demonstrated calcifications in the brainstem tegmentum, adjacent to the floor 
of the fourth ventricle, and two CT scans22 showed bilateral calcifications in the 
basal ganglia and thalamus.  A hypoplastic cerebellum was seen in four CT6,25,28,35 
and seven MRI24,25,28,29,31,34,36 studies, two of theses cases demonstrating hypoplasia 
�
�
Figure 4. T-1weighted MR images 
of patients 1and 6. (A) Arnold-
Chiari and pineal cyst in patient 1. 
Normal measurement of the mid-
saggital anteroposterior diameter 
of the pons (line). (B) Arnold-Chiari 
and a deformed pons in patient 6.
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of the vermis35,36 and another poorly defined vermian fissures.29 In 12 of 63 cases, 
other brain malformations have been described such as bilateral ventricle enlarge
ment,18,24,31,36,37 unilateral ventricle enlargement,35,38 hypoplasia 
of the corpus callosum,24,31,35,36 Dandy-Walker variant,6,24,29,35,36 and hydrocephalus 
with aqueductal stenosis5 and a posterior fossal cyst, each in one case.
To the best of our knowledge, the present study is the ﬁrst radiological study 
in Möbius syndrome to illustrate the origin of the cranial nerves in detail. Three-
dimensional CISS sequences allow detailed imaging of the cisternal and canalicular 
portion of both seventh and eighth cranial nerves. The sixth cranial nerves are too 
small to be detected reliably. Using this radiological technique, we were unable to 
visualize the facial nerve in our six patients. This ﬁnding is remarkable because we 
observed residual motor activity in some lower facial muscles. The characteristic 
pattern of facial weakness in Möbius patients consist of severe involvement of 
the upper facial muscles and a relative sparing of the lower facial muscles which 
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contrasts with that found in the common supranuclear and infranuclear types of 
facial palsy.1 Our present radiological ﬁndings suggest that other cranial nerves, 
possibly the trigeminal, hypoglossal, or glossopharyngeal nerve, innervates 
aberrantly some facial muscles especially in the lower part of the face, probably 
due to a mechanism similar to that in Duane syndrome.39 One cannot, of course, 
rule out the possibility that the facial nerve was severely atrophic and escaped 
visualization despite the high spatial resolution of the three-dimensional CISS 
method (0.6 x 0.5 x 1.0 mm in plane resolution); however, it seems unlikely that a 
small nerve remnant could be responsible for the preserved muscle movements 
in the lower half of the face in Möbius syndrome. 
In our patients there were no gross hearing problems were present and, 
accordingly, MRI in all patients demonstrated fully developed statoacusticus 
nerves.
Hypoplasia of the brainstem has been described in 32% of the reported 
radiological studies in the literature in which no quantitative data were presented. 
In this study of relatively mildly affected Möbius patients, we found signs of 
brainstem hypoplasia on the MR by quantitative measurements of the pons. 
These findings support our hypothesis that Möbius syndrome is a developmental 
disorder of the entire lower brainstem. The cases that do not show brainstem 
hypoplasia or show just a mild hypoplasia are generally more mildly affected 
than those with marked hypoplasia, usually the more severely affected young 
patients with respiratory insufficiency. Choosing only fully cooperative patients 
introduced a bias in this study. However, comparing MR findings in our 6 patients, 
who form the less affected part of the Möbius spectrum, with those in 22 Dutch 
Möbius patients covering the whole spectrum of the syndrome, no differences 
were recognized apart from facial nerve absence as demonstrated by the new 
techniques (Table 3). These 22 patients underwent imaging as a routine workup 
soon after birth; they include 2 patients with primary respiratory failure. Our 6 
patients showed associated malformations in the same percentage as in the 22 
other Dutch patients (Table 3).
MRI in all six cases and earlier CT scanning of the brain in three cases (cases 
3, 4 and 6) revealed no tegmental calciﬁcations. MRI is not, however, the best 
instrument for identifying calciﬁcations,12,18,20,23,26,31,34,37 and CT fails to discover 
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mild calciﬁcations.3,5,12,18,37
Reviewing the literature on radiological and pathological reports of Möbius 
patients, it is apparent that all cases with tegmental calciﬁcations or marked 
brainstem hypoplasia on imaging have primary respiratory failure or recurrent 
apneas, and that all patients who died from these respiratory problems have 
both tegmental necrosis with calciﬁcations and marked brainstem hypoplasia at 
autopsy. If marked brainstem hypoplasia is present, it can be taken as a suggestion 
for a possible poor prognosis, an indication strengthened by the additional 
presence of tegmental calciﬁcations. In the literature, none of the patients 
survived primary respiratory dysfunction25,37 and only a minority of cases survived 
episodic apnea without artiﬁcial support.8,17 We therefore suggest measuring the 
pons in patients with Möbius syndrome.
From a clinical point of view, absence of the facial nerves, demonstrated with 
the MR technique used in this study (three-dimensional CISS sequences), is very 
useful for making an early diagnosis of Möbius syndrome and avoids unnecessary 
additional tests.  Also, an imaging study might be helpful in determining the 
prognosis and consequently the clinical management of the patient, especially in 
the management of severely affected patients with primary respiratory failure
Hence, the reported radiological and pathological ﬁndings support the concept 
that in patients with Möbius syndrome with central respiratory dysfunction, the 
entire brainstem, especially the caudal part of the tegmentum, is severely affected.1 
As in other developmental disorders,40 calciﬁcations occur at various sites in 
Möbius syndrome, and consequently they are probably not indicative of a speciﬁc 
pathogenetic mechanism.  
In the present study, all patients showed mild motor signs, such as clumsiness1; 
one of them demonstrated cerebellar hypoplasia, and normal cerebellar volumes 
were present in ﬁve. In some cases, cerebellar hypoplasia is probably in the cause 
of clumsiness. In other cases, mild clumsiness occurs without demonstrable 
cerebellar or pontine hypoplasia and may be related to more subtle hypoplasia of 
the cerebellum or of the corticospinal or pontinecerebellar tracts.1
The concomitant presence of other developmental abnormalities in mildly 
as in more severely affected patient, mentioned both in the literature and in the 
present study (Table 3), suggests that Möbius syndrome is, in some cases, part 
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of a more complex, congenital anomaly of the posterior fossa, a notion that has 
escaped attention in the literature. Our previous clinical study1 and the present 
study point to the same conclusion: Möbius syndrome should be viewed as a 
single entity, a developmental anomaly of the rhombencephalon, in which a wide 
spectrum of structures is involved to varying degrees of severity. It suggests that 
Möbius syndrome, i.e. the facial weakness and impairment of ocular abduction, is 
only the most salient feature of a more extensive developmental disorder, with 
probably diverse pathogenetic mechanisms. 
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Abstract
Objective
 We studied the nature and extent of facial muscle innervation and the 
involvement of the motor and sensory long tracts in Möbius syndrome, in order 
to shed light on the pathophysiological mechanism of the syndrome. 
Methods
Standardized blink reﬂexes, direct responses of the facial nerves to the orbicularis 
oculi muscles and concentric needle electrode electromyography in orbicularis 
oculi and/or oris muscles were measured in 11 patients with Möbius syndrome, 
of whom six participated in MRI studies, all showing absent facial nerves. We 
performed motor- and somatosensory-evoked potentials in seven Möbius 
patients.
Results
We demonstrated three distinct patterns of abnormalities suggesting different 
sites of the primary lesion in different patients. (i) Presence of normal blink 
reﬂexes and facial compound motor action potentials, normal habituation tests, 
a reduced recruitment in the facial muscles and an aberrant ‘blink reﬂex-like’ 
response of the orbicularis oculi muscle upon stimulation of the facial nerve 
region, which suggests a supranuclear origin of the defect. (ii) Absent blink 
reﬂexes, absent direct responses of the facial nerves and absent motor activity 
on needle electromyography, indicating a defect at the facial nuclear level. 
However, the nuclear defect might mask an additional supranuclear defect, which 
cannot, therefore, be excluded in these patients. (iii) A disperse pattern of facial 
compound action potentials combined with long latencies that were recorded 
with concentric needle electrodes, indicating involvement of motor axons 
in the facial nerve, possibly secondary to nuclear involvement.  An additional 
supranuclear defect cannot be excluded in these cases.  All evoked potentials 
studied were normal. 
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Conclusion
The electrophysiological ﬁndings of the facial muscles show a spectrum of 
disturbances varying in degree of severity and diverse in the extent of structures 
involved, in 11 Möbius patients.  At one end of the spectrum are patients with 
completely immobile faces in whom electrophysiological testing shows no signs 
of involvement of the facial nuclei, nerves or muscles, suggestive of a dysfunction 
at the supranuclear level. At the other extreme of the spectrum are patients 
with complete absence of responses upon facial nerve stimulation and absence 
of motor unit activity. This is at least indicative of a defect at the facial nuclear 
level. While a supranuclear defect is compatible with the concept that Möbius 
syndrome is a developmental disorder of the lower brainstem, intact facial nuclei 
as part of the syndrome has not been suggested before. The ﬁndings corroborate 
the concept of the Möbius syndrome being a complex regional developmental 
disorder of the brainstem. 
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Introduction
In 1888, Möbius reported patients with congenital, nonprogressive, bilateral facial 
and abducens nerve palsy.1 Varying deﬁnitions have hampered a clear delineation 
of the Möbius syndrome. Isolated congenital facial palsy and the extended 
phenotype of congenital facial palsy with ocular muscle weakness, with or without 
craniofacial dysmorphisms and congenital abnormalities of the extremities, were 
criteria for the diagnosis of Möbius syndrome.2 Recently, we suggested facial 
palsy with impairment of ocular abduction as the primary criterion for Möbius 
syndrome.3 Dysfunction of other cranial nerves, orofacial malformations, limb 
malformations and musculoskeletal system defects are commonly associated 
features, but they are not necessary for the diagnosis making the syndrome 
extremely variable in its clinical manifestation. 
Möbius syndrome is most frequently described as a sporadic condition. 
However, rare instances of autosomal dominant, autosomal recessive and even 
X-linked recessive inheritance have been described.3 It is distinct from congenital 
facial palsy, in the sense that in Möbius syndrome abduction impairment is present.
Although neither the aetiology nor the pathogenesis of the syndrome have 
yet been elucidated, there are two theories: a developmental rhombomeric 
defect including the facial cranial nerve nuclei due to a genetic cause,4,5 or an 
interruption in the vascular supply of the brainstem resulting in ischaemia in the 
region of the facial cranial nerve nuclei owing to an environmental, mechanical 
or a genetic cause.6-13 The postulated pathogenetic mechanisms are based on 
limited post mortem observations,14 and the site of the primary lesion has been 
localized in the nucleus, the nerve or the muscle. In a recent pathological study of 
our group, we presented evidence to exclude a primary developmental disorder 
of the facial muscle and a primary defect in the periphery of the facial nerve as 
possible aetiological mechanisms in autosomal dominant congenital facial palsy.15
In our clinical study, we argued that sporadic Möbius syndrome is more than 
a cranial nerve or cranial nuclear developmental disorder, and could be viewed 
as a developmental disorder of the rhombencephalon, including motor nuclei 
and axons, as well as traversing long tracts.3 Our pathological study offered 
support for this hypothesis, which was corroborated recently by pathological 
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data on two patients with Möbius syndrome.16 Also, radiologically, we provided 
evidence for Möbius syndrome being part of a more complex congenital anomaly 
of the posterior fossa with hypoplasia of the entire brainstem and with other 
congenital brain abnormalities.17 Electrophysiologically, this hypothesis has been 
conﬁrmed by the results of brainstem auditory-evoked potentials (BAEPs) in 
several case reports of Möbius patients who had, in the vast majority, normal 
hearing,5,18-36 and by the results of motor-evoked potentials (MEPs) in one 
patient33 and somatosensory-evoked potentials (SSEPs) in ﬁve of seven patients 
studied.18,20,24,30,33 These results are consistent with a lesion of the central pathways 
in the brainstem, suggesting a widespread involvement of the brainstem, possibly 
including the long tracts, as part of the syndrome.
Furthermore, in our radiological paper we demonstrated the absence of the 
facial nerve in six patients with Möbius syndrome.17 This ﬁnding was puzzling in 
the light of the often observed residual motor function in lower facial muscles, 
which is the characteristic pattern of facial weakness in Möbius patients. Our 
radiological ﬁndings argue that other cranial nerves aberrantly innervate some 
facial muscles, especially in the lower part of the face. This innervation is probably 
similar to the mechanism of reinnervation described in Duane syndrome.37,38 
No systemic study has been carried out on the electrophysiological 
characteristics of the facial muscles and nerves in Möbius syndrome. Several 
case reports mention electrophysiological examination without discussing its 
signiﬁcance. To the best of our knowledge, one electrophysiological study of a 
series of seven Möbius patients has been reported, suggesting a brainstem process 
predominantly affecting the facial nuclei and their internuclear connections.32 
In order to study the nature and extent of facial muscle innervation in 
Möbius syndrome and to clarify the pathophysiological mechanism of the 
syndrome, we assessed standardized blink reﬂexes and direct responses of facial 
nerves, and we performed electromyography of facial muscles in 11 patients 
with Möbius syndrome, six of whom lacked facial nerves.  Additionally, to ﬁnd 
electrophysiologically further evidence for a lesion of the motor and sensory long 
tracts at brainstem level, we performed MEPs and SSEPs in seven Möbius patients.
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Subjects and methods
Subjects
In a previous study, we examined 37 sporadic Dutch Möbius patients in a 
nationwide survey.3 All patients met the inclusion criteria of nonprogressive 
congenital facial weakness and impairment of ocular abduction. For the 
present study, we randomly selected out of this group 11 cooperative patients 
in whom we performed blink reﬂexes, direct responses of facial nerves and 
electromyography (EMG) of facial muscles. Six of these patients participated in 
brain MRI studies; facial nerves were absent in all of them. In seven cooperative 
patients we assessed MEPs and SSEPs; of these, six patients had MRI, of which ﬁve 
showed mild brainstem hypoplasia. 
Blink reﬂex 
The blink reﬂex was elicited according to the standard technique of Kimura.39 The 
electrodes were placed over the orbicularis oculi muscles and the supraorbital 
nerves were stimulated by a single stimulus of 0.1 ms duration. The ipsilateral 
early component of the response (iR1) is considered to be delayed if its latency 
exceeds 13.0 ms, and the late ipsi- and contralateral components (iR2 and cR2) 
delayed if their latencies exceed 40 and 41 ms, respectively. In addition, the latency 
difference between the two sides is also considered abnormal if it exceeds 1.2 ms 
for R1 and 5.0 ms for R2. The normal amplitude39 and duration40 of the R1 and R2 
components are shown in Table 1. If the blink reﬂex was present, we performed a 
habituation test. The recovery cycle of the R2 component of the blink reﬂex was 
studied by applying two pulses, with an interval of 1 s, to the supraorbital nerve at 
an intensity of three times the threshold.39,41 In normal subjects the amplitude of 
the R2 decreases to ~30% of unconditioned values.40
Direct response of the facial nerve and electromyography of the facial muscles
The nerves were stimulated with a bipolar block electrode, and all the EMG 
recordings were made using bipolar surface or concentric needle electrodes 
placed on or in various facial muscles. The EMG signals were recorded and stored 
using a two-channel EMG System (Medelec Synergy®
, 
Oxford Instruments, UK). 
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Sweep duration was 20-200ms. Bandpass ﬁlters were set at 20 Hz and 3 kHz. 
The method for eliciting facial nerve conduction was adapted from Kimura.39 
The electrodes were placed over the orbicularis oculi muscles. Direct electrical 
stimulation of the facial nerve below the ear using constant square wave current 
of 0.1 ms duration elicited a facial compound motor action potential (fCMAP) 
of the muscle. The stimulus strength was increased to a supramaximal level. The 
upper limit of normal latency of the fCMAP is set at 4.1ms. In addition, the latency 
difference between the two sides should not exceed 0.6 ms. Table 1 shows the 
normal amplitude of the direct response.39 
Concentric needle EMG studies were performed in the orbicularis oculi 
and/or oris muscles (Table 2).  At rest, attention was focused on spontaneous 
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activity. On planned voluntary muscle contraction, shape and duration of motor 
unit action potentials (MUAPs) were noted, and at maximal effort, the pattern of 
recruitment and the amplitude of the MUAPs were reported. 
Evoked potentials 
MEPs were evoked by a Magstim 200 (2.0 Tesla) magnetic stimulator and recorded 
from both tibialis anterior and vastus medialis muscles. SSEPs were evoked by 
applying electrical stimuli to both median and tibial nerves. Both evoked potentials 
were elicited according to standard techniques.42
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Results
Subjects  
The clinical characteristics of eight male and three female patients with Möbius 
syndrome, the youngest being 12 years and the oldest 49 years of age, are 
summarized in Table 3. Clinical examination disclosed, in seven patients, a paralysis 
of the upper facial muscles and a relative sparing of the lower facial muscles 
including the perioral muscles, and in six patient, a complete facial palsy with 
in three of them a bilateral paralysis. The extent of the residual facial muscle 
function is illustrated in Figure 1. Duane syndrome type I, characterized by 
marked limitation of abduction with minimally defective or normal adduction 
and retraction of the adducting eye, was present in one case. Six patients had 
Duane syndrome type II, characterized by marked limitation of both abduction 
and adduction of the eyes and retraction of the eye on attempted adduction, and 
two patients had horizontal gaze palsy. Trigeminal sensory nerve functions were 
normal in all subjects.  All patients except one showed global hypoglossia, three 
patients had an asymmetrical dysplastic tongue and one patient a paretic tongue. 
In all cases, oral dysfunction, consisting of impaired swallowing, palatal weakness, 
regurgitation or dysarthria was present. These and other clinical characteristics of 
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the patients have been reported in detail.3 The abnormalities of the seventh cranial 
nerve and other malformations of the fossa posterior in six of the 11 patients are 
listed in Table 4. 
Blink reﬂex  
Table 1 shows the blink reﬂex responses. In eight cases (cases 1, 2, 5, 6, 8, 9, 10 
and 11), electrically elicited blink reﬂexes showed absent R1 and R2 responses. 
In cases 3 and 4, iR1 and iR2 responses on the right side could not be elicited; on 
the left side they produced a motor response with prolonged latency and normal 
amplitude in the left orbicularis oculi muscle (Figure 2a) In case 3, on stimulation 
of the left facial nerve, both normal and high voltaged and late and normal 
voltaged motor responses were present in the left orbicularis oculi muscle; no 
motor responses were obtained in the left zygomatic muscle (Figure 2b). Since an 
electrical stimulus to peripheral nerves, speciﬁcally the median nerve at the wrist, 
may induce a startle response in the orbicularis oculi muscles,41 the right median 
nerve was stimulated in case 3, but no motor response was obtained in the left 
orbicularis oculi muscle. In case 7, a normal blink reﬂex was obtained. In cases 3, 4 
and 7, the habituation test was normal. MRI in cases 3 and 7 revealed absence of 
both facial nerves.
Figure 1. The, for Möbius 
syndrome, characteristic 
distribution of the facial 
palsy, with more severe 
involvement of the upper 
facial muscles. (A) Raising 
eyebrows, (B) smiling.
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Figure 2. (A) In case 3, on stimulation 
of the right facial nerve, a motor 
response with prolonged latency and 
normal amplitude was obtained in the 
left orbicularis oculi muscle [channels 
1.1 (latency: 48.60 ms, amplitude 
0.6 mV), 2.1 (latency: 42.00 ms, 
amplitude 0.7 mV), 3.1 (latency: 33.00 
ms, amplitude 1.0 mV)]. No motor 
response was observed in the right 
orbicularis oculi (channels 1.2, 2.1, 3.2).
Figure 2. (B) On stimulation of the 
left facial nerve, a high voltaged motor 
response with normal latency [channels 
1.1 (latency: 2.4 ms, amplitude 2.9 
mV), 2.1 (latency: 2.00 ms, amplitude 
2.3 mV), 3.1 (latency: 2.35 ms, 
amplitude 2.6 mV)] and a second, 
late normal voltaged motor response 
was found in the left orbicularis oculi 
muscle, in case 3  [channels 1.1 
(latency: 40.00 ms, amplitude 1.1 mV), 
2.1 (latency: 36.75 ms, amplitude 0.9 
mV), 3.1 (latency: 37.60 ms, amplitude 
1.2 mV)]. No motor response was seen 
in the right orbicularis oculi (channels 
1.2, 2.1, 3.2). 
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Direct response of the facial nerve and electromyography of the facial muscles
Electrophysiological characteristics of the direct response of the facial nerves of 
11 patients with Möbius syndrome are summarized in Table 1. Direct responses 
of the facial nerves were absent in seven cases bilaterally (cases 1, 2, 5, 6, 8, 9 
and 11) and in three cases unilaterally (cases 3, 4 and 10). On MRI, facial nerves 
were absent in cases 2, 3, 5, 7, 9 and 11. The left fCMAPs in cases 3 and 4 had 
normal distal latency and duration and high amplitude. In case 10, the right fCMAP 
showed a normal response. In case 7, who presented with a symmetrical facial 
diplegia and in whom neuroimaging revealed absence of both facial nerves, the 
facial motor distal latencies were asymmetric, the right being prolonged compared 
with the left, but both were within the limits of normal; the amplitudes were 
slightly increased. In all cases, a high stimulation threshold was required to elicit 
a response. Using a needle electrode, in cases 2 and 6, the responses were found 
to be severely delayed and disperse (Figure 3). The electromyographic ﬁndings are 
listed in Table 2. In ﬁve cases needle EMG was not performed. 
Figure 3. Using a needle electrode 
in case 6, on direct stimulation of the 
left facial nerve a severely delayed 
(latency: 21.50 ms, amplitude 0.2 
mV) and disperse motor response 
was obtained.
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Evoked potentials  
MEPs were performed in four of the initially seven cooperative patients. In three 
patients, the studies could not be ﬁnished because of patients’ discomfort. MEPs 
of the tibialis anterior or vastus medialis muscles, obtained in cases 2, 7, 8 and 
11, were normal. In all seven patients, normal SSEPs of the median and peroneal 
nerves were recorded at both arms and legs.
Discussion
To date, only one electrophysiological study on the facial nerves and muscles of 
a series of Möbius patients has been reported. Jaradeh suggested a brainstem 
process predominantly affecting the facial nuclei and their internuclear 
connections.32 Other studies on electrophysiological ﬁndings in Möbius 
syndrome mainly deal with case reports without discussing the signiﬁcance of 
electrophysiology. In the literature, blink reﬂex studies have been carried out in 
12 patients. Blink reﬂexes were absent in ﬁve cases20,31-34 and long latencies were 
found in seven.30,32 Facial nerve conduction studies have been performed in 22 
cases, 11 of whom revealed no response to the orbicularis oculi muscle;20,32,43-49 
seven of these patients did reveal a response to the orbicularis oris muscle.43,44,46-49 
The latency to the orbicularis oculi muscles was prolonged32,50-52 and normal30,32,53 
in six cases despite facial palsy and a reduced amplitude of the fCMAP was 
demonstrated in nine cases.30,32,53 In none of the above-mentioned cases imaging 
of the facial nerves has been performed. Needle EMG studies have been carried 
out in some 19 cases, revealing absent action potentials during planned activity in 
10 cases.18,20,31,32,51,52,54-56 Impaired recruitment was seen in four instances,31,45,53,57 
and a single motor unit pattern in one case.50 Though not always mentioned, 
MUAPs were found to be normal in three cases,32 high voltaged in one,50 and 
polyphasic, low voltaged and disperse in four cases.32 EMG revealed spontaneous 
activity in the form of ﬁbrillations in ﬁve cases.32,43,45 From all these reports one 
can draw the overall conclusion that the electrophysiological study performed in 
the individual patient is too incomplete for any deductions to be made about the 
site of the primary lesion. 
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The electrophysiological ﬁndings in our study support our hypothesis that 
Möbius syndrome is more than a cranial nuclear developmental disorder, and that 
it should be viewed as a diffuse developmental disorder of the rhombencephalon. 
By electrophysiological means, we demonstrated three sites of primary lesion in 
our patients. 
(i) In two patients with the characteristic pattern of facial weakness in 
Möbius syndrome, i.e. severe involvement of the upper facial muscles with a 
relative sparing of the lower facial muscles (cases 3 and 4), and in two patients 
with complete facial diplegia (cases 4 and 7), within the two cases studied with 
MRI absence of facial nerves on MRI (cases 3 and 7), normal blink reﬂexes 
and facial CMAPs and normal habituation tests were found, suggesting a 
supranuclear dysfunction. The reduced recruitment of the facial muscles supports 
a supranuclear aetiological component (cases 3 and 4). The aberrant ‘blink 
reﬂex-like’ response of the orbicularis oculi muscle upon stimulation of the 
facial region (case 3) suggests the presence of abnormal projections to the facial 
nucleus that, most probably, extend via interneurons located in the supranuclear 
region, since the habituation of the blink reﬂex responses is normal. The inability 
to record blink reﬂexes despite the presence of facial CMAPs (case 2, 6 and 
10), points to greater conduction abnormalities in the proximal portion of the 
facial nerve or in the brainstem, or to a possible trigeminal nerve involvement. 
We postulate extensive reorganization of motor and sensory connections in a 
way similar to that found in the Duane syndrome.37,38 Our ﬁndings indicating a 
defect at the supranuclear level are in agreement with reported abnormalities of 
brainstem auditory evoked potentials (BAEPs), suggesting a pontine anomaly at a 
supranuclear site to be part of the syndrome.5,18,19,29,30,53
(ii) Absent blink reﬂexes, absent direct responses of the facial nerves (cases 1, 
3, 4, 5, 8, 9 and 11), and in addition, absent motor activity on needle EMG (cases 3, 
4, 8 and 10), indicate a defect at the facial nuclear level. In case 3, 5, 9 and 11, MRI 
studies were performed and revealed both facial nerves to be absent. In addition, 
paucity of potentials in the pattern of recruitment suggests an incomplete 
development of the facial nucleus (cases 2 and 6).  A supranuclear defect, however, 
might be masked by the defect at the nuclear level and cannot, therefore, be 
excluded in these patients. 
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(iii) Disperse patterns of facial compound action potentials combined with 
long latencies, recorded with concentric needle electrodes, indicating a motor 
facial nerve disorder that might be secondary to a nuclear involvement, were 
found in cases 2 and 6. These ﬁndings could be either on account of a primary 
motor nerve cell disorder resulting in small, poorly myelinated axons or the result 
of secondary sprouting with small ﬁbres conducting slowly.  Alternatively, aberrant 
innervating ﬁbres from the trigeminal nerve may be poorly myelinized. The 
absence of synkinesia, owing to reinnervation as seen in Bells palsy, is remarkable 
and argues against reinnervation in Möbius syndrome. In addition, the presence of 
ﬁbrillation potentials suggests insufﬁcient or absent reinnervation.  An additional 
supranuclear defect cannot, however, be excluded in these cases.
All three electrophysiological types of defects, representing three different 
sites of lesion, might be combined in a single patient, which results in a spectrum 
of electrophysiological disturbances and could explain the variability in the 
clinical manifestation of the syndrome. However, of our two patients with 
distinct levels of electrophysiological defects on each side (cases 3 and 4), one 
showed symmetrical and one showed asymmetrical facial weakness; patients with 
asymmetrical facial weakness (cases 1, 10 and 11) appeared to have the same 
defect at both sides. 
In a recent radiological study, the proximal portion of the facial nerve appeared 
to be absent in all six patients studied; two of them had facial diplegia and four 
demonstrated the characteristic pattern of facial weakness in Möbius syndrome. 
If any residual motor function was present, it was only found in some lower facial 
muscles (Table 3). These ﬁndings suggest that another cranial nerve, probably, 
the trigeminal, less likely the glossopharyngeal, or hypoglossal nerve, aberrantly 
innervates facial muscles, especially in the lower part of the face. This is probably 
due to a similar mechanism of reinnervation as found in the Duane syndrome.37,38 
The fact that we could stimulate electrophysiologically the facial nerve in three 
patients, in whom MRI had revealed facial nerves to be absent (cases 2, 3 and 
7) probably supports our hypothesis of aberrant innervation. One cannot 
exclude the possibility that the facial nerve, which could not be visualized in our 
radiological study, was severely hypoplastic or atrophic and escaped visualization 
despite the high spatial resolution (0.6 x 0.5 x 1.0 mm in plane resolution) of 
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the three-dimensional CISS MR method.17 However, then, we would have not 
obtained the widespread of electrophysiological responses.
We started out on this study with the assumption that published BAEP studies 
in Möbius syndrome had demonstrated a pontine anomaly at a supranuclear 
site, which was the reason why we did not record BAEPs in our patients. It is 
amazing that, based on these studies, it was not concluded previously that Möbius 
syndrome is more than a cranial nerve nuclear developmental disorder and 
should be viewed as a more regional developmental disorder of the brainstem, 
possibly including the central pathways. In a recent radiological and pathological 
study, we obtained support for this hypothesis by demonstrating brainstem 
hypoplasia.15,17 The results of the evoked potentials in this study, however, do 
not offer electrophysiological evidence for a lesion of the long tracts traversing 
through the brainstem in Möbius syndrome. Normal MEPs and SSEPs can be 
explained by the fact that only the conduction time of the fastest ﬁbres is 
measured; lesion of only part of the long tracts would leave enough normal ﬁbres 
to measure. Therefore, based on normal evoked potentials in our Möbius patients, 
a reduction of the traversing long tracts at pontine level can not be excluded. 
 
Conclusions 
The most prominent ﬁnding of this study is the fact that the electrophysiological 
results in patients with Möbius syndrome show a spectrum of disturbances 
varying in degree of severity and extent of structures involved, suggesting defects 
at three levels i.e. supranuclear, nuclear and peripheral, which might be combined 
in one patient.  At one end of the spectrum are patients with completely immobile 
faces, some of whom lack facial nerves on MRI, who show no abnormalities of the 
facial nerve or muscles on electrophysiological testing. This suggests a dysfunction 
at the supranuclear level. This situation is corroborated by abnormal late 
responses on stimulation of the facial nerve.  At the other end of the spectrum 
are patients with totally absent responses on facial nerve stimulation, absence of 
motor unit activity and absence of facial nerves on neuroimaging. These ﬁndings 
indicate at least a defect at the facial nuclear level; a supranuclear defect is not 
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excluded. 
Our ﬁndings support the hypothesis that the primary site of the lesion in 
Möbius syndrome is not necessarily restricted to the cranial nerve nuclei, but is 
localized more regionally in the brainstem. 
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Abstract 
 
Background 
In a previous clinical study, we observed in over 80% of patients with Möbius 
syndrome clumsiness, i.e. lack of ﬁne motor skills and poor coordination and 
balance performance without further signs of a cerebellar syndrome, sensory 
ataxia, or peripheral nerve involvement. The authors suggested that clumsiness 
is the functional result of the often visible brainstem hypoplasia with possible 
hypoplasticity, i.e. maldevelopment of either the corticospinal or cortico-ponto- 
cerebellar tracts. In this sense, we suggested that Möbius syndrome could be 
viewed as a rhombencephalic developmental disorder involving both motor nuclei 
and axons as well as long tracts. 
Objective 
To study the nature of clumsiness in Möbius syndrome in terms of motor or 
sensory deﬁcits, and to clarify the pathophysiological mechanism of the syndrome. 
Methods 
Standardized electrophysiological studies were conducted, with special emphasis 
on the long motor and sensory tracts and peripheral nerves, in seven Möbius 
patients with clumsiness, of whom six participated in MRI studies showing 
brainstem hypoplasia.
Results 
All performed motor evoked potentials were normal. In all patients, normal 
somatosensory evoked potentials were recorded and peripheral nerve 
conduction assessment revealed no abnormalities.
Conclusion 
Our electrophysiological data indicate that the traversing motor as well as 
sensory tracts through the brainstem, and the peripheral nerves are not affected 
in Möbius syndrome. 
Electrophysiological assessment in 
patientspatients with Möbius syndrome and clumsiness
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Introduction
Möbius syndrome is a rare congenital disorder characterized by facial weakness 
with impairment of ocular abduction.1 Dysfunction of other cranial nerves, 
orofacial malformations, limb malformations, and musculoskeletal system defects 
are common associated features, but not obligatory for the diagnosis.1
In a previous clinical study, we suggested that lack of ﬁne motor skills, poor 
coordination, and balance performance in Möbius syndrome, best summarized as 
clumsiness, could be the functional result of hypoplasticity, i.e. maldevelopment 
of either the corticospinal or cortico-pontocerebellar tracts.1 In this sense, 
we suggested that Möbius syndrome is more than a cranial nerve or nuclear 
developmental disorder and that it could be viewed as a rhombencephalic 
developmental disorder involving both motor nuclei and axons as well as long 
tracts.1 Recently, we provided pathological and radiological evidence for this 
theory by demonstrating brainstem hypoplasia.2,3 Electrophysiologically, this 
hypothesis has been conﬁrmed by the results of brainstem auditory-evoked 
potentials (BAEPs) in several case reports of Möbius patients who have, in the 
vast majority, normal hearing.4-23 These results are consistent with a lesion of the 
central pathways in the brainstem, suggesting a widespread involvement of the 
brainstem, including the long tracts, as part of the syndrome. Just three cases 
demonstrated normal BAEP studies.9,13,15 To date, just a few electrophysiological 
reports, studying the long tracts in Möbius syndrome, have been published.5,7,11,17,20  
In order to study the nature of clumsiness in Möbius syndrome and to 
shed some light on the pathophysiological mechanisms involved, we performed 
standardized electrophysiological studies placing special emphasis on the long 
motor tracts in seven Möbius patients. We also studied the long sensory tracts 
and peripheral nerves.
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Subjects and methods
Subjects
In a previous study, we examined 37 sporadic Dutch Möbius patients in a nation-
wide survey.1 All patients met the inclusion criteria: nonprogressive congenital facial 
weakness and impairment of ocular abduction. For the current study we randomly 
selected out of this group seven cooperative subjects with mild clumsiness; five 
males and two females, the youngest being 12 years of age and the oldest 26, gave 
informed consent. Six of these patients participated in brain MRI studies (cases 1, 
2, 3, 4, 6 and 7); five showed brainstem hypoplasia (cases 2, 3, 4, 6 and 7). 
Clumsiness has been characterized by the presence of two or more of the 
following symptoms: lack of ﬁne motor skills, a poor diadochokinesis of the 
underarms, deﬁcient foot tapping, a disturbed tandem walk deﬁned as an inability 
to perform 10 steps in a row without side steps, or impaired balance performance. 
All patients showed slow motor development; it took longer than average to 
master the milestones of major motor skills, and ﬁne motor skills did not reach 
normal levels at older ages, even when skeletal deformities were taken into 
account. Dysdiadochokinesis and deﬁcient foottapping was present in all cases, and 
abnormal tandem walk in ﬁve of them (cases 2, 3, 4, 6 and 7). Two patients showed 
hypotonia till the age of one year and an axial imbalance till the age of three and 
one years (cases 4 and 5).
Nerve conduction and electromyography studies  
A Synergy system (Medelec®, Oxford Medical Instruments) was used to record 
nerve conduction and concentric needle electromyography (EMG) studies and 
were performed according to standard techniques.24 A predesigned protocol was 
applied and covered motor nerve conduction studies (mNCS) of the median, 
peroneal and tibial nerve, antidromic sensory nerve conduction studies (sNCS) 
of the radial and sural nerves, and H-reflexes recording the soleus-gastrocnemius 
muscle. The amplitudes of the compound muscle action potentials (CMAPs) 
and the sensory nerve action potential (SNAP) were measured from peak to 
peak. CMAPs below 7mV in the upper extremities and below 5mV in the lower 
extremities were considered abnormal; for SNAPs these values were 10µV and 
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5µV, respectively. Concentric needle electrode EMG study was performed in the 
gastrocnemius and tibial anterior muscles.  
Transcranial magnetic stimulation 
Motor evoked potentials (MEPs) were evoked by a Magstim 200 (2.0 Tesla) 
magnetic stimulator and recorded from both tibialis anterior (TA) or vastus 
medialis (VM) muscles.24 The stimulator was fitted by a circular 70mm coil and 
stimulation intensity was set at 100%. Lumbar motor roots were stimulated over 
the lumbar region. During cortex stimulation the target muscle was contracted 
slightly. In case of a TA muscle MEP, the peroneal nerve at the popliteal fossa was 
electrically stimulated, in order to assess the maximal CMAP of the TA muscle. 
Two subsequent stimuli were given at each stimulation site, in order to assess 
their reproducibility. The central motor conduction time (CMCT) was calculated 
by subtracting the shortest latency of the MEP in response to root stimulation 
from the shortest latency of the MEP in response to cortical stimulation. Signals 
were amplified and filtered between 10 Hz and 1 KHz. Both the absence of a MEP 
to cortical stimulation in one or more muscles and a CMCT 2 SD beyond the 
mean of our normal values were considered abnormal.
Somatosensory evoked potentials study
Somatosensory evoked potentials (SSEPs) were recorded and stored using a 
Synergy System (Medelec®, Oxford Instruments, UK). Electrical stimuli were 
applied percutaneously to both median and tibial nerves.24 The stimulus rate was 
0.3Hz and the evoked potentials were calculated by averaging the recordings after 
1000 stimuli. Two averages were recorded under identical conditions to assess 
the reproducibility of the evoked response components. Electrodes were placed 
at Erb’s point, vertebra C7, and cortical C3’ and C4’ for stimulating the median 
nerves, and at the popliteal fossa, vertebra T12, and Cz’ for stimulating the tibial 
nerves. Latency and amplitude of components N9 (Erb’s point), N13 (cervical 
spine), N18 (pons), and the cortical complex (N20-P27) were analysed for the 
median nerves, and of components N8 (popliteal fossa), SN1 (thoracal spine), 
and the cortical complex (N50-P60) for the tibial nerves. The recordings were 
compared with our normal values.
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Results
Nerve conduction studies and EMG recording  
Table 1 shows the mNCSs and sNCSs wich were recorded from the arms and 
legs. Patient 1 through 7 revealed no abnormalities, except for some minor 
changes in one patient (case 3); the amplitude of the right extensor digitorum 
brevis muscle was low, however, the amplitude of the right tibialis anterior muscle 
and the distal latency and velocity of the peroneal nerve to both muscles were 
normal. Probably, the low amplitude is due to atrophy of the extensor digitorum 
brevis muscle, which could be attributed, as well as the absent right sural nerve 
response, to a previous talipes operation in this area. 
Just in one of the seven patients concentric needle EMG was performed, six 
patients did not cooperate. In patient 7, needle EMG of the gastrocnemius and 
tibial anterior muscles was normal, either at rest or during contraction.
Transcranial magnetic stimulation  
MEPs were performed in four of the six patients with clumsiness. In two of these 
patients, the studies could not be finished because of patients’ discomfort. MEPs 
of the TA or VM muscles, obtained in patients 1, 4, 5, and 7, were normal (Table 1).
Somatosensory evoked potentials study  
In all patients, normal SSEPs of the median and peroneal nerves were recorded at 
both arms and legs. 
 
Discussion
To date, just a few electrophysiological reports on the long motor and sensory 
tracts and peripheral nerves in Möbius syndrome have been published. One 
MEP has been performed and showed an increased central conduction time, 
suggesting a pontine lesion.20 Of seven reported SSEPs, ﬁve showed abnormalities 
suggesting pontine pathology,5,11,20 and two were normal.7,17 Twenty-three 
EMG studies on extremities of Möbius patients have been performed, in some 
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cases because of slightly hypotonic limbs, but in most cases as part of routine 
diagnostic work-up. In 17 of them, no peripheral neuropathy or myopathy has 
been observed,5,10,17-19,25,26 in ﬁve cases a peripheral neuropathy was present which 
was already suggested on the basis of the clinical signs, with in four of them 
hypogonadotrophic hypogonadism9,27-29 and in one Kallman syndrome,30 and in one 
case facioscapulohumeral dystrophy appeared to be present instead of Möbius 
syndrome.9 We interpret this rather wide range of observations as reﬂecting at 
a neurophysiological level the range of clinical features in addition to the core 
deﬁnition of facial muscle and ocular abduction weakness. 
We started this study with the assumption that BAEP studies in Möbius 
syndrome demonstrate a pontine anomaly at a supranuclear site as part of the 
syndrome, which was the reason why we did not record BAEPs in our patients. 
An important point is that evidence of a supranuclear lesion in the brainstem 
clearly indicates a more general involvement of the rhombencephalon than cranial 
nerve nuclei alone. It is amazing that, based on these evoked potentials, it was 
not concluded previously that Möbius syndrome should be viewed as a more 
regional developmental disorder of the brainstem including the central pathways. 
We suggested that in our patients with clumsiness the lesion of the traversing 
long tracts might be localized at brainstem level. In a recent pathological and 
radiological study, we obtained support for this hypothesis by demonstrating mild 
hypoplasia of the entire brainstem.2,3 The results of the evoked potentials in the 
current study, however, demonstrate no abnormalities; therefore, we could not 
substantiate evidence of involvement of the long tracts through the brainstem 
in patients with Möbius on the basis of electrophysiology. Normal MEPs and 
SSEPs can, however, be explained by the fact that only the conduction time of 
the fastest fibres is measured. The developmental nature of clumsiness, probably 
precluding recognizable pyramidal or cerebellar signs, might affect only part of 
the corticospinal tracts, which would leave enough normal fibres to measure. 
Therefore, based on normal evoked potentials in our Möbius patients, a reduction 
of the traversing long tracts at pontine level can not be excluded. 
Subtle hypoplasia of the corticospinal tracts at brainstem level might still be an 
important factor in causing mild clumsiness in Möbius syndrome; also hypoplasia 
of the cerebellum or of the cortico-pontocerebellar tracts could contribute to 
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the summary ﬁnding of clumsiness. 
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Summary
This thesis presents the results of clinical, genetic, neuropathological, radiological 
and electrophysiological research into Möbius syndrome. The general introduction 
to the Möbius syndrome and review of the literature in Chapter 1 is followed in 
Chapter 2 by an outline of the thesis itself.
Subsequent chapters evolved along two lines.
1. It became increasingly clear as our studies progressed that Möbius syndrome 
and hereditary congenital facial palsy are two distinct disorders. Clinically 
and pathologically the disorders proved to be different.  Also genetically the 
disorders appear not to be identical.
2. Finally, we were unable to build a solid foundation for the genetic nature of 
Möbius syndrome. On the contrary, the possibility that a vascular or toxic 
start of events may lead to the Möbius syndrome condition is still a matter of 
debate.
In Chapter 3, we performed linkage analysis in a large Dutch family with 
autosomal dominant congenital facial nerve palsy; some of these cases were 
suffering from deafness. 
After exclusion of more than 90% of the genome, we localized the gene to the 
long arm of chromosome 10 at 10q21.3-22.1 in this family. 
We thus demonstrated genetic heterogeneity for autosomal dominant 
inherited congenital facial palsy, as we had previously described a locus for this 
disorder on chromosome 3q21-22.
In Chapter 4, the clinical characteristics of Möbius syndrome, deﬁned as 
congenital facial palsy with impairment of ocular abduction, were studied in 37 
Dutch patients of different age groups to gain insight into the widely variable 
clinical picture of Möbius syndrome and thereby into the pathogenesis of the 
disorder. 
Of 37 patients with facial paresis, 97% had bilateral and 3% had unilateral 
ocular abduction weakness. Further analysis showed an isolated abducens 
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nerve palsy in 9%, a conjugated horizontal gaze paresis in 48%, features of 
Duane retraction syndrome in 34% and congenital ﬁbrosis of the extraocular 
muscles in 9%. In 77% of the patients there was  lingual involvement and in 56% 
dysfunction of palate and pharynx. General motor disability was present in 88%, 
poor coordination in 83% and respiratory abnormalities in 19% of the cases. We 
were not able to conﬁrm the impression of a high rate of mental retardation as 
mentioned in the literature. 
Since we had redefined, as a primary criterion of Möbius syndrome, congenital 
facial palsy with impairment of ocular abduction, we restricted the definition 
and thus ascertained congenital facial palsy, on clinical grounds, to be a separate 
entity. We obtained a homogeneous clinical picture for Möbius syndrome, which 
showed  diversity both in the extent of structures involved and in the severity of 
involvement. 
Based on these clinical characteristics, we concluded that Möbius syndrome 
is more than a cranial nerve or nuclear developmental disorder, and that it is 
a complex regional developmental disorder of the rhombencephalon involving 
predominantly motor nuclei and axons, as well as traversing long tracts.
In Chapter 5, the actual frequency of mental retardation in a group of 12 
Dutch patients with Möbius syndrome is examined. Subsequently, if global 
mental retardation was absent, we screened some major aspects of memory and 
attention, in order to assess possible pervasive dysfunction in these cognitive 
domains, which might be responsible for the current view that mental retardation 
occurs frequently in Möbius syndrome.
 To avoid the use of heterogeneous and non-equivalent tests, the participants 
had to be 17 years of age or older.  All school-age children below the age of 17 
years attended normal elementary and secondary school, thus contradicting 
an increased rate of occurrence of mental retardation. We noticed that the 
occurrence of mental retardation in our 12 Möbius patients did not deviate from 
that in the normal Dutch population. Of the total group of 37 patients, two (5.4%) 
showed signs of mental retardation. Since, an IQ of 75 in a standard population 
equals the fifth percentile (mental retardation is defined as IQ ≤ 75), we 
demonstrated evidence that the occurrence of mental retardation in patients with 
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Möbius syndrome is not significantly different compared to the normal Dutch 
population. 
In the two mentally retarded patients, autism occurred, a ﬁnding which 
suggests an association between mental retardation and autism rather than 
between mental retardation and Möbius syndrome. In this sense, we were unable 
to support the notion of a strong association of Möbius syndrome and autism as 
has been suggested. 
Furthermore, although we cannot exclude very specific and subtle deficits, we 
observed no evidence of firm attention and memory dysfunction in our group of 
not mentally retarded Möbius patients. 
In Chapter 6, we performed a neuropathological study of the brainstem in 
three members of one family with autosomal dominant congenital facial palsy, 
and compared these findings with those of patients with Möbius syndrome, to 
characterize the neuropathology of hereditary congenital facial palsy and to 
support our clinically based hypothesis that hereditary congenital facial palsy and 
Möbius syndrome are two different entities.
In the patients with congenital facial palsy, we observed a marked decrease in 
the number of neurons in the facial motor nucleus with corresponding small facial 
nerve remnants. No signs of neuronal degeneration or necrosis with neuronal 
loss, gliosis, or calcifications were present. There were no other abnormalities of 
the rhombencephalon and its associated structures. In contrast, Möbius syndrome 
is part of a more complex congenital anomaly of the posterior fossa with 
hypoplasia of the entire brainstem, including the traversing long tracts, with signs 
of neuronal degeneration and other congenital brain abnormalities. 
This neuropathological study confirmed our clinical observation that 
hereditary congenital facial palsy and Möbius syndrome are two different entities 
with a different pathogenesis. We noticed that the congenital facial palsy in our 
family, and in some sporadic cases, is due to dysgenesis of the facial motor nucleus 
probably with a primary genetic cause. We suggest that dysgenesis is probably 
also the mechanism involved in cases with Möbius syndrome; however, in Möbius 
syndrome a developmental defect of the entire lower brainstem is implied.
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In Chapter 7, the MRI abnormalities in 6 patients with Möbius syndrome were 
described in order to clarify the pathogenetic mechanisms of the syndrome and 
to find support for the concept that the Möbius syndrome is a syndrome of 
rhombencephalic maldevelopment rather than a nuclear developmental disorder.
In this study of relatively mildly affected Möbius patients, we found signs of 
brainstem hypoplasia on the MR by quantitative measurements of the pons, 
supporting our hypothesis that Möbius syndrome is a developmental disorder of 
the entire lower brainstem. The MRI’s demonstrated the concomitant presence 
of other developmental brain abnormalities, suggesting that Möbius syndrome is, 
in some cases, part of a more complex, congenital anomaly of the posterior fossa, 
a notion that has escaped attention in the literature. These radiological findings 
suggested that Möbius syndrome is a rhombencephalic developmental disorder 
with a wide spectrum of structures involved and with varying degrees of severity. 
Most remarkably, we demonstrated absent facial nerves on MRI in all 
patients studied. This ﬁnding, in combination with the residual function in some 
lower facial muscles in most of the patients, which is in accordance with the 
characteristic pattern of facial weakness in Möbius patients consisting of severe 
involvement of the upper facial muscles and a relative sparing of the lower facial 
muscles, suggests that other cranial nerves aberrantly innervate some of the 
lower facial muscles; the mechanism of reinnervation is probably similar to that in 
Duane retraction syndrome.
In Chapter 8, we conducted standardized blink reflexes, direct responses of facial 
nerves and electromyography of facial muscles in 11 Möbius patients to study the 
nature and extent of facial muscle innervation in Möbius syndrome and to clarify 
the pathophysiological mechanism of the syndrome.
By electrophysiological means, we demonstrated a spectrum of disturbances 
variable in degree of severity and diverse in extent of structures involved.  At 
one end of the spectrum are patients with completely immobile faces in whom 
electrophysiological testing shows no signs of involvement of the facial nuclei, 
nerves or muscles, suggesting a defect at the supranuclear level.  At the other 
end of the spectrum are patients with complete absence of responses upon facial 
nerve stimulation and absence of motor unit activity. This is at least indicative of a 
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defect at the facial nuclear level. 
These findings corroborated the concept of the Möbius syndrome being a 
complex regional developmental disorder of the brainstem. While a supranuclear 
defect is compatible with this concept, intact facial nuclei as part of Möbius 
syndrome has not been suggested before. It is conceivable that the facial muscles 
have been aberrantly innervated, explaining some of the observations.
Since we could stimulate the facial nerve in 3 patients, in whom the facial 
nerve was radiologically demonstrated to be absent, we provided support for our 
hypothesis of an aberrant innervation of the facial muscles by - most probably 
- the trigeminal nerves and less likely the glossopharyngeal or hypoglossal nerves.
In Chapter 9, we performed electrophysiological studies in 7 Möbius patients 
exhibiting clumsiness, placing special emphasis on the long motor and sensory 
tracts and peripheral nerves, in order to study the nature of clumsiness in 
Möbius syndrome and to shed more light on the pathophysiological mechanism 
of the syndrome. Clumsiness (deﬁned as a  lack of ﬁne motor skills and poor 
coordination and balance performance), a symptom which we observed in over 
80% of patients in our clinical study, was suggested to be the functional result of 
hypoplasticity, i.e. maldevelopment of the long motor tracts.
Since BAEP studies in Möbius syndrome reported a pontine anomaly at a 
supranuclear site in the brainstem as part of the syndrome, we suggested that the 
lesion of the long tracts in our patients might be localized at brainstem level.  An 
important point is that evidence of a supranuclear lesion in the brainstem clearly 
indicates a more general involvement of the rhombencephalon than cranial nerve 
nuclei alone. In a recent pathological and radiological study, we obtained support 
for this hypothesis by demonstrating brainstem hypoplasia. The results of the 
evoked potentials in the current study, however, demonstrate no abnormalities; 
therefore, we could not substantiate evidence of involvement of the long tracts in 
patients with Möbius syndrome on the basis of electrophysiology. Normal MEPs 
and SSEPs can, however, be explained by the fact that only the conduction time of 
the fastest fibres is measured. The developmental nature of clumsiness, probably 
precluding recognizable pyramidal or cerebellar signs, might affect only part of 
the corticospinal tracts, which would leave enough normal fibres to measure. 
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Therefore, based on normal evoked potentials in our Möbius patients, a reduction 
of the traversing long tracts at pontine level cannot be excluded.
Subtle hypoplasia of the corticospinal tracts at brainstem level might still be an 
important factor in causing mild clumsiness in Möbius syndrome; also hypoplasia 
of the cerebellum or of the cortico-pontocerebellar tracts which is not an 
infrequent neuroradiological ﬁnding could contribute to the summary ﬁnding of 
clumsiness.
Conclusions
Based upon the summary we were able to draw the following conclusions:
1. The overall conclusion of this study is that the Möbius condition contains two 
distinct disorders: 
 First of all, an autosomal disorder which can best be described as hereditary 
congenital facial palsy, and secondly, a disorder that occurs mainly sporadically 
and for which we reserve the name Möbius syndrome (see 2.). The two 
disorders may have different pathogenetic mechanisms.
 This conclusion is based upon the following clinical, genetic and pathological 
ﬁndings:
a) Hereditary congenital facial palsy is clinically characterized by an isolated 
congenital facial palsy, and in some cases deafness is present. In contrast, 
the primary criterion for Möbius syndrome is congenital facial palsy with 
impairment of ocular abduction; other congenital defects are frequently 
associated (see 2.), defects which are absent in hereditary congenital facial 
palsy.
b) The genetic loci for hereditary congenital facial palsy have been excluded as 
a major cause in Möbius syndrome.
c) Neuropathological ﬁndings in hereditary congenital facial palsy consist of 
isolated hypoplasia of the facial motor nuclei and nerves, which is due to 
dysgenesis of the facial motor nucleus probably with a primary genetic 
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cause.  And, in contrast, in Möbius syndrome the ﬁndings consist of 
hypoplasia of the entire brainstem, including the traversing long tracts, with 
signs of neuronal degeneration and other congenital brain abnormalities, 
suggesting a more complex congenital anomaly of the posterior fossa than 
of cranial nuclei only.
2. The primary criterion for Möbius syndrome is:
Congenital facial palsy with impairment of ocular abduction.  And, 
while dysfunction of other cranial nerves, orofacial malformations, limb 
malformations and musculoskeletal system defects are frequently associated 
features, they are not obligatory for the diagnosis Möbius syndrome.
3. Our results allowed us to postulate a new concept for the narrow deﬁnition 
of Möbius syndrome (see 2.): 
Möbius syndrome is a complex regional developmental disorder of the entire 
rhombencephalon involving predominantly motor nuclei and axons, as well 
as traversing long tracts, rather than of the cranial nerve nuclei only. There 
is a clinical spectrum with at one end the most seriously affected patients 
with such a brainstem dysfunction that sufﬁcient spontaneous breathing 
is not possible, and at the other extreme patients characterised with the 
minimal criteria containing of nervus facialis paresis and impairment of ocular 
abduction.  Additionally, overlap with mesencephalic developmental syndromes 
occurs more frequently than previously thought
 This concept is based on the following clinical, genetic, pathological, 
radiological and electrophysiological conclusions:
a) The distribution of the facial palsy in the Möbius syndrome cases, with 
more severe involvement of the upper facial muscles and a relative 
sparing of the lower facial muscles, appears to be characteristic of Möbius 
syndrome and suggests that other cranial nerves, most probably the 
trigeminal nerves and less likely the glossopharyngeal or hypoglossal nerves, 
aberrantly innervate some facial muscles especially in the lower part of the 
face. 
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b) The inability to abduct the eye beyond the midline is caused in a minority 
of cases by an isolated abducens nerve palsy, and in the majority we found 
horizontal gaze palsies and Duane retraction syndrome suggesting that 
more than the 6th cranial nerve nucleus is involved. Less frequently we 
observed cases with oculomotor palsies, which we diagnosed as CFEOM, 
suggesting that overlap with mesencephalic developmental syndromes 
occurs more frequently than previously thought.
c) Lack of fine motor skills and poor coordination and balance performance, 
best summarized as clumsiness, is often present in Möbius syndrome. 
We suggest that clumsiness is the functional result of hypoplasticity, i.e. 
maldevelopment of either the corticospinal or cortico-pontocerebellar long 
tracts.  
d) In a minority of cases primary respiratory dysfunction is present, 
supporting the concept that the caudal part of the brainstem is poorly 
developed.
e) Neuropathological findings in Möbius syndrome consist of hypoplasia of the 
entire brainstem, including the traversing long tracts, with signs of neuronal 
degeneration and other congenital brain abnormalities, suggesting a more 
complex congenital anomaly of the posterior fossa than of cranial nuclei 
only.
f) Hypoplasia of the brainstem and the presence of other developmental 
abnormalities on MRI support the notion that Möbius syndrome is a 
developmental anomaly of the entire rhombencephalon, in which a wide 
spectrum of structures is involved to varying degrees of severity, rather 
than a developmental disorder of cranial motor nuclei only.
g) By electrophysiological means, i.e. standardized blink reflexes, direct 
responses of facial nerves and electromyography of facial muscles, we 
demonstrated a spectrum of disturbances of variable degree of severity and 
diverse in extent of structures involved at the supranuclear and the facial 
nuclear level.
h) Although BAEP studies in the literature demonstrate a pontine anomaly 
at a supranuclear site as part of the syndrome, suggesting a regional 
developmental disorder of the brainstem including the central pathways, 
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we could not, on the basis of electrophysiology, i.e. by means of motor and 
somatosensory evoked potentials, substantiate evidence of involvement 
of the long tracts traversing through the brainstem in Möbius syndrome. 
Using normal MEP and SSEP measurements, however, subtle hypoplasia of 
the motor or sensory long tracts at pontine level cannot be excluded.
4. The conclusion of our neuropsychological study is that the rate of occurrence 
of mental retardation in our representative group of Möbius patients did not 
differ from that in the normal Dutch population. In addition, an association 
between mental retardation and autism was observed rather than between 
mental retardation and Möbius syndrome. We were unable to support the 
notion of a strong association of Möbius syndrome and autism as has been 
suggested.
5. Our neuropathological ﬁndings in hereditary congenital facial palsy strengthen 
the brainstem pathogenetic concept of CCDDs, i.e. congenital developmental 
defects of one or more cranial nerves and/or nuclei. Both neuropathological 
and genetic studies suggest that at least a subset of these disorders results 
from distinct, but analogous, primary developmental defects of motor nuclei 
in the brainstem. Formerly, Möbius syndrome has also been classiﬁed as a 
CCDD.  At present, however, based upon our research, it is obvious that 
Möbius syndrome is more than a developmental disorder of cranial motor 
nuclei only and rather a complex regional developmental disorder of the entire 
rhombencephalon, involving motor nuclei and axons, as well as traversing long 
tracts, in which in extreme cases the caudal part of the brainstem is affected. 
For this reason Möbius syndrome must be placed outside the actual definition 
of the CCDDs.
Some thoughts on the pathogenesis in Möbius syndrome
In Möbius syndrome the pathogenesis is unclear. Two major explanations 
have been proposed: a developmental defect due to a genetic cause and an 
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ischaemic cause due to an environmental insult, possibly in addition to a genetic 
susceptibility.
It is hard to conceive that the vascular hypothesis for Möbius syndrome, i.e. 
an ischaemic event in the lower brainstem due to hypoperfusion or occlusion of 
the developing primitive subclavian artery,4-6 leads to speciﬁc and recognizable 
syndromes with involvement of a limited number of structures, tissues and 
germ layers. In addition, this vascular hypothesis does not explain the frequent 
occurrence of lower extremity involvement (86% in our series) or congenital 
abnormalities outside the subclavian arterial bed. Moreover, a causal direct 
relationship between environmental factors, such as drugs and trauma and 
ischaemia has not been well established. This assumption can be conﬁrmed by the 
absence of teratogens as a possible cause of the syndrome in our Möbius patients. 
Ischaemic events due to or collaborating with genetic mechanisms cannot, 
however, be excluded.
It is still unclear to what extent the sporadic Möbius syndrome is due to a 
genetic mechanism and how environmental factors could interfere. Evidence 
for the genetic theory is given by reports of abnormal karyotypes in Möbius 
patients,7,8 identical twins with Möbius syndrome,9 and families with autosomal 
dominant, autosomal recessive and X-linked inherited Möbius syndrome.10 In 
our study, we observed a mother and son with Möbius syndrome suggesting that 
dominant inheritance is likely. We also observed one proband with three healthy 
children, which does not make autosomal dominant inheritance likely. We found 
no secondary cases in the families of our Möbius patients, making autosomal 
recessive inheritance unlikely. The lack of a clear hereditary pattern in the vast 
majority of cases does not rule out genetic causes. It is conceivable that the 
lack of affected siblings may best be explained by the fact that the disorder is 
polygenetic, i.e. the phenotype only emerges if there are coexisting mutations in 
more than one developmental gene, which has been shown for the Bardet-Biedl 
syndrome.11 This mechanism could explain the variability in phenotypes.  Also, 
genes acting as modiﬁers may prevent or enhance the phenotype, as recently 
demonstrated in the tubby mice.12 Also, just as folic acid in pregnancy lowers the 
risk of neural tube defects in humans and retinoic acid can rescue the inner-ear 
defects of Hoxa1 deﬁcient mice,13 external factors inﬂuencing the intrauterine 
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environment could play a modifying role in the manifestations of Möbius 
syndrome. Such explanations are in accordance with observations that drug abuse 
is occasionally associated with the occurrence of Möbius syndrome.14-27 It is, 
therefore, our hypothesis that the whole clinical spectrum of Möbius syndrome is 
the sum of changes in a number of genes, that are functional in the organization 
and development of the lower brainstem at a speciﬁc gestational age. In some 
cases these genetic changes may also interact with environmental factors in a 
speciﬁc time-window in the development of the lower brainstem. 
Möbius syndrome and congenital facial palsy are one of the disorders formerly 
defined as congenital cranial dysinnervation disorders (CCDDs), disorders that 
tend to reflect genetic entities.3 Our neuropathological findings in hereditary 
congenital facial palsy strengthen the brainstem pathogenetic concept of CCDDs, 
i.e. congenital developmental defects of one or more cranial nerves or their 
nuclei. In contrast, in Möbius syndrome a developmental defect of the entire 
lower brainstem involving both motor nuclei and traversing long tracts is implied, 
suggesting a possible different pathogenetic mechanism, which places Möbius 
syndrome outside the category of CCDD. 
The considerable overlap in clinical manifestations within the CCDDs is 
suggested to be compatible with the known redundancy and overlap in the 
biology of axon guidance, cell migration and brainstem segmentation. There is, 
in fact, ample room for alternative explanations, such as environmental factors 
and toxins interfering with neuronal or vascular developmental pathways which 
have been put forward on more than one occasion. The variability of the genetic 
background in individual cases determines whether such factors lead to a 
recognizable and reproducible phenotype.
In the developing nervous system, differentiating neurons position themselves 
in deﬁned locations along the anterior-posterior and dorso-ventral axes and 
project axons and dendrites toward their ﬁnal destination. This is a process that is 
regulated by an interplay of attractive and repulsive guidance molecules which are 
present in the extracellular environment of developing neurons and are sensed by 
receptors on the advancing growth cones.28 Mutations that impair the positioning 
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of cell bodies in the neural tube, or disrupt axon guidance in the periphery can 
have consequences for the function and survival of motor neurons. It is known 
that blood vessels use similar signals and principles to differentiate, grow and 
navigate towards their targets.  It has, therefore, been proposed that common 
genetic pathways regulate the development of both the neural and the vascular 
system. Possibly, these mechanisms play a role in the pathogenesis of Möbius 
syndrome.28
Future perspectives
The renewed deﬁnition of the Möbius syndrome and the identiﬁcation of the 
underlying disease genes may assist clinicians in their evaluation of Möbius 
patients in order to delineate reproducible phenotypes that allow proper 
pathophysiological studies and will hopefully contribute to our understanding of 
the signaling cascade required for normal facial motor nuclear development.
 
To expand the knowledge on the genetic defects involved in hereditary congenital 
facial palsy, it would be very helpful to identify the various genes responsible in 
our two Dutch families and in additional families with FNP.  Subsequently, it would 
be interesting to test these genes in sporadic cases of Möbius syndrome.
The identiﬁcation of the FNP genes as well as following functional studies of these 
genes, for example by establishing a mouse model for the FNP genes, will help to 
study developmental biology of the facial nucleus and/or nerve and will offer the 
background for therapeutic studies.
Studying pathways for facial nerve development and the interference of these 
pathways with those of brainstem development is an approach which will help 
us in understanding the biology of axon guidance, cell migration and brainstem 
segmentation.  Also, the analysis of the effect of environmental factors on these 
pathways is of importance. 
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Future studies of the CCDDs as a group of disorders should lead to a greater 
understanding of the unique developmental and physiological features of the 
cranial nuclei and may help us to understand their selective involvement in various 
neurological disorders and their treatment.
 
Both the nervous and vascular systems use common genetic pathways which may 
form links between vascular biology and neurobiology in Möbius syndrome. This 
integrated view of the development of nerves and blood vessels could provide 
new mechanistic insights and therapeutic opportunities.  To further elucidate the 
concept of aberrant innervation of the facial muscles in Möbius syndrome, further 
electrophysiological study is required, especially in patients in whom the facial 
nerves could be stimulated while MRI revealed absent facial nerves.
                                                                                                                     
The moment of reinnervation in Möbius syndrome needs to be deﬁned.  Also, 
factors that sustain the facial muscles without their innervation have to be 
determined. All such efforts aim to develop strategies for treating facial weakness 
by biological factors and push for a maximal result by various physiological 
mechanisms.
In patients with completely immobile faces in whom electrophysiological testing 
shows no signs of involvement of the facial nuclei, nerves or muscles, suggesting a 
defect at the supranuclear level, feedback training needs to be explored to further 
delineate the therapeutic options in Möbius syndrome.
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Inleiding
Een congenitale nervus facialis parese gepaard gaande met een parese van de 
nervus abducens is voor het eerst door Von Graefe beschreven in 1880. In 1888, 
beschreef Paul Julius Möbius drie patiënten met een congenitale niet progressieve 
bilaterale parese van de nervus facialis en de nervus abducens, en sindsdien 
wordt het eponiem Möbius syndroom voor deze aandoening gebruikt. In de 
loop der jaren zijn door meerdere auteurs verschillende criteria gebruikt voor 
het diagnosticeren van het syndroom waardoor de groep van Möbius patiënten, 
zoals beschreven in de literatuur, zeer heterogeen is geworden; zowel een 
geïsoleerde nervus facialis parese als een uitgebreider fenotype bestaande uit 
een congenitale nervus facialis en nervus abducens parese al dan niet gepaard 
gaand met afwijkingen van andere hersenzenuwen, defecten van het skelet- en 
spierstelsel, dysmorfieën van het gelaat en mentale retardatie waren criteria 
voor het stellen van de diagnose Möbius syndroom. Recentelijk hebben wij, op 
grond van ons overzicht over de grootste serie persoonlijk onderzochte Möbius 
patiënten, de primaire criteria van het syndroom geherdefinieerd: congenitale 
niet progressieve parese van de nervus facialis en abductiezwakte van de ogen; 
Alhoewel, andere hersenzenuwen vaak aangedaan zijn en gelaatsafwijkingen en 
spier- en skeletdefecten regelmatig geassocieerd zijn, zijn deze kenmerken niet 
essentieel voor het stellen van de diagnose Möbius syndroom. Door inperking 
van de definitie, zoals door ons gedaan op basis van klinische waarnemingen, 
is de congenitale geïsoleerde parese van de nervus facialis buiten de definitie 
van Möbius syndroom komen te staan. Gaande het onderzoek zijn wij, op basis 
van neuropathologische bevindingen, tot het inzicht gekomen dat het Möbius 
syndroom en de congenitale nervus facialis parese twee verschillende entiteiten 
zijn en derhalve van elkaar gescheiden moeten worden. De congenitale nervus 
facialis parese is een ontwikkelingsdefect van de facialis motorneuronen 
alleen en het Möbius syndroom is een ontwikkelingsstoornis van het gehele 
rhombencephalon met betrokkenheid van de motore kernen en zenuwen en van 
de passerende lange banen.
Nederlandse samenvatting
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Deze nieuwe inzichten in de congenitale onderste hersenstamsyndromen 
leidden tot een conferentie waar de verschillen en overeenkomsten tussen de 
bovenste en onderste hersenstamsyndromen bediscussieerd werden. Ondanks 
het feit dat er onvoldoende klinisch en neuropathologisch bewijs was, werden 
de verschillende syndromen die vooral de motorische kernen in de hersenstam 
betreffen gecategoriseerd onder de titel ‘congenital cranial dysinnervation 
disorders’ (CCDDs). De CCDDs worden klinisch gekarakteriseerd door een 
abnormale motoriek van de ogen en de oogleden en/of door een gestoorde 
motoriek van de facialis spieren. Zo zijn er duidelijk herkenbare dezelfde 
aandoeningen van de bovenste motore hersenzenuwen, zoals congenitale 
fibrose van de extraoculaire spieren (CFEOM), congenitale ptosis (CP), Duane’s 
retraction syndroom (DURS) en horizontale blikverlamming met progressieve 
scoliose (HGPPS); die van de onderste motore hersenzenuwen zijn minder goed 
gekarakteriseerd en hiertoe behoren de congenitale nervus facialis parese en 
mogelijk het Möbius syndroom. Echter op grond van ons recente onderzoek 
waaruit blijkt dat het Möbius syndroom een regionale ontwikkelingsstoornis is 
van het onderste gedeelte van de hersenstam komt het Möbius syndroom strikt 
genomen buiten de definitie van de CCDDs te vallen.
Op basis van de huidige literatuur is er geen duidelijke uitspraak te doen over 
het voorkomen van mentale retardatie bij patiënten met het Möbius syndroom. 
Schattingen variëren tussen de 10 en 50%, en op basis van drie studies waarin 
onderzoek is gedaan naar de cognitieve functies in relatie tot Möbius syndroom 
varieert de incidentie van 33 tot 75%.  Aangezien wij in de omgang met onze 
patiënten niet de indruk kregen deze hoge percentages te kunnen bevestigen 
hebben we neuropsychologisch onderzoek verricht om de werkelijke incidentie 
van mentale retardatie bij Möbius patiënten te bepalen; mentale retardatie bleek 
bij Möbius patiënten niet meer voor te komen dan in de normale Nederlandse 
populatie. 
Zowel de etiologie als de pathogenese van het Möbius syndroom zijn 
onopgehelderd. Er bestaan twee hypothetische verklaringen voor de pathogenese: 
(i) een genetisch defect met als gevolg een ontwikkelingsstoornis van het 
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rhombencephalon, inclusief de facialis kern, resulterend in een stoornis in de 
innervatie van de facialis spieren, (ii) een verstoorde doorbloeding en daardoor 
ischemie van de hersenstam vroeg in de embryonale ontwikkeling, een en ander 
ten gevolge van toxische, mechanische of genetische factoren of een combinatie 
hiervan. Teratogene factoren zouden een belangrijke, mogelijk secundaire factor 
in beide mechanismen zijn. Ons onderzoek heeft ons tot op heden nog niet in 
staat gesteld om een gedegen grond voor een genetische oorsprong te vinden, 
en ook een vasculaire of toxische oorzaak voor gebeurtenissen die uiteindelijk 
tot het Möbius syndroom leiden staat nog steeds ter discussie. De gepostuleerde 
pathogenetische mechanismen zijn gebaseerd op beperkte pathologisch-
anatomische bevindingen bij een beperkt aantal Möbius patiënten, te weten (a) 
hypoplasie van de hersenzenuw kernen, (b) atrofie van de hersenzenuw kernen 
met degeneratieve afwijkingen veroorzaakt door degeneratie van de perifere 
zenuw, en (c) atrofie van de hersenzenuw kernen met degeneratieve afwijkingen 
in combinatie met focale necrose in de hersenstam. 
De niet-traumatische congenitale facialis parese erft frequent op een autosomaal 
dominante wijze en minder frequent op een autosomaal recessieve wijze over. 
Inmiddels hebben wij twee verschillende loci voor deze aandoening aangetoond 
waardoor genetische heterogeniteit een feit is.
Het Möbius syndroom, ofwel congenitale parese van de nervus facialis 
met abductiezwakte van de ogen, is een niet veel voorkomende aandoening 
die voornamelijk sporadisch voorkomt (4 per 189.000 nieuw geborenen in 
Nederland). Echter, in zeldzame gevallen zijn er ook families beschreven waarin 
het syndroom autosomaal dominant of recessief of X-gebonden recessief 
overerft, wat op zichzelf een aanwijzing is dat het Möbius syndroom een 
genetische oorsprong kan hebben. Deze aanwijzing wordt versterkt door een 
aantal cytogenetische afwijkingen die, in combinatie, nog eens twee verschillend 
chromosomale loci voor Möbius syndroom doen veronderstellen. 
De diagnose Möbius syndroom wordt gesteld op klinische gronden, veelal in de 
eerste levensjaren.  Aanvullende diagnostiek, te weten radiologisch en klinisch 
neurofysiologisch onderzoek, levert geen positieve diagnose op, echter in 
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sommige gevallen kan dit onderzoek, door uitsluiten van alternatieve diagnoses, 
de diagnose Möbius syndroom ondersteunen. 
In zijn meest ernstige vorm gaat de ziekte gepaard met ademhalingsin-
sufficiëntie waarvan de ernst in belangrijke mate de prognose bepaalt.  Als 
kinderen deze fase met ademhalingsproblemen doorstaan en eveneens geen 
belangrijke verslikproblemen hebben, is er geen reden aan te nemen dat hun 
levensverwachting anders is dan die van de rest van de Möbius populatie, een 
verwachting die, voor zover we nu denken, gelijk is aan die van de gezonde 
populatie.
Therapeutische opties voor het Möbius syndroom bestaan uit symptomatische 
behandeling van ademhalingsproblemen, zuig- en slikstoornissen, spraak- en 
articulatiestoornissen, oogstandafwijkingen en gelaat- en extremiteitdefecten en 
ook een “gestoorde” motoriek en/of een ontwikkelingsvertraging daarin kan met 
fysiotherapeutische behandeling verbeterd worden. Verder is het van belang dat 
erfelijkheidsadvisering aangeboden wordt.
Uiteenzetting van de dissertatie
Dit proefschrift beschrijft verschillende aspecten van het Möbius syndroom. Onze 
inzichten in het Möbius syndroom hebben zich gaande het onderzoek ontwikkeld 
en gewijzigd, een proces dat duidelijk wordt in een serie, in dit proefschrift 
opgenomen artikelen die op verschillende momenten gedurende de studie 
geschreven zijn.
Aangezien ik deze paragraaf schrijf met de huidige kennis over het syndroom 
zal ik proberen te reconstrueren hoe we tegen bepaalde vragen, zoals gesteld in 
elk artikel, aankeken op het moment dat we dat specifieke aspect van het Möbius 
syndroom onderzochten, en zal ik samenvatten wat onze huidige visie op het 
onderwerp is.
Wij vinden dat in het verleden de term Möbius syndroom dubbelzinnig is 
gebruikt. Het omvatte twee aandoeningen: ten eerste een autosomaal dominant 
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overervende aandoening welke het best als een congenitale nervus facialis parese 
beschreven kan worden, en ten tweede een aandoening welke voornamelijk 
sporadisch voorkomt en waarvoor wij de naam Möbius syndroom reserveren en 
welke wij zien als een ontwikkelingsstoornis van het onderste gedeelte van de 
hersenstam.
Deze studie werd in 1997 gestart met het doel het Möbius syndroom in meer 
detail en meer accuraat te definiëren om zo reproduceerbare fenotypes te 
beschrijven met als doel pathofysiologische studies mogelijk te maken en de 
genetische en zo mogelijk de moleculaire kenmerken van het Möbius syndroom 
op te helderen.
Bij aanvang van de studie kenden wij twee Nederlandse families met 
autosomaal dominant overervend Möbius syndroom. We namen aan dat deze 
families met een congenitale nervus facialis parese het milde uiteinde vormden 
van een aandoening die in zijn ernstigste vorm zich als een sporadische 
gebeurtenis zou manifesteren. De verwachting was dat met deze twee families 
het gen voor het Möbius syndroom kon worden gevonden, en dat vervolgens 
dit gen kon worden getest in sporadische patiënten met Möbius syndroom. 
De identificatie van het gen en de daarop volgende functionele studies zouden 
hopelijk bijdragen aan een beter begrip van de ontwikkelingsbiologie van de 
facialis motorneuronen en wellicht daarmee ook van de unieke fysiologische 
kenmerken van andere motore hersenzenuw kernen, wat ons opheldering zou 
kunnen geven over hun selectieve betrokkenheid in verschillende neurologische 
aandoeningen.
Wij begonnen met het koppelingsonderzoek in de tweede grote Nederlandse 
familie met een autosomaal dominant overervende congenitale parese van de 
nervus facialis (Hoofdstuk 3). Klinisch onderzoek van de twee families wees uit 
dat congenitale nervus facialis parese een betere naam was voor deze condities 
en dat deze aandoening duidelijk verschillend was van het Möbius syndroom. 
Koppelingsonderzoek in de eerste grote familie was reeds verricht en had een 
locus op chromosoom 3q21-25 aangetoond, een locus wat in de tweede familie 
kon worden uitgesloten. 
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Ondertussen spoorden wij sporadische patiënten met het Möbius syndroom 
op; na twee jaar waren er 37 Nederlandse Möbius patiënten bij ons bekend. 
Na uitgebreider klinisch onderzoek van de twee families en de sporadische 
patiënten bleek dat congenitale nervus facialis parese, een aandoening die duidelijk 
verschillend leek van Möbius syndroom, een veel geschiktere naam was voor de 
aandoening in de families, en dat het klinisch beeld van Möbius syndroom veel 
complexer was dan tot dan toe was aangenomen maar steeds gekenmerkt werd 
door het samen voorkomen van een congenitale parese van de nervus facialis 
en abductiezwakte van de ogen. We concludeerden dat onder de term Möbius 
syndroom een aantal variabele fenotypes die alle enige overlap in klinische 
kenmerken vertonen, te onderscheiden zijn. Gecombineerd klinisch, genetisch, 
radiologisch, pathologisch-anatomisch en elektrofysiologisch onderzoek zou 
meer inzicht kunnen verschaffen in de verschillende fenotypes en tevens in de 
pathogenese van het Möbius syndroom.
De klinische aspecten van onze 37 sporadische patiënten werden vastgesteld 
en vergeleken met de Möbius patiënten beschreven in de literatuur om zo 
meer helderheid te verschaffen over de klinische variabiliteit van het Möbius 
syndroom (Hoofdstuk 4). Klinische overeenkomsten en verschillen werden 
duidelijk en suggereerden een homogene aandoening welke divers is in de mate 
van betrokkenheid van de hersenstam en daardoor ook divers in ernst: (a) in 
de meerderheid van de patiënten zagen we een homogeen klinisch beeld dat 
gekenmerkt wordt door een parese van de facialis spieren, abductiezwakte van 
de ogen, hypoglossia, gelaats- en skeletdefecten en milde langebaansverschijnselen, 
(b) de verdeling van de facialis zwakte, bestaande uit een meer aangedaan zijn 
van de spieren in de bovenste gelaatshelft en een relatief gespaard zijn van de 
spieren in de onderste helft, lijkt karakteristiek te zijn voor Möbius syndroom, 
(c) in tegenstelling tot eerdere studies blijkt dat  de abductiezwakte slechts in 
een minderheid van de gevallen veroorzaakt wordt door een parese van de 
nervus abducens en veel vaker door een horizontale blik parese of een Duane 
syndroom en minder frequent door congenitale ﬁbrose van de extra-oculaire 
spieren, (d) in een klein gedeelte van de patiënten komt ademhalingsinsufﬁ-
ciëntie voor, (e) de beschreven hoge percentages mentale retardatie konden 
niet bevestigd worden. Kortom, we vonden dat het Möbius syndroom een 
215
Nederlandse samenvatting
complexe regionale ontwikkelingsstoornis van het gehele rhombencephalon is 
met voornamelijk betrokkenheid van de motore kernen en zenuwen, maar ook 
van de passerende lange banen, en tevens suggereerden we dat overlap met 
een ontwikkelingsstoornis van het mesencephalon vaker voorkomt dan eerder 
gedacht.
Aangezien we in de omgang met de patiënten gedurende het klinische onderzoek 
de indruk kregen dat we de hoge percentages mentale retardatie zoals in de 
literatuur genoemd niet zouden kunnen bevestigen, is nader neuropsychologisch 
onderzoek verricht. Bij 12 Möbius patienten werd de intelligentie, geheugen 
en aandacht onderzocht gebruik makend van een aantal gestandaardiseerde 
neuropsychologische testen (Hoofdstuk 5).
Als gevolg van het gebruik van verschillende criteria voor het Möbius syndroom 
in het verleden is de literatuur over het Möbius syndroom zeer heterogeen. 
Er is genoemd dat een congenitale parese van de nervus facialis voldoende is 
om tot de diagnose Möbius syndroom te komen, maar ook een uitgebreider 
fenotype bestaande uit een congenitale nervus facialis en nervus abducens 
parese al dan niet gepaard gaand met afwijkingen van andere hersenzenuwen, 
defecten van het skelet- en spierstelsel en dysmorﬁeën van het gelaat is als 
vereist voor de diagnose genoemd. In de klinische en genetische literatuur 
bestaat reeds lang de discussie of congenitale nervus facialis parese en Möbius 
syndroom dezelfde entiteiten zijn. Gebaseerd op onze eigen resultaten hebben 
we de primaire criteria voor het Möbius syndroom geherdeﬁnieerd: congenitale 
niet-progressieve parese van de nervus facialis met abductiezwakte van de ogen. 
Door deze hernieuwde deﬁnitie sluiten we congenitale nervus facialis parese 
uit van de diagnose Möbius syndroom en als zodanig stellen we dat congenitale 
nervus facialis parese en Möbius syndroom twee aparte entiteiten zijn. Om 
nieuwe argumenten aan te dragen voor deze hypothese wilden we meer inzicht 
verkrijgen in de pathologie van beide aandoeningen. Om deze rede hebben we de 
pathologische bevindingen van de hersenstam in drie leden van één familie met 
autosomaal dominant overervende congenitale nervus facialis parese en in één 
patiënt met Möbius syndroom in kaart gebracht (Hoofdstuk 6). 
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Op basis van de resultaten van het klinisch onderzoek van 37 sporadische 
Möbius patiënten suggereerden we dat het syndroom meer is dan een 
ontwikkelingsstoornis van de hersenzenuw kernen alleen en dat het gezien moet 
worden als een regionale ontwikkelingsstoornis van het gehele rhombencephalon 
met voornamelijk betrokkenheid van de motore kernen en zenuwen, maar ook 
van de passerende lange banen, waarbij in extreme gevallen het caudale deel van 
de hersenstam zo slecht ontwikkeld is dat ademhalingsproblemen optreden. Om 
bewijs aan te leveren voor dit nieuwe concept hebben we de MRI kenmerken van 
de hersenen bij zes Möbius patiënten bestudeerd (Hoofdstuk 7). 
 De bevinding dat de facialis zenuw bij alle onderzochte patiënten ontbrak 
was opmerkelijk vanwege de aanwezige restactiviteit in enkele facialis spieren 
met name in de onderste gelaatshelft waardoor de karakteristieke verdeling van 
facialis zwakte ontstaat. Deze radiologische bevinding suggereert dat een andere 
hersenzenuw op een aberrante wijze enkele facialis spieren in het onderste 
gedeelte van het gezicht innerveert. 
Om de wijze en mate van innervatie van de facialis spieren bij patiënten met 
het Möbius syndroom te onderzoeken en om te trachten het pathofysiologisch 
mechanisme op te helderen, hebben we elektrofysiologische studies uitgevoerd, te 
weten een blink reﬂex, een directe respons van de facialis zenuw en elektro- 
myograﬁe van de facialis spieren bij zes Möbius patiënten bij wie op de MRI 
de facialis zenuw ontbrak en nog bij vijf andere Möbius patiënten bij wie geen 
radiologisch onderzoek is verricht (Hoofdstuk 8).
In onze klinische studie observeerden we dat in meer dan 80% van de door ons 
onderzochte patiënten er sprake was van onhandigheid ofwel verminderde ﬁjne 
motore vaardigheden, slechte coördinatie en balansstoornissen. We opperden 
dat deze onhandigheid het gevolg is van een ontwikkelingsstoornis van de 
corticospinale banen of van de cortico-pontocerebellaire banen ter hoogte van 
de hersenstam. Om de oorsprong van de onhandigheid te bestuderen, verrichtten 
we elektrofysiologisch onderzoek met speciale aandacht voor de lange motore 
en sensibele banen en voor de perifere zenuwen van de extremiteiten in zeven 
Möbius patiënten met onhandigheid (Hoofdstuk 9).
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Deze dissertatie behelst de resultaten van klinisch, genetisch, neuropathologisch, 
radiologisch en elektrofysiologisch onderzoek bij het Möbius syndroom. Na de 
algemene inleiding en review over de aandoening Möbius syndroom in Hoofd- 
stuk 1 volgt de uiteenzetting van het onderzoek en het beloop daarvan in 
Hoofdstuk 2.
De volgende hoofdstukken ontwikkelden zich langs twee lijnen:
1. Gaande het onderzoek werd op basis van klinische en pathologische 
bevindingen duidelijk dat het Möbius syndroom en congenitale nervus facialis 
parese twee verschillende entiteiten zijn. Ook genetisch leken de aandoeningen 
niet identiek te zijn.
2. Uiteindelijk waren we niet in staat om een bewijs te leveren voor een 
genetische oorspong van het Möbius syndroom. Derhalve, behoort een 
vasculaire of toxische oorzaak nog steeds tot de mogelijkheden.
In Hoofdstuk 3 werd het koppelingsonderzoek beschreven dat in de tweede 
grote Nederlandse familie met autosomaal dominant overervende congenitale 
nervus facialis parese werd uitgevoerd. 
Na exclusie van meer dan 90% van het genoom, lokaliseerden wij het gen dat 
betrokken is in deze familie op chromosoom 10q21.3-22.1. Met deze bevinding 
toonden wij genetische heterogeniteit voor autosomaal dominant overervende 
aangeboren aangezichtsverlamming aan, omdat we eerder een locus voor deze 
aandoening beschreven op chromosoom 3q21-22.
In hoofdstuk 4, werden de klinische karakteristieken van het Möbius syndroom, 
gedeﬁnieerd als een congenitale nervus facialis parese met abductiezwakte van 
de ogen, bij 37 Nederlandse patiënten van verschillende leeftijd in kaart gebracht. 
Het doel was om meer inzicht te verkrijgen in het zeer variabele klinisch beeld 
dat in de literatuur van Möbius syndroom bestond en hiermee in de pathogenese 
van de aandoening. 
Van 37 patiënten met een nervus facialis parese had 97% beiderzijds en 3% 
enkelzijdig een abductiezwakte van de ogen. Verdere analyse demonstreerde 
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een geïsoleerde nervus abducens parese in 9%, een geconjugeerde horizontale 
blikparese in 48%, kenmerken van het Duane syndroom in 34% en congenitale 
ﬁbrose van de extraoculaire spieren in 9%. In 77% van de patiënten was de tong 
aangedaan en in 56% van hen was er sprake van een disfunctie van het palatum 
en de pharynx. Een gestoorde motoriek van romp en extremiteiten was aanwezig 
bij 88%, een slechte coördinatie bij 83%, en ademhalingsinsufﬁciëntie bij 19% van 
de patiënten. We konden niet het hoge percentage mentale retardatie zoals in de 
literatuur beschreven is, bevestigen. 
We hebben als de primaire criteria voor het Möbius syndroom congenitale 
nervus facialis parese met abductiezwakte van de ogen geherdeﬁnieerd. Hiermee 
hebben we de deﬁnitie van het syndroom ingeperkt en als zodanig hebben we 
op klinische gronden gesteld dat congenitale parese van de nervus facialis een 
aparte entiteit is. Door deze beperkingen hebben we een homogeen klinisch 
beeld van het Möbius syndroom verkregen dat steeds nog wel divers is zowel 
in de mate van betrokkenheid van hersenstamstructuren als wel in de ernst van 
betrokkenheid.
Gebaseerd op bovenstaande klinische bevindingen, concludeerden wij dat het 
Möbius syndroom meer is dan een ontwikkelingsstoornis van een hersenzenuw 
of kern en dat het een complexe regionale ontwikkelingsstoornis van het 
rhombencephalon is met voornamelijk betrokkenheid van de motore kernen en 
zenuwen, maar ook van de passerende lange banen.
In hoofdstuk 5, werd het voorkomen van mentale retardatie in een groep van 
12 Nederlandse patiënten met het Möbius syndroom bestudeerd en hebben 
we aanvullend, in het geval dat globale mentale retardatie afwezig was, enkele 
aspecten van geheugen en aandacht onderzocht om zo mogelijke pervasieve 
disfunctie in deze cognitieve domeinen op te sporen.
Om het mogelijk te maken dat alle patiënten met een identieke reeks 
gestandaardiseerde testen onderzocht konden worden, werden alleen patiënten 
van 17 jaar of ouder geïncludeerd in de studie. 
Wij stelden vast dat het voorkomen van mentale retardatie in de door ons 
onderzochte groep van 12 Möbius patiënten niet afwijkt van dat bij de normale 
Nederlandse bevolking. In de groep schoolgaande kinderen die jonger waren 
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dan 17 jaar leek er op grond van schoolprestaties evenmin aanwijzingen te 
bestaan voor een verhoogd voorkomen van mentale retardatie. In de totale 
groep van 37 waren er twee personen (5.4%) mentaal geretardeerd.  Aangezien 
mentale retardatie gedeﬁnieerd wordt als een IQ ≤ 75, toonden we aan dat 
mentale retardatie bij Möbius patiënten niet vaker voorkomt dan in de normale 
Nederlandse populatie. 
De twee mentaal geretardeerde patiënten waren tevens autistisch, wat 
suggereert dat er eerder een associatie bestaat tussen mentale retardatie en 
autisme dan tussen mentale retardatie en het Möbius syndroom. We waren niet 
in staat de sterke associatie tussen autisme en Möbius syndroom zoals die in de 
literatuur gesuggereerd is te bevestigen. 
Verder, alhoewel we zeer specifieke en subtiele afwijkingen niet konden 
uitsluiten, vonden we geen duidelijke aanwijzingen voor een dysfunctie van 
aandacht of geheugen in onze groep niet mentaal geretardeerde Möbius patiënten. 
In Hoofdstuk 6, verrichtten wij een neuropathologische studie van de 
hersenstam in drie leden van één familie met autosomaal dominant overervende 
congenitale nervus facialis parese, en vergeleken deze bevindingen met die van 
patiënten met het Möbius syndroom. Het doel was de neuropathologie van 
erfelijke congenitale nervus facialis parese te karakteriseren en om argumenten te 
verzamelen voor onze, op klinische gronden gebaseerde, hypothese dat erfelijke 
congenitale nervus facialis parese en het Möbius syndroom twee verschillende 
entiteiten zijn. 
Bij de patiënten met congenitale nervus facialis parese, zagen wij een 
duidelijke afname in het aantal neuronen in de motore facialis kern met 
hiermee corresponderend geringe resten van de facialis zenuw. Er waren geen 
tekenen van neuronale degeneratie of necrose met neuronen verlies, gliose of 
verkalkingen.  Andere afwijkingen van het rhombencephalon en van de daaraan 
geassocieerde structuren ontbraken. In contrast hiermee, maakte het Möbius 
syndroom deel uit van een meer complexe congenitale afwijking van de fossa 
posterior met hypoplasia van de gehele hersenstam, inclusief de passerende lange 
banen, met daarnaast tekenen van neuronale degeneratie en andere congenitale 
hersenafwijkingen.
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Deze pathologische studie steunt onze klinische observatie dat de erfelijke 
congenitale nervus facialis parese en het Möbius syndroom twee verschillende 
entiteiten zijn met een verschillende pathogenese. 
We stelden vast dat de congenitale nervus facialis parese in onze familie 
en in sommige gevallen in sporadische patiënten, het gevolg is van dysgenesie 
van de facialis kern, waarschijnlijk met een primair genetische oorzaak. 
Bovendien suggereerden we dat eenzelfde mechanisme betrokken is in sommige 
gevallen van Möbius syndroom; echter, bij het Möbius syndroom wordt een 
ontwikkelingsdefect van de gehele lage hersenstam verondersteld.
In Hoofdstuk 7, werden de MRI afwijkingen in zes patiënten met het Möbius 
syndroom beschreven.
De MRI’s toonden een hypoplasie van de hersenstam aan en tevens 
de aanwezigheid van andere congenitale cerebrale ontwikkelingsdefecten. 
Deze bevindingen steunden onze hypothese dat het Möbius syndroom een 
ontwikkelingsstoornis van de gehele lagere hersenstam is eerder dan een 
aanlegstoornis van enkel de hersenzenuwkernen, en suggereerden tevens dat het 
Möbius syndroom, in sommige gevallen, onderdeel is van een meer complexe 
congenitale afwijking van de fossa posterior. Deze radiologische bevindingen 
suggereerden dat het Möbius syndroom een ontwikkelingsstoornis van het 
rhombencepahalon is met een breed spectrum van aangedane structuren met een 
variabele ernst. 
Bij geen van de patiënten konden we de facialis zenuw aantonen. Deze 
bevinding was opmerkelijk aangezien er in de meerderheid van de patiënten 
motore rest activiteit in de facialis spieren in de onderste gelaatshelft 
aanwezig was wat in overeenstemming is met de voor het Möbius syndroom 
karakteristieke verdeling van de facialis zwakte waarbij de spieren in de bovenste 
gelaatshelft meer aangedaan zijn en de spieren in de onderste helft relatief 
gespaard zijn. Tezamen suggereerde dit dat andere hersenzenuwen, mogelijk de 
trigeminus, glossopharyngeus, vagus of hypoglossus zenuw, op een aberrante 
wijze enkele van de facialis spieren in de onderste gelaatshelft innerveren; 
het mechanisme van reïnnervatie is waarschijnlijk gelijk aan dat in het Duane 
syndroom.
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In Hoofdstuk 8, hebben wij een gestandaardiseerde blink reﬂex, een directe 
respons van de nervus facialis en elektromyograﬁe van facialis spieren bij elf 
Möbius patiënten uitgevoerd. Het doel was de wijze en mate van innervatie van 
de facialis spieren in Möbius syndroom te bestuderen en het pathofysiologisch 
mechanisme van het syndroom op te helderen.
Bij dit elektrofysiologisch onderzoek vonden wij een spectrum van afwijkingen. 
Aan het ene einde bevinden zich patiënten met compleet bewegingsloze gezichten 
bij wie bij elektrofysiologisch onderzoek geen aanwijzingen gevonden werden 
voor een dysfunctie van de facialis kern, zenuw of spieren, wat een defect op 
supranucleair niveau suggereert.  Aan het andere uiterste van het spectrum 
bevinden zich patiënten met afwezige responsies bij poging tot stimulatie van de 
facialis zenuw en het ontbreken van motor unit activiteit, wat op zijn minst een 
indicatie is voor een defect op nucleair niveau.
Deze bevindingen steunden opnieuw het concept dat het Möbius syndroom 
een aandoening is bestaande uit en complex regionale ontwikkelingsstoornis van 
de hersenstam.
Terwijl een supranucleair defect in overeenstemming is met het concept dat 
het Möbius syndroom het gevolg is van een ontwikkelingsstoornis van de lage 
hersenstam, is een intacte facialis kern als onderdeel van het Möbius syndroom 
niet eerder in overwegingen meegenomen.
Aangezien wij een respons kregen in de faciale musculatuur bij elektrofysio- 
logisch stimuleren in de regio van de nervus facialis onder het oor bij drie 
patiënten, bij wie de facialis zenuw op MRI afwezig was, hebben we een mogelijke 
ondersteuning voor onze hypothese van een aberrante innervatie van de 
facialis spieren. Mogelijkerwijze is er proximaal van de plaats van stimulatie een 
anastomose tussen het distale gedeelte van de facialis zenuw en de trigeminus, 
glossopharyngeus, vagus of hypoglossus zenuw.
In Hoofdstuk 9, verrichtten wij elektrofysiologisch onderzoek met speciale 
aandacht voor de lange motore en sensibele banen en voor de perifere zenuwen 
van de extremiteiten bij zeven Möbius patiënten met onhandigheid. Dit onderzoek 
werd verricht om de oorsprong van dit symptoom dat in meer dan 80% van 
de Möbius patiënten aanwezig is, te bestuderen. Onhandigheid, gedeﬁnieerd als 
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een verminderde ﬁjne motoriek, een slechte coördinatie en balansstoornissen, 
zou het functionele resultaat kunnen zijn van hypoplasie ofwel van een 
ontwikkelingsstoornis van de lange motore banen.
Aangezien eerdere BAEP studies bij patiënten met het Möbius syndroom 
een pontine laesie op een supranucleair niveau in de hersenstam aantoonden, 
suggereerden wij dat de laesie van de lange banen in onze patiënten gelokaliseerd 
kan worden op het niveau van de hersenstam. Een belangrijk punt is dat bewijs 
voor een supranucleaire laesie in de hersenstam een duidelijke indicatie is voor 
een meer algemene betrokkenheid van het rhombencephalon dan hersenzenuw 
kernen alleen. In ons recent pathologisch en radiologisch onderzoek, hebben we 
als ondersteuning voor deze hypothese hypoplasie van de hersenstam gevonden. 
Elektrofysiologisch konden wij echter geen bewijs leveren voor betrokkenheid 
van de lange motore of sensibele banen of het perifere zenuw systeem bij Möbius 
patiënten met onhandigheid. Echter, de normale MEP en SSEP studies kunnen 
worden verklaard door het feit dat alleen de conductietijd van de snelste vezels 
wordt gemeten. Daarom, gebaseerd op normale evoked potential studies bij onze 
Möbius patienten, kan een afname in omvang van de passerende lange banen op 
het niveau van de pons niet uitgesloten worden.
Hypoplasie van de corticospinale banen op het niveau van de hersenstam 
kan nog steeds een belangrijke factor zijn in het veroorzaken van onhandigheid 
in het Möbius syndroom; ook hypoplasie van het cerebellum of van de cortico-
pontocerebellaire banen, wat niet een weinig voorkomende neuroradiologische 
bevinding is, zouden van betekenis kunnen zijn voor dit fenomeen.
In Hoofdstuk 10 wordt een samenvatting van het gehele onderzoek gegeven en 
tevens worden onze conclusies geformuleerd, te weten:
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Conclusies
1. De algemene conclusie van deze studie is dat de Möbius conditie zoals die 
tot nu toe in de literatuur gedeﬁnieerd wordt bestaat uit twee verschillende 
aandoeningen:
 Ten eerste, een erfelijke congenitale nervus facialis parese, die autosomaal 
dominant overerft, en ten tweede, het Möbius syndroom dat voornamelijk 
sporadisch voorkomt en klinisch gedeﬁnieerd kan worden volgens minimale 
criteria (zie 2.); beide aandoeningen hebben waarschijnlijk een verschillend 
pathogenetisch mechanisme.
Deze conclusie is gebaseerd op de volgende klinische, genetische en 
pathologische bevindingen:
a) De erfelijke congenitale nervus facialis parese wordt klinisch gekarakteriseerd 
door een geïsoleerde nervus facialis parese, met in sommige gevallen 
doofheid. Hier tegenover staan de minimale criteria voor het Möbius 
syndroom, te weten een congenitale nervus facialis parese en abductie 
zwakte van de ogen; hiermee zijn ook andere congenitale afwijkingen 
geassocieerd (zie 2.), deze ontbreken bij de erfelijke congenitale nervus 
facialis parese.
b) De genetische loci voor erfelijke congenitale nervus facialis parese zijn 
uitgesloten als een belangrijke oorzaak voor het ontstaan van het Möbius 
syndroom.
c) De neuropathologische bevindingen bij patiënten met een erfelijke 
congenitale nervus facialis parese bestaan uit een hypoplasie van de facialis 
motorneuronen welke het gevolg is van een ontwikkelingsstoornis van de 
hersenzenuwkernen met een primaire genetische oorzaak. Daarentegen is bij 
patiënten met het Möbius syndroom sprake van een hypoplasie van de gehele 
hersenstam met tekenen van neuronale degeneratie en de aanwezigheid van 
andere congenitale hersenafwijkingen. Eenzelfde ontwikkelingsmechanisme als 
voor de erfelijke congenitale nervus facialis parese kan gepostuleerd worden, 
echter in het geval van het Möbius syndroom wordt een ontwikkelingsdefect 
van de gehele lage hersenstam verondersteld.
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2. De minimale criteria voor Möbius syndroom zijn:
Een congenitale nervus facialis parese en abductie zwakte van de ogen. 
Ondanks het feit dat andere hersenzenuwen vaak zijn aangedaan en 
gelaatsdysmorﬁeën en spier- en skeletdefecten frequent geassocieerd zijn, zijn 
deze kenmerken niet essentieel voor het stellen van de diagnose.
3. Wij postuleren een nieuw concept voor het Möbius syndroom zoals door ons 
is geherdeﬁnieerd (zie 2.): 
Het Möbius syndroom is een ontwikkelingsstoornis van het gehele 
rhombencephalon met voornamelijk betrokkenheid van de motore kernen en 
zenuwen maar ook van de passerende lange banen, en niet van de hersenzenuw 
kernen alleen. Er is sprake van een klinisch spectrum met in de ernstigste 
vorm een dusdanige stamdysfunktie dat er naast multipele congenitale 
hersendefecten geen sufﬁciënte spontane ademhaling mogelijk is, en aan de 
andere kant de minst ernstige vorm gekenmerkt door de minimale criteria 
bestaande uit een zwakte van de facialis spieren en de abductie van de ogen. 
Verder komt overlap met andere hersenstamsyndromen vaker voor dan eerder 
gedacht.
Dit concept is gebaseerd op de volgende klinische, pathologische, radiologische 
en elektrofysiologische conclusies:
a) De verdeling van de zwakte van de facialis spieren, bestaande uit een meer 
aangedaan zijn van de spieren in de bovenste gelaatshelft en een relatief 
gespaard zijn van de spieren in de onderste helft, lijkt karakteristiek te 
zijn voor Möbius syndroom. Ons onderzoek suggereert dat een andere 
hersenzenuw, de nervus trigeminus, glossopharyngeus of hypoglossus, de 
spieren in de onderste gelaatshelft op een aberrante wijze innerveert. 
b) De abductiezwakte van de ogen wordt slechts in een minderheid van de 
gevallen veroorzaakt door een parese van de nervus abducens en in een 
meerderheid van de gevallen door een horizontale blik parese en het 
Duane syndroom, wat suggereert dat meer dan alleen de nervus abducens 
kern is aangedaan. Minder frequent zien we een congenitale ﬁbrose van de 
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extra-oculaire spieren. Hieruit blijkt dat een gelijktijdig voorkomen van een 
ontwikkelingsstoornis van het mesencephalon frequenter voorkomt dan 
eerder aangenomen.
c) Onhandigheid, gekenmerkt door gebrek aan ﬁjne motore vaardigheden, 
slechte coördinatie en balansstoornissen, komt vaak voor bij Möbius 
patiënten. We denken dat dit het gevolg is van een ontwikkelingsstoornis 
van de corticospinale of corticoponto-cerebellaire banen op het niveau van 
de hersenstam.
d) In een minderheid van de patiënten komt ademhalingsinsufﬁciëntie voor wat 
het concept dat het onderste gedeelte van de hersenstam slecht ontwikkeld 
is, ondersteunt.
e) De neuropathologische bevindingen bij patiënten met het Möbius syndroom 
bestaan uit een hypoplasie van de gehele hersenstam, inclusief de in de 
hersenstam passerende lange banen, met tekenen van neuronale degeneratie 
en de aanwezigheid van andere congenitale hersenafwijkingen. Deze 
bevindingen passen eerder bij een meer complexe congenitale afwijking van 
de fossa posterior dan bij een aanlegstoornis van hersenzenuwkernen alleen.
f) Hypoplasie van de hersenstam en de aanwezigheid van andere cerebrale 
ontwikkelingsafwijkingen op de MRI ondersteunen het feit dat het Möbius 
syndroom een ontwikkelingsstoornis is van het gehele rhombencephalon 
met een variabel spectrum van betrokken structuren uiteenlopend in ernst 
van het klinisch beeld, en niet meer zozeer een ontwikkelingsstoornis is van 
enkel de hersenzenuwkernen.
g) Door middel van elektrofysiologisch onderzoek, te weten de blinkreﬂex, 
directe respons van de nervus facialis en electromyograﬁe van de facialis 
spieren, toonden we een spectrum van afwijkingen aan, welke varieerde in 
uitgebreidheid van de aangedane structuren en in ernst, op supranucleair 
en nucleair niveau, hetgeen het concept van het Möbius syndroom als een 
complex regionaal ontwikkelingsstoornis van de hersenstam ondersteunt.
h) Alhoewel BAEP studies demonstreren dat een pontine afwijking op 
supranucleair niveau onderdeel is van het Möbius syndroom, konden wij 
met behulp van MEPs en SSEPs geen bewijs leveren voor betrokkenheid van 
de langs de hersenstam passerende banen. Echter, normale MEP en SSEP 
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resultaten sluiten een reductie van de lange banen op hersenstam niveau 
niet uit.
4. Op basis van het neuropsychologisch onderzoek concluderen we dat mentale 
retardatie bij het Möbius syndroom niet méér voorkomt dan in de normale 
Nederlandse bevolking. Verder constateerden wij een associatie tussen 
mentale retardatie en autisme; dientengevolge waren we niet in staat de 
sterke associatie tussen autisme en Möbius syndroom, zoals in de literatuur 
gesuggereerd wordt, te bevestigen.
5. De pathologische bevindingen bij patiënten met een erfelijke congenitale 
nervus facialis parese bevestigen het concept van de hersenstam pathogenese 
in CCDDs welke bestaat uit een congenitaal ontwikkelingsdefect van een of 
meer hersenzenuwen en/of -kernen. Zowel neuropathologische als genetische 
studies suggereren dat op zijn minst een gedeelte van deze aandoeningen 
het gevolg is van verschillende, maar analoge ontwikkelingsstoornissen 
van motorneuronen in de hersenstam. Eerder werd ook het Möbius 
syndroom gecategoriseerd in de groep van de CCDDs. Echter, ons huidige 
onderzoek maakt duidelijk dat het Möbius syndroom een complex regionale 
ontwikkelingsstoornis is van het hele rhombencephalon inclusief de motore 
hersenzenuwkernen en zenuwen, de passerende lange banen en, in ernstige 
gevallen, het caudale deel van de hersenstam, zodat een andere pathogenese 
waarschijnlijk is en het tot de conclusie leidt dat het Möbius syndroom strikt 
genomen buiten de deﬁnitie van de CCDDs valt.
Toekomstig onderzoek
De herdeﬁniëring van het Möbius syndroom en de identiﬁcatie van de 
onderliggende ziektegenen kan artsen steunen bij hun evaluatie van Möbius 
patiënten om zo tot meer reproduceerbare fenotypes te komen waardoor 
pathofysiologische studies mogelijk gemaakt worden, wat hopelijk zal bijdragen 
aan ons begrip van de ‘signaling cascade’ welke vereist is voor de ontwikkeling van 
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een normaal motorneuron. 
Om de kennis over de genetische defecten welke betrokken zijn bij de erfelijke 
congenitale parese van de nervus facialis te vergroten, zal identiﬁcatie van de 
verschillende genen in onze twee Nederlandse families en tevens in andere 
families met FNP behulpzaam zijn. Vervolgens zou het interessant zijn om deze 
genen te testen bij sporadische patiënten met het Möbius syndroom.
De identiﬁcatie van de FNP genen als ook de daarop volgende functionele studies 
door bijvoorbeeld een muizenmodel voor het FNP gen te maken, zal ons helpen 
de ontwikkelingsbiologie van de facialis kern en/of zenuw te bestuderen en zal 
mogelijk basis bieden voor therapeutische studies.
Het bestuderen van de ‘pathways’ voor de ontwikkeling van de facialis zenuw 
en de interferentie van deze ‘pathways’ met die van de ontwikkeling van de 
hersenstam is een andere benadering die ons zou kunnen helpen de biologie van 
‘axon guidance’, cel migratie en hersenstamsegmentatie te begrijpen. Ook de 
analyse van het effect van omgevingsfactoren op deze ‘pathways’ is van belang.
Toekomstige studies naar de CCDD’s zou moeten leiden tot een beter begrip van 
de pathofysiologische kenmerken van de hersenzenuwkernen en zou ons kunnen 
helpen hun selectieve betrokkenheid in verschillende neurologische aandoeningen 
en hun behandeling te begrijpen.
Zowel het zenuwstelsel als het vasculaire systeem gebruiken gemeenschappelijke 
‘pathways’ welke links zouden kunnen vormen tussen de vasculaire biologie 
en de neurobiologie in het Möbius syndroom. Deze geïntegreerde visie op 
de ontwikkeling van zenuwen en bloedvaten zou nieuwe inzichten in het 
ontstaansmechanisme en therapeutische mogelijkheden kunnen verschaffen. 
Om het concept van de aberrante innervatie van de facialis spieren in het Möbius 
syndroom verder op te helderen zijn elektrofysiologische vervolg studies vereist, 
met name bij de patiënten bij wie de facialis zenuwen, ondanks het ontbreken van 
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deze zenuwen op de MRI, konden worden gestimuleerd. 
Het tijdstip van reïnnervatie moet worden bepaald en factoren die zorgen voor 
het behoud van de facialis spieren bij het ontbreken van innervatie moeten 
worden vastgesteld, met als doel strategieën te ontwikkelen voor de behandeling 
van facialis zwakte door biologische factoren, teneinde een maximaal resultaat bij 
verschillende fysiologische mechanismen te behalen.
Bij patiënten met compleet bewegingsloze gezichten bij wie bij elektrofysiologisch 
onderzoek geen afwijkingen duidend op betrokkenheid van de facialis kernen, -
zenuwen of -spieren gevonden werden, hetgeen een laesie op supranucleair niveau 
verondersteld, moet feedback training worden getest om de therapeutische opties 
voor het Möbius syndroom verder te beschrijven.
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Het schrijven van een dankwoord is als een Spiegel der zelfgenoegzaamheid; het 
laat je zonder weerga beseffen dat een proefschrift en promotie niet tot stand kan 
komen zonder de assistentie van velen om je heen. Zonder iemand te kort te wil-
len doen, wil ik de belangrijksten noemen.
Allereerst dank ik mijn promotor, hooggeleerde heer George Padberg. Hij stelde 
in het prille begin van mijn artsenbestaan het vertrouwen in mij om aan weten-
schappelijk onderzoek te beginnen. Gedurende alle jaren is professor Padberg 
een grote inspirator geweest zowel bij de eerste stappen in het vakgebied als bij 
het opzetten en afronden van dit ‘project’. Hij heeft als geen ander de artikelen 
en daarmee mijn gedachten bijgeslepen tot uiteindelijk publicatie mogelijk was. 
Zijn oneindige wetenschappelijke kwaliteiten, gecombineerd met zijn kunde om 
met weinig woorden tot groots resultaat te komen, zijn onmisbaar gebleken bij 
de totstandkoming van het uiteindelijke manuscript. Tenslotte heeft hij mij geen 
strobreed in de weg gelegd bij het ontdekken van de wereld in het kader van mijn 
wetenschappelijk onderzoek.
Geen enkel artikel kon gepubliceerd worden zonder wetenschappelijke ﬁjnproe-
verij van de coauteurs, zonder wie de ﬁnesse, balans, juiste kaders en interpretatie 
van de bevindingen niet tot stand kon komen. Dank hiervoor. Vergun mij om één 
coauteur er uit te lichten, hooggeleerde heer Machiel Zwarts, wiens positivisme 
mijn zelfvertrouwen in de promotie deed groeien.
Gedurende mijn jaren op de afdeling Neurologie van het Universitair Medisch 
Centrum St. Radboud wist ik mij omringd door een aantal fantastische collega’s 
met wie alle perikelen die samengaan met het onderzoek gedeeld mochten wor-
den. Ik noem Janneke, Pieter, Elly, Daniëlle, Gerald, Jasper, Mariëlle, Carla, Lucille en 
Bart, en wens hen tevens vanaf deze plaats alle sterkte toe met hun respectieve-
lijke werk, onderzoek en promoties.
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Chapter 12
Alle patiënten met het Möbius syndroom en alle patiënten met een congenitale 
facialis parese die de aanleiding en mogelijkheden voor dit proefschrift gegeven 
hebben, heel veel dank voor jullie grote bereidwilligheid mee te werken aan de 
verschillende onderzoeken. Zonder patiënten, geen proefschrift!
De Nederlandse Möbius vereniging dank ik heel hartelijk voor de geboden moge-
lijkheid een grotere patiëntenpopulatie te bereiken.
Promoveren als proeve van wetenschappelijke bekwaamheid is de enge deﬁni-
tie, ruimer en kleurrijker gesteld is promoveren het feest der wetenschappelijke 
proeve. Wat is het bijzonder zich gesteund te weten, niet alleen vandaag maar al 
die jaren her, door mijn paranimfen Elly van der Kooi en Reinout van Crevel. Ik 
ben hen beiden bijzondere dank verschuldigd voor alle steun en toeverlaat. Elly, 
aan jou heb ik altijd veel gehad, meer dan dat je denkt. Reinout, onze wedijver bij 
het verkrijgen van de NWO subsidiëring is uitgegroeid tot een voor mij dierbare 
vriendschap. 
Mijn promotie ligt als tastbaar bewijs thans in Uw handen. Ik ben veel dank ver-
schuldigd aan mijn lieve Oom Joop, die het mogelijk heeft gemaakt U dit leesbaar 
te presenteren in een kleurrijke uitvoering. 
De artikelen vormen de kern van dit proefschrift. Leesbare artikelen, wel te 
verstaan. Het is pappie geweest die in den beginne onvermoeid eindeloze epistels 
las en mij voorzag van linguïstieke ondersteuning tot in punten en komma’s. Zijn 
begripsvermogen als leidend criterium is onmisbaar gebleken U mijn inzicht te 
verschaffen.
Is promoveren moeilijk? Nee, wel vraagt het doorzettingsvermogen en geduld. 
Mijn lieve ouders hebben mij gezegend met deze gaven.  Aan hen is deze disserta-
tie opgedragen, als blijk van mijn dank voor het grenzeloze vertrouwen wat zij in 
mij gesteld hebben. Zij gaven mij, soms met een enkel gebaar of woord, de steun 
en kracht om door te gaan, genoten mee van mijn lach en troostten mijn traan 
tijdens mijn tegenslagen. Lieve mammie en pappie, ik dank U beiden vanuit heel 
mijn hart. 
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In ﬁne, mijn man. Het was sinds ik Daan heb leren kennen mijn wens getrouwd te 
promoveren, en dat is heden gelukt! Daan heeft mij de liefde en steun gegeven die 
nodig waren om mij door de laatste loten van de promotie heen te loodsen. Zijn 
vertrouwen in mij is onbeperkt. Lieve Daan, dank je wel.
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Harriëtte Verzijl werd geboren op 11 juni 1969 te Roermond. In 1987 behaalde 
zij haar eindexamen Gymnasium-betha aan het Mgr. Zwijsen College te Veghel. Na 
te zijn uitgeloot voor de studie Geneeskunde startte zij in 1987 met de studie 
Tandheelkunde aan de Katholieke Universiteit Nijmegen, welke in 1988 met het 
behalen van het propadeutisch examen werd afgesloten. In 1988 ving zij aan met 
de opleiding Geneeskunde aan de Katholieke Universiteit Nijmegen. In novem-
ber 1992 legde zij het doctoraal examen met succes af. In 1993 verbleef zij in het 
kader van een buitenlandse student-stage in San Lazaro Hospital en Santo Tomas 
University Hospital in Manilla, de Filippijnen. In 1994 volbracht zij een wetenschap-
pelijk stage op de afdeling Neurologie aan het Universitair Medisch Centrum St. 
Radboud te Nijmegen. Na het behalen van haar artsexamen in oktober 1995 was 
zij van december 1995 tot en met december 1996 werkzaam als AGNIO op de 
afdeling neurologie in het Universitair Medisch Centrum St. Radboud te Nijmegen. 
Vanaf januari 1997 is zij, in dit zelfde ziekenhuis in opleiding tot neuroloog (op-
leiders: prof.dr. G.W.A.M. Padberg en prof. dr. M.J. Zwarts). Vanaf 1997 heeft zij in 
het kader van een NWO-stipendium haar opleiding gecombineerd met promo-
tieonderzoek met als onderwerp het Möbius syndroom. Per 1 januari 2005 is zij 
geregistreerd als neuroloog. 
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Toen ons gevraagd werd de omslag te ontwerpen voor dit proefschrift; ‘Möbius 
syndrome.  A clinical, radiological, neurophysiological, genetic and neuropathologi-
cal study’, hadden wij nog nooit van Möbius syndrome gehoord. Zoals Harriëtte 
ons vertelde, hebben mensen die dit syndrome hebben geen gezichtsuitdrukking, 
althans niet voor de aanschouwer. In het hoofd van de persoon speelt zich een 
hoop af qua uitdrukkingen maar aan de buitenkant kunnen wij dit niet waarnemen.
Bovenstaande heeft Dapper vormgevers visueel in een vorm willen gieten. Op de 
omslag zie je het ‘uitdrukkingsloze’ gezicht van een vrouw. In haar hoofd speelt 
zich van alles af. Dit is weergegeven door hele duidelijke speciﬁeke uitdrukkingen 
achter haar gezicht te plaatsten. Haar belevingswereld verschilt enorm van haar 
daadwerkelijke uitdrukking. Om dit te benadrukken zie je het ‘uitdrukkingloze’ 
gezicht pas als je een tweede keer kijkt. Niet alles is altijd wat het lijkt.
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